headline,link,date_str,parsed_date_iso,sentiment_score
"Breakthrough pill for expectant mothers granted patent, provides rapid relief from nausea",https://www.financialexpress.com/business/healthcare-breakthrough-pill-for-expectant-mothers-granted-patent-provides-rapid-relief-from-nausea-3833232/,2025-05-05T17:43:03+05:30,2025-05-05T12:13:03,0.6249
Q3FY25: Alembic Pharma’s profit dips 23.29 percent to Rs 138.42 crore,https://www.financialexpress.com/business/healthcare-q3fy25-alembic-pharmas-profit-dips-23-29-percent-to-rs-13842-crore-3736421/,2025-02-03T15:50:36+05:30,2025-02-03T10:20:36,0.4404
USFDA gives nod to Alembic Pharma’s anti-epileptic drug,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-anti-epileptic-drug-3696359/,2024-12-20T14:13:49+05:30,2024-12-20T08:43:49,0.0
USFDA gives nod to Alembic Pharma’s generic formulation to treat itchy eyes,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-generic-formulation-to-treat-itchy-eyes-2-3683904/,2024-12-04T13:47:12+05:30,2024-12-04T08:17:12,0.1531
USFDA gives nod to Alembic Pharma for its generic formulation to treat hypertension,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharma-for-its-generic-formulation-to-treat-hypertension-3661864/,2024-11-11T13:08:32+05:30,2024-11-11T07:38:32,0.4019
USFDA gives nod to Alembic Pharma’s generic formulation to treat heart disorder,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-generic-formulation-to-treat-heart-disorder-3645359/,2024-10-21T11:25:30+05:30,2024-10-21T05:55:30,0.0
USFDA gives nod to Alembic Pharma’s generic formulation to treat itchy eyes,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-generic-formulation-to-treat-itchy-eyes-3630484/,2024-10-04T14:25:25+05:30,2024-10-04T08:55:25,0.1531
USDA gives nod to Alembic Pharma’s generic formulation to treat seizures,https://www.financialexpress.com/business/healthcare-usda-gives-nod-to-alembic-pharmas-generic-formulation-to-treat-seizures-3629411/,2024-10-03T14:17:20+05:30,2024-10-03T08:47:20,0.4019
Alembic Q1 Results: Net profit jumps 12 percent to Rs 135 crore; US business grows by 18 percent,https://www.financialexpress.com/business/healthcare-alembic-q1-results-net-profit-jumps-12-percent-to-rs-135-crore-us-business-grows-by-18-percent-3577444/,2024-08-08T15:01:43+05:30,2024-08-08T09:31:43,0.4404
USFDA gives nod to Alembic Pharma’s generic formulation to treat leukemia,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-generic-formulation-to-treat-leukemia-3571941/,2024-08-02T12:27:52+05:30,2024-08-02T06:57:52,0.4019
USFDA gives nod to Alembic Pharma’s generic formulation to treat high blood pressure in lungs,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-generic-formulation-to-treat-high-blood-pressure-in-lungs-3554252/,2024-07-15T16:17:55+05:30,2024-07-15T10:47:55,0.128
USFDA gives nod to Alembic Pharmaceuticals’ generic formulation to prevent stroke,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmaceuticals-generic-formulation-to-prevent-stroke-3528141/,2024-06-18T17:08:03+05:30,2024-06-18T11:38:03,0.0258
Alembic Pharma gets USFDA nod for its injection to treat rare genetic condition,https://www.financialexpress.com/business/healthcare-alembic-pharma-gets-usfda-nod-for-its-injection-to-treat-rare-genetic-condition-3527081/,2024-06-17T15:30:38+05:30,2024-06-17T10:00:38,0.4019
Alembic Pharmaceuticals gets USFDA nod to its generic formulation to treat heart failure,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-gets-usfda-nod-to-its-generic-formulation-to-treat-heart-failure-3507372/,2024-05-30T16:56:44+05:30,2024-05-30T11:26:44,-0.1531
Alembic Pharmaceuticals gets EIR for its Oncology Formulation Facility in Gujarat,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-gets-eir-for-its-oncology-formulation-facility-in-gujarat-3478722/,2024-05-06T15:46:31+05:30,2024-05-06T10:16:31,0.0
Alembic Pharmaceuticals appoints Manish Kejriwal as Independent Director,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-appoints-manish-kejriwal-as-independent-director-3443713/,2024-04-02T11:51:46+05:30,2024-04-02T06:21:46,0.0
USFDA gives nod to Alembic Pharma’s breast cancer drug,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-breast-cancer-drug-3442885/,2024-04-01T14:21:09+05:30,2024-04-01T08:51:09,-0.6597
"Alembic Pharmaceuticals Q3 Results: Profit up 48% at Rs 180.45 crore, revenue rises 8.1% on-year",https://www.financialexpress.com/business/industry-alembic-pharmaceuticals-q3-results-profit-up-48-at-rs-180-45-crore-revenue-rises-81-on-year-3384742/,2024-02-05T14:51:17+05:30,2024-02-05T09:21:17,0.4404
Alembic Pharma gets six USFDA approvals for its generic formulations in Q2FY24,https://www.financialexpress.com/business/healthcare-alembic-pharma-gets-six-usfda-approvals-for-its-generic-formulations-in-q2fy24-3262451/,2023-10-04T11:41:39+05:30,2023-10-04T06:11:39,0.0
Alembic Pharmaceuticals reports consolidated PAT at Rs. 152.60 Crore in Q4FY23,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-reports-consolidated-pat-at-rs-15260-crore-in-q4fy23-3078423/,2023-05-08T10:58:42+05:30,2023-05-08T05:28:42,0.0
USFDA gives final nod to Alembic Pharmaceuticals’ Glaucoma drug,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-alembic-pharmaceuticals-glaucoma-drug-3027016/,2023-03-30T14:12:46+05:30,2023-03-30T08:42:46,0.0
USFDA tentatively approves Alembic Pharmaceuticals’ schizophrenia Tablets,https://www.financialexpress.com/business/healthcare-usfda-tentatively-approves-alembic-pharmaceuticals-schizophrenia-tablets-3004623/,2023-03-10T13:05:37+05:30,2023-03-10T07:35:37,0.4019
USFDA approves Alembic Pharmaceuticals’ for cancer injection,https://www.financialexpress.com/business/healthcare-usfda-approves-alembic-pharmaceuticals-for-cancer-injection-3000775/,2023-03-06T12:22:33+05:30,2023-03-06T06:52:33,-0.4019
USFDA approves Alembic Pharmaceuticals’ anti-cancer injection,https://www.financialexpress.com/business/healthcare-usfda-approves-alembic-pharmaceuticals-anti-cancer-injection-2996167/,2023-03-01T13:29:58+05:30,2023-03-01T07:59:58,0.4019
USFDA tentatively approves Alembic Pharmaceuticals’ anti-cancer capsules,https://www.financialexpress.com/business/healthcare-usfda-tentatively-approves-alembic-pharmaceuticals-anti-cancer-capsules-2954681/,2023-01-20T11:57:39+05:30,2023-01-20T06:27:39,0.4019
USFDA gives final nod to Alembic Pharmaceuticals’ tablets for overactive bladder,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-alembic-pharmaceuticals-tablets-for-overactive-bladder-2939370/,2023-01-06T19:38:14+05:30,2023-01-06T14:08:14,0.0
USFDA gives final nod to Alembic Pharmaceuticals’ breast cancer injection,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-alembic-pharmaceuticals-breast-cancer-injection-2928996/,2022-12-28T11:51:23+05:30,2022-12-28T06:21:23,-0.6597
Alembic Pharmaceuticals gets PAS approval for its anti-anxiety capsules,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-gets-pas-approval-for-its-anti-anxiety-capsules-2923416/,2022-12-22T16:03:17+05:30,2022-12-22T10:33:17,0.4767
Alembic Pharmaceuticals gets USFDA nod for eczema cream,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-gets-usfda-nod-for-eczema-cream-2907627/,2022-12-09T15:41:23+05:30,2022-12-09T10:11:23,0.0
USFDA gives final nod to Alembic Pharmaceutical’s cardiac disorder tablets,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-alembic-pharmaceuticals-cardiac-disorder-tablets-2868211/,2022-11-21T14:52:56+05:30,2022-11-21T09:22:56,-0.4019
Alembic Pharma Q2 PAT dips 19% Y-O-Y; Revenue up 14% to Rs. 1475 crores,https://www.financialexpress.com/business/healthcare-alembic-pharma-q2-pat-dips-19-y-o-y-revenue-up-14-to-rs-1475-crores-2806164/,2022-11-11T16:03:49+05:30,2022-11-11T10:33:49,0.0
Alembic Pharma receives final approval from USFDA for generic Mesalamine extended-release capsules,https://www.financialexpress.com/business/healthcare-alembic-pharma-receives-final-approval-from-usfda-for-generic-mesalamine-extended-release-capsules-2767616/,2022-11-02T11:24:38+05:30,2022-11-02T05:54:38,0.4767
"USFDA approves Alembic Pharmaceuticals’ Chlorthalidone Tablets USP, 25 mg and 50 mg",https://www.financialexpress.com/business/healthcare-usfda-approves-alembic-pharmaceuticals-chlorthalidone-tablets-usp-25-mg-and-50-mg-2648481/,2022-08-29T18:00:03+05:30,2022-08-29T12:30:03,0.4019
Aleor Dermaceuticals Limited receives USFDA final approval for Diclofenac Sodium Topical Gel,https://www.financialexpress.com/business/healthcare-aleor-dermaceuticals-limited-receives-usfda-final-approval-for-diclofenac-sodium-topical-gel-2610919/,2022-07-29T17:52:10+05:30,2022-07-29T12:22:10,0.296
Alembic Pharma gets final USFDA nod for generic version of Arformoterol Tartrate inhalation solution,https://www.financialexpress.com/business/healthcare-alembic-pharma-gets-final-usfda-nod-for-generic-version-of-arformoterol-tartrate-inhalation-solution-2520334/,2022-05-11T13:48:09+05:30,2022-05-11T08:18:09,0.3182
Alembic Pharmaceuticals receives USFDA approval for Lacosamide Tablets,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-receives-usfda-approval-for-lacosamide-tablets-2467154/,2022-03-21T21:27:41+05:30,2022-03-21T15:57:41,0.4767
Cadila Pharmaceuticals inaugurates API plant at Dahej in Gujarat’s Bharuch district,https://www.financialexpress.com/business/healthcare-cadila-pharmaceuticals-inaugurates-api-plant-at-dahej-in-gujarats-bharuch-district-3319089/,2023-11-28T07:00:00+05:30,2023-11-28T01:30:00,0.0
Cadila Pharma appoints Ashraf Allam as global COO,https://www.financialexpress.com/business/healthcare-cadila-pharma-appoints-ashraf-allam-global-coo-2920843/,2022-12-20T17:37:39+05:30,2022-12-20T12:07:39,0.0
Cadila Pharma launches generic versions of sitagliptin for type 2 diabetes in India,https://www.financialexpress.com/business/healthcare-cadila-pharma-launches-generic-versions-of-sitagliptin-for-type-2-diabetes-in-india-2614414/,2022-08-02T11:52:47+05:30,2022-08-02T06:22:47,0.0
"Emcure acquires Manx Healthcare, UK",https://www.financialexpress.com/business/healthcare-emcure-acquires-manx-healthcare-uk-3799387/,2025-04-04T23:04:28+05:30,2025-04-04T17:34:28,0.0
Three momentum stocks for 2025,https://www.financialexpress.com/market/stock-insights/three-momentum-stocks-for-2025/3790810/,2025-03-28T06:02:00+05:30,2025-03-28T00:32:00,0.0
"GSK’s blood cancer drug fails main trial goal, shares fall",https://www.financialexpress.com/business/healthcare-gsks-blood-cancer-drug-fails-main-trial-goal-shares-fall-2781784/,2022-11-07T16:04:55+05:30,2022-11-07T10:34:55,-0.7184
GSK launches single-inhaler triple therapy in India for COPD patients,https://www.financialexpress.com/business/healthcare-gsk-single-inhaler-triple-therapy-copd-patients-2504225/,2022-04-26T17:41:29+05:30,2022-04-26T12:11:29,0.0
2 Favourite stocks of this Warren Buffett of India are trading at a discount…,https://www.financialexpress.com/market/stock-insights/2-favourites-of-this-warren-buffett-of-india-are-trading-at-a-discount/3835055/,2025-05-07T05:30:00+05:30,2025-05-07T00:00:00,0.0
Glenmark Pharmaceuticals launches generic formulation to treat bacterial infections,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-launches-generic-formulation-to-treat-bacterial-infections-3795058/,2025-04-01T11:22:06+05:30,2025-04-01T05:52:06,0.4019
Glenmark launches generic version of Boehringer’s blockbuster diabetes drug in India,https://www.financialexpress.com/business/healthcare-glenmark-launches-generic-version-of-boehringers-blockbuster-diabetes-drug-in-india-3775232/,2025-03-12T11:08:41+05:30,2025-03-12T05:38:41,0.5994
Glenmark recalls 15 lakh bottles of ADHD medication due to ‘CGMP Deviations’ in United States,https://www.financialexpress.com/business/healthcare-glenmark-recalls-15-lakh-bottles-of-adhd-medication-due-to-cgmp-deviations-in-united-states-3764599/,2025-03-02T12:23:05+05:30,2025-03-02T06:53:05,0.4215
Glenmark Pharma launches injection to treat severe allergic reactions in United States,https://www.financialexpress.com/business/healthcare-glenmark-pharma-launches-injection-to-treat-severe-allergic-reactions-in-united-states-3761807/,2025-02-27T10:19:52+05:30,2025-02-27T04:49:52,0.1779
Glenmark Telma’s journey to Rs 1000cr becomes a Harvard case study,https://www.financialexpress.com/business/healthcare-the-rise-of-glenmarks-telma-how-this-blood-pressure-drug-became-a-rs-1000-crore-brand-3750269/,2025-02-15T17:20:07+05:30,2025-02-15T11:50:07,0.0
Row over redundancy at Glenmark,https://www.financialexpress.com/business/healthcare-row-over-redundancy-at-glenmarknbsp-3719062/,2025-01-19T10:04:16+05:30,2025-01-19T04:34:16,0.0
Ichnos Glenmark Innovation presents first clinical data from Phase I study of its novel therapy to treat Multiple Myeloma,https://www.financialexpress.com/business/healthcare-ichnos-glenmark-innovation-presents-first-clinical-data-from-phase-i-study-of-its-novel-therapy-to-treat-multiple-myeloma-3688306/,2024-12-10T10:18:35+05:30,2024-12-10T04:48:35,0.765
Glenmark launches generic formulation for Glaucoma in United States,https://www.financialexpress.com/business/healthcare-glenmark-launches-generic-formulation-for-glaucoma-in-united-states-3678380/,2024-11-27T13:36:56+05:30,2024-11-27T08:06:56,0.4215
"Various unmet needs exist in Multiple Myeloma treatment; Our novel therapy’s early data shows remarkable response: Cyril Konto, President, Ichnos Glenmark Innovation",https://www.financialexpress.com/business/healthcare-various-unmet-needs-exist-in-multiple-myeloma-treatment-our-novel-therapys-early-data-shows-remarkable-response-cyril-konto-president-ichnos-glenmark-innovation-3677957/,2024-11-26T21:15:34+05:30,2024-11-26T15:45:34,0.8176
Ichnos Glenmark Innovation to present data from Phase I study on its drug candidate to treat myeloma,https://www.financialexpress.com/business/healthcare-ichnos-glenmark-innovation-to-present-data-from-phase-i-study-for-its-drug-candidate-to-treat-myeloma-3657662/,2024-11-06T10:01:39+05:30,2024-11-06T04:31:39,0.6486
"We are continuously exploring opportunities to enhance our dermatology portfolio to address diverse needs: Alok Malik, President – India Formulations, Glenmark Pharma",https://www.financialexpress.com/business/healthcare-we-are-continuously-exploring-opportunities-to-enhance-our-dermatology-portfolio-alok-malik-president-business-head-india-formulations-glenmark-pharma-3648607/,2024-10-24T16:08:48+05:30,2024-10-24T10:38:48,0.3818
"Glenmark Pharma agrees to pay $25 million over five years, interest at rate of 4.25% to settle US investigations",https://www.financialexpress.com/business/industry-glenmark-pharma-agrees-to-pay-25-million-over-five-years-interest-at-rate-of-4-25-to-settle-us-investigations-3602105/,2024-09-05T10:38:23+05:30,2024-09-05T05:08:23,0.5267
"Glenmark Pharma records surge in Q1 profit at Rs 340.27 crore on strong demand, CMD says confident of meeting FY25 objectives",https://www.financialexpress.com/business/industry-glenmark-pharma-records-surge-in-q1-profit-at-rs-340-27-crore-on-strong-demand-cmd-says-confident-of-meeting-fy25-objectives-3583633/,2024-08-15T12:15:50+05:30,2024-08-15T06:45:50,0.836
Glenmark inks agreement with BeiGene for marketing and distribution of cancer drugs in India,https://www.financialexpress.com/business/healthcare-glenmark-inks-agreement-with-beigene-for-marketing-and-distribution-of-cancer-drugs-in-india-3495431/,2024-05-21T09:18:08+05:30,2024-05-21T03:48:08,-0.296
Glenmark Pharmaceuticals gets USFDA approval for its drug to treat glaucoma,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-gets-usfda-approval-for-its-drug-to-treat-glaucoma-3491330/,2024-05-17T10:41:08+05:30,2024-05-17T05:11:08,0.7003
Glenmark Pharma gets USFDA nod for its generic formulation of major painkiller,https://www.financialexpress.com/business/healthcare-glenmark-pharma-gets-usfda-nod-for-its-generic-formulation-of-major-painkiller-3475920/,2024-05-03T10:42:21+05:30,2024-05-03T05:12:21,0.0
"Glenmark recalls 6,528 bottles of blood pressure drug after samples fail quality test",https://www.financialexpress.com/business/healthcare-glenmark-recalls-6528-bottles-of-blood-pressure-drug-after-samples-fail-quality-test-3457074/,2024-04-15T10:45:44+05:30,2024-04-15T05:15:44,-0.6908
Glenmark partners with Pfizer to launch oral drug for atopic dermatitis in India,https://www.financialexpress.com/business/healthcare-glenmark-partners-with-pfizer-to-launch-oral-drug-for-atopic-dermatitis-in-india-3380243/,2024-01-31T17:31:44+05:30,2024-01-31T12:01:44,0.0
Glenmark announces alliance with its biotech subsidiary to accelerate new drug discovery in cancer treatment,https://www.financialexpress.com/business/healthcare-glenmark-announces-alliance-with-its-biotech-subsidiary-to-accelerate-new-drug-discovery-in-cancer-treatment-3379098/,2024-01-30T18:12:51+05:30,2024-01-30T12:42:51,-0.6597
"Glenmark signs license agreement with Jiangsu Alphamab Biopharmaceuticals, 3D Medicines for cancer immunotherapy",https://www.financialexpress.com/business/healthcare-glenmark-signs-license-agreement-with-jiangsu-alphamab-biopharmaceuticals-3d-medicines-for-cancer-immunotherapy-3374674/,2024-01-25T11:20:44+05:30,2024-01-25T05:50:44,-0.296
Glenmark launches biosimilar of popular anti-diabetic drug in India,https://www.financialexpress.com/business/healthcare-glenmark-launches-biosimilar-of-popular-anti-diabetic-drug-in-india-3353953/,2024-01-03T12:25:01+05:30,2024-01-03T06:55:01,0.4215
"As we move up the value chain, developing comprehensive portfolio for global market to be key priority: Glenn Saldanha, CMD, Glenmark Pharmaceuticals",https://www.financialexpress.com/business/healthcare-we-will-continue-to-explore-opportunities-for-in-licensing-in-our-core-therapeutic-areas-glenn-saldanha-md-glenmark-pharmaceuticals-3344119/,2023-12-21T12:40:17+05:30,2023-12-21T07:10:17,0.5267
Glenmark Pharma posts Q2 loss on exceptional legal costs,https://www.financialexpress.com/business/industry-glenmark-pharma-posts-q2-loss-on-exceptional-legal-costs-3304508/,2023-11-10T21:45:32+05:30,2023-11-10T16:15:32,-0.2023
USFDA grants approval to Glenmark’s generic formulation to treat schizophrenia,https://www.financialexpress.com/business/healthcare-usfda-grants-approval-to-glenmarks-generic-formulation-to-treat-schizophrenia-3299347/,2023-11-07T11:31:57+05:30,2023-11-07T06:01:57,0.7717
Glenmark launches triple drug formulation for type 2 diabetes patients in India,https://www.financialexpress.com/business/healthcare-glenmark-launches-triple-drug-formulation-for-type-2-diabetes-patients-in-india-3276130/,2023-10-18T11:11:17+05:30,2023-10-18T05:41:17,0.0
USFDA gives final nod to Glenmark’s psoriasis drug,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-glenmarks-psoriasis-drug-3275095/,2023-10-17T12:25:29+05:30,2023-10-17T06:55:29,0.0
Glenmark’s subsidiary Ichnos Sciences enters into licensing agreement with Astria Therapeutics for its monoclonal antibody portfolio,https://www.financialexpress.com/business/healthcare-glenmarks-subsidiary-ichnos-sciences-enters-into-licensing-agreement-with-astria-therapeutics-for-its-monoclonal-antibody-portfolio-3270430/,2023-10-12T11:12:20+05:30,2023-10-12T05:42:20,0.4939
Expect gains from the Nirma deal on our books from FY25 & fruits from innovation play from FY27: Glenn Saldanha,https://www.financialexpress.com/business/healthcare-expect-gains-from-the-nirma-deal-on-our-books-from-fy25-fruits-from-innovation-play-from-fy27-glenn-saldanha-3251850/,2023-09-22T15:41:15+05:30,2023-09-22T10:11:15,0.7506
Glenmark Pharmaceuticals gets ANDA approval for its anti-diabetic drug,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-gets-anda-approval-for-its-anti-diabetic-drug-3194924/,2023-08-01T11:43:44+05:30,2023-08-01T06:13:44,0.4767
Glenmark Pharma slashes price of breast cancer drug Trastuzumab,https://www.financialexpress.com/business/healthcare-glenmark-pharma-slashes-price-of-breast-cancer-drug-trastuzumab-3127299/,2023-06-16T13:08:34+05:30,2023-06-16T07:38:34,-0.7351
Glenmark Pharmaceuticals receives ANDA approval for its psychosis tablets,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-receives-anda-approval-for-its-psychosis-tablets-3016073/,2023-03-20T15:17:00+05:30,2023-03-20T09:47:00,0.4767
USFDA accepts Glenmark’s application to initiate human trial of molecule for advanced solid tumors and lymphomas,https://www.financialexpress.com/business/healthcare-usfda-accepts-glenmarks-application-to-initiate-human-trial-of-molecule-for-advanced-solid-tumors-and-lymphomas-3012071/,2023-03-16T17:01:17+05:30,2023-03-16T11:31:17,0.5994
USFDA approves Glenmark Pharmaceuticals’ bacterial infection capsules,https://www.financialexpress.com/business/healthcare-usfda-approves-glenmark-pharmaceuticals-bacterial-infection-capsules-3008636/,2023-03-14T12:47:19+05:30,2023-03-14T07:17:19,0.4019
Glenmark and Cediprof announce exclusive distribution agreement in US,https://www.financialexpress.com/business/healthcare-glenmark-and-cediprof-announce-exclusive-distribution-agreement-in-us-3003086/,2023-03-09T09:25:48+05:30,2023-03-09T03:55:48,0.5719
Glenmark Pharmaceuticals receives second ANDA tentative approval for blood-sugar-lowering tablets,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-receives-second-anda-tentative-approval-for-blood-sugar-lowering-tablets-2985843/,2023-02-19T13:29:00+05:30,2023-02-19T07:59:00,0.4767
"Glenmark Pharma reports revenue growth of 9.2 percent, PAT of 21.3 percent YoY in Q3FY23",https://www.financialexpress.com/business/healthcare-glenmark-pharma-reports-revenue-growth-of-9-2-percent-pat-of-213-percent-yoy-in-q3fy23-2980868/,2023-02-14T12:11:32+05:30,2023-02-14T06:41:32,0.3818
Glenmark launches injection to prevent chemotherapy-induced nausea and vomiting in India,https://www.financialexpress.com/business/healthcare-glenmark-launches-injection-to-prevent-chemotherapy-induced-nausea-and-vomiting-in-india-2957062/,2023-01-23T11:23:42+05:30,2023-01-23T05:53:42,0.0258
"ITC, ICICI Lombard, Glenmark Pharma, Tata Metaliks, Delta Corp, RVNL, IndusInd Bank stocks in focus",https://www.financialexpress.com/market/stocks-to-watch-itc-icici-lombard-glenmark-pharma-tata-metaliks-delta-corp-rvnl-indusind-bank-stocks-in-focus-2951587/,2023-01-18T08:16:42+05:30,2023-01-18T02:46:42,0.0
Glenmark launches generic version of Novartis’ heart failure drug in India,https://www.financialexpress.com/business/healthcare-glenmark-launches-generic-version-of-novartis-heart-failure-drug-in-india-2950867/,2023-01-17T13:27:14+05:30,2023-01-17T07:57:14,-0.5106
Glenmark Pharmaceuticals launches congestive heart failure injection in United States,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-launches-congestive-heart-failure-injection-in-united-states-2942200/,2023-01-10T12:14:49+05:30,2023-01-10T06:44:49,-0.128
Glenmark becomes first company to launch triple fixed-dose combination for type 2 diabetes in India,https://www.financialexpress.com/business/healthcare-glenmark-becomes-first-company-to-launch-triple-fixed-dose-combination-for-type-2-diabetes-in-india-2921530/,2022-12-21T17:41:20+05:30,2022-12-21T12:11:20,0.0
Glenmark Pharmaceuticals gets final nod for its generic chest pain capsules,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-gets-final-nod-for-its-generic-chest-pain-capsules-2919066/,2022-12-19T12:04:51+05:30,2022-12-19T06:34:51,-0.5106
Glenmark Pharmaceuticals Rating: neutral; Working on many fronts to improve outlook,https://www.financialexpress.com/market/glenmark-pharmaceuticals-rating-neutral-working-on-many-fronts-to-improve-outlook-2873100/,2022-11-22T02:45:00+05:30,2022-11-21T21:15:00,0.4404
Glenmark becomes first to launch Lobeglitazone for uncontrolled Type 2 Diabetes in India,https://www.financialexpress.com/business/healthcare-glenmark-becomes-first-to-launch-lobeglitazone-for-uncontrolled-type-2-diabetes-in-india-2701762/,2022-10-06T11:01:42+05:30,2022-10-06T05:31:42,-0.25
Bausch Health and Glenmark announce approval of Hay fever nasal spray in Canada,https://www.financialexpress.com/business/healthcare-bausch-health-and-glenmark-announce-approval-of-hay-fever-nasal-spray-in-canada-2688820/,2022-09-23T16:04:20+05:30,2022-09-23T10:34:20,0.4767
Glenmark Pharma gets approval from Health Canada for nasal spray Ryaltris,https://www.financialexpress.com/business/healthcare-glenmark-pharma-gets-approval-from-health-canada-for-nasal-spray-ryaltris-2688489/,2022-09-23T13:12:00+05:30,2022-09-23T07:42:00,0.4767
Hikma launches RYALTRIS seasonal allergic rhinitis nasal spray in US,https://www.financialexpress.com/business/healthcare-hikma-launches-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-us-2649780/,2022-08-30T18:41:11+05:30,2022-08-30T13:11:11,-0.296
Glenmark Pharma’s shares weak in trade as firm announces recall of generic skin ointment in United States,https://www.financialexpress.com/business/healthcare-glenmark-pharmas-shares-weak-in-trade-as-firm-announces-recall-of-generic-skin-ointment-in-united-states-2632525/,2022-08-16T20:32:37+05:30,2022-08-16T15:02:37,0.2732
"Pharma majors Glenmark, Sun Pharma and Dr Reddy’s recall products in United States",https://www.financialexpress.com/business/healthcare-pharma-majors-glenmark-sun-pharma-and-dr-reddys-recall-products-in-united-states-2630924/,2022-08-15T19:06:38+05:30,2022-08-15T13:36:38,0.4215
Glenmark Pharmaceuticals announces Q1 Results; Profit declines 31% to Rs 211.1 crore,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-announces-q1-results-profit-declines-31-to-rs-211-1-crore-2625773/,2022-08-11T12:07:36+05:30,2022-08-11T06:37:36,0.4404
Glenmark Pharmaceuticals receives ANDA approval for generic version of Taytulla Capsules,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-receives-anda-approval-for-generic-version-of-taytulla-capsules-2610959/,2022-07-29T17:58:42+05:30,2022-07-29T12:28:42,0.4767
"Sun Pharma, Glenmark recall products due to manufacturing issues in United States",https://www.financialexpress.com/business/healthcare-sun-pharma-glenmark-recall-products-due-to-manufacturing-issues-in-united-states-2605585/,2022-07-25T18:08:34+05:30,2022-07-25T12:38:34,0.4215
Glenmark Pharmaceuticals and SaNOtize announce their Phase 3 Clinical Trials results on novel nasal spray for COVID-19,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-and-sanotize-announce-their-phase-3-clinical-trials-results-on-novel-nasal-spray-for-covid-19-2593052/,2022-07-13T18:37:11+05:30,2022-07-13T13:07:11,0.3182
Glenmark Pharmaceuticals launches India’s first Topical Minocycline 4% Gel for moderate to severe acne,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-launches-indias-first-topical-minocycline-4-gel-for-moderate-to-severe-acne-2589832/,2022-07-11T12:58:46+05:30,2022-07-11T07:28:46,-0.3818
Glenmark Pharma launches gel for acne treatment,https://www.financialexpress.com/business/healthcare-glenmark-pharma-launches-gel-for-acne-treatment-2589696/,2022-07-11T11:36:30+05:30,2022-07-11T06:06:30,0.0
Glenmark launches Sitagliptin and its fixed-dose combinations at affordable price for Adults with Type 2 Diabetes in India,https://www.financialexpress.com/business/healthcare-glenmark-launches-sitagliptin-and-its-fixed-dose-combinations-at-affordable-price-for-adults-with-type-2-diabetes-in-india-2586066/,2022-07-07T13:37:42+05:30,2022-07-07T08:07:42,0.0
Glenmark USA continues to expand its Over-The-Counter Portfolio with acquisition of new drugs from Wockhardt Limited,https://www.financialexpress.com/business/healthcare-glenmark-usa-continues-to-expand-its-over-the-counter-portfolio-with-acquisition-of-new-drugs-from-wockhardt-limited-2575274/,2022-06-28T14:02:58+05:30,2022-06-28T08:32:58,0.1027
Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-acquires-certain-otc-drugs-from-wockhardt-in-us-2575018/,2022-06-28T11:27:11+05:30,2022-06-28T05:57:11,0.2732
Glenmark Pharma launches Whatsapp chatbot to help patients with fungal infections,https://www.financialexpress.com/business/healthcare-glenmark-pharma-launches-whatsapp-chatbot-to-help-patients-with-fungal-infections-2535937/,2022-05-24T13:55:23+05:30,2022-05-24T08:25:23,0.4019
Glenmark Pharma gets final USFDA nod for generic version of Abiraterone Acetate tabs,https://www.financialexpress.com/business/healthcare-glenmark-pharma-gets-final-usfda-nod-for-generic-version-of-abiraterone-acetate-tabs-2531965/,2022-05-20T11:13:07+05:30,2022-05-20T05:43:07,0.0
"Buy these two stocks for gains; Nifty support visible at 17300-17150, Bank Nifty support at 36900",https://www.financialexpress.com/market/cafeinvest-buy-these-two-stocks-for-gains-nifty-support-visible-at-17300-17150-bank-nifty-support-at-36900-2494553/,2022-04-18T08:04:02+05:30,2022-04-18T02:34:02,0.9042
Glenmark receives DCGI nod to conduct clinical trials of its molecule on cancer patients,https://www.financialexpress.com/business/healthcare-glenmark-receives-dcgi-nod-to-conduct-clinical-trials-of-its-molecule-on-cancer-patients-2487752/,2022-04-11T12:06:08+05:30,2022-04-11T06:36:08,-0.6597
"Stocks to buy: Glenmark Pharma, NTPC shares may rally as much as 17% in next three months",https://www.financialexpress.com/market/stocks-to-buy-glenmark-pharma-ntpc-shares-may-rally-as-much-as-17-in-next-three-months-2485754/,2022-04-08T13:24:01+05:30,2022-04-08T07:54:01,0.296
FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges,https://www.financialexpress.com/business/healthcare-fe-pharma-summit-to-see-industry-titans-swap-ideas-on-steps-to-counter-prickly-challenges-2469214/,2022-03-23T15:05:08+05:30,2022-03-23T09:35:08,-0.1531
Glenmark Life Sciences listing: No bumper gains; shares debut at 4% premium to IPO price,https://www.financialexpress.com/market/glenmark-life-sciences-listing-no-bumper-gains-shares-debut-at-4-premium-to-ipo-price-2305485/,2021-08-06T10:20:01+05:30,2021-08-06T04:50:01,0.34
Glenmark Life Sciences IPO subscribed 12.19 times so far; check grey market premium here,https://www.financialexpress.com/market/ipo-news-glenmark-life-sciences-ipo-subscription-update-public-issue-open-full-subscribe-day-1-grey-market-premium-2298550/,2021-07-29T13:13:26+05:30,2021-07-29T07:43:26,0.1189
"Glenmark Life Sciences IPO caught amid pharma sell-off, grey market premium weak; should you subscribe?",https://www.financialexpress.com/market/ipo-news-glenmark-life-sciences-ipo-opens-tomorrow-grey-market-premium-at-20-should-you-subscribe-2297665/,2021-07-28T12:25:14+05:30,2021-07-28T06:55:14,-0.4019
"Glenmark Life Sciences’ Rs 1,513.6-crore IPO fixes price band; check bid lot size, listing date, other details",https://www.financialexpress.com/market/ipo-news-glenmark-life-sciences-rs-1515-crore-ipo-fixes-price-band-check-bid-lot-size-listing-date-other-details-glenmark-pharmaceuticals-2294608/,2021-07-21T10:24:35+05:30,2021-07-21T04:54:35,0.0
"Glenmark Life Sciences IPO opens July 27, IPO size reduced; plans to sell now 63 lakh shares via OFS",https://www.financialexpress.com/market/ipo-news-glenmark-life-sciences-ipo-opens-july-27-ipo-size-reduced-plans-to-sell-63-lakh-shares-via-ofs-glenmark-pharmaceuticals-2294070/,2021-07-20T14:30:51+05:30,2021-07-20T09:00:51,0.296
Glenmark Q4 net profit up 6 pc at Rs 233.87 cr,https://www.financialexpress.com/business/industry-glenmark-q4-net-profit-up-6-pc-at-rs-233-87-cr-2261301/,2021-05-29T13:50:51+05:30,2021-05-29T08:20:51,0.4404
Glenmark Life Sciences files IPO papers with SEBI; plans to sell over 73 lakh shares via OFS,https://www.financialexpress.com/market/ipo-news-glenmark-life-sciences-files-ipo-papers-with-sebi-plans-to-sell-over-73-lakh-shares-via-ofs-2234936/,2021-04-17T12:48:58+05:30,2021-04-17T07:18:58,0.296
Glenmark Pharma share price jumps 7% today on upbeat April-June quarter results,https://www.financialexpress.com/market/glenmark-pharma-share-price-jumps-7-today-on-upbeat-april-june-quarter-results/2057290/,2020-08-17T10:57:42+05:30,2020-08-17T05:27:42,0.296
"Stocks in focus: Rossari Biotech, Glenmark Pharma, L&T, HDFC AMC, Vodafone Idea, Axis Bank",https://www.financialexpress.com/market/rossari-biotech-glenmark-pharma-lt-hdfc-amc-vodafone-idea-axis-bank-stocks-in-focus-glenmark-pharmaceuticals-biocon-sgx-nifty-2032600/,2020-07-23T08:57:05+05:30,2020-07-23T03:27:05,0.0
Glenmark Pharmaceuticals share price rallies 15% as firm launches COVID-19 drug Favipiravir,https://www.financialexpress.com/market/glenmark-pharmaceuticals-share-price-rallies-15-as-firm-launches-covid-19-drug-favipiravir-1999235/,2020-06-22T10:20:06+05:30,2020-06-22T04:50:06,0.296
"Stocks in focus: Glenmark Pharma, Cipla, Reliance Capital, HDFC Bank shares to remain in news today",https://www.financialexpress.com/market/glenmark-pharma-cipla-reliance-capital-hdfc-bank-hdfc-dhanlaxmi-bank-info-edge-q4-results-stocks-in-focus-coronavirus-covid-19-drug-1999175/,2020-06-22T08:54:53+05:30,2020-06-22T03:24:53,0.296
Sun Pharma shares fall over 4% today. Here’s what’s behind the drop,https://www.financialexpress.com/market/sun-pharma-shares-fall-over-4-today-heres-whats-behind-the-drop-3854860/,2025-05-23T13:38:15+05:30,2025-05-23T08:08:15,0.0258
Can branded pharma keep pace as Jan Aushadhi scales up? Kotak flags long-term growth risks,https://www.financialexpress.com/business/industry-can-branded-pharma-keep-pace-as-jan-aushadhi-scales-up-kotak-flags-long-term-growth-risks-3853253/,2025-05-22T10:21:52+05:30,2025-05-22T04:51:52,0.128
Gland Pharma Q4 Results: Net profit drops by 3% at Rs 186.54 crore on revenue decline on US market,https://www.financialexpress.com/business/industry-gland-pharma-q4-results-net-profit-drops-by-3-at-rs-186-54-crore-on-revenue-decline-on-us-market-3851373/,2025-05-20T18:30:29+05:30,2025-05-20T13:00:29,0.4404
Govt invites fresh applications bulk drugs PLI,https://www.financialexpress.com/business/healthcare-govt-invites-fresh-applications-bulk-drugs-pli-3846457/,2025-05-15T23:50:19+05:30,2025-05-15T18:20:19,0.3182
"Indian generics drug market safe from Trump’s drug price order, says IPA",https://www.financialexpress.com/business/industry-indian-generics-drug-market-safe-from-trumps-drug-price-ordernbspsays-ipanbsp-3843449/,2025-05-13T18:57:01+05:30,2025-05-13T13:27:01,0.4404
Cipla Q4 FY25 results: profit rises 30 percent to Rs 1222 crore,https://www.financialexpress.com/business/industry-cipla-q4-fy25-results-profit-rises-30-percent-to-rs-1222-crore-3843290/,2025-05-13T16:42:13+05:30,2025-05-13T11:12:13,0.4404
"Three reasons why markets are falling today: Sensex slides 1,100 points, Nifty down over 1%",https://www.financialexpress.com/market/three-reasons-why-markets-are-falling-today-sensex-slides-1000-points-nifty-down-1-3842690/,2025-05-13T13:14:42+05:30,2025-05-13T07:44:42,0.2732
‘Fat shot drug’: Trump’s wild Ozempic story inspires weight loss medication price control plan,https://www.financialexpress.com/world-news/fat-shot-drug-trumps-wild-ozempic-story-inspires-weight-loss-medication-price-control-plan/3842389/,2025-05-13T07:28:05+05:30,2025-05-13T01:58:05,0.1531
"US price cut to seriously dent India’s pharma exports, stocks hit",https://www.financialexpress.com/business/healthcare-us-price-cut-to-seriously-dent-indias-pharma-exports-stocks-hit-3842079/,2025-05-12T22:18:03+05:30,2025-05-12T16:48:03,-0.4215
These 2 stocks are trading below 10-year PE averages — value picks or value traps?,https://www.financialexpress.com/market/stock-insights/these-2-stocks-are-trading-below-10-year-pe-averages-value-picks-or-value-traps/3830491/,2025-05-03T06:00:00+05:30,2025-05-03T00:30:00,0.5859
"Why are markets surging today? 4 key reasons why Sensex, Nifty rally over 1%",https://www.financialexpress.com/market/why-are-markets-surging-today-4-key-reasons-why-sensex-nifty-rally-over-1-3824949/,2025-04-28T12:19:16+05:30,2025-04-28T06:49:16,0.4019
5 stocks Warren Buffetts of India just added to their portfolios,https://www.financialexpress.com/market/stock-insights/5-stocks-warren-buffetts-of-india-just-added-to-their-portfolios/3821352/,2025-04-25T05:30:00+05:30,2025-04-25T00:00:00,0.0
Syngene International shares plummet 13%: Here’s what’s worrying investors,https://www.financialexpress.com/market/syngene-internationals-shares-tanked-over-13-as-q4-net-profit-declined-8-3820487/,2025-04-24T14:22:43+05:30,2025-04-24T08:52:43,-0.0516
"India may gain in short-term from Trump’s 90-day tariff break but uncertainty persists, says Kotak Securities",https://www.financialexpress.com/policy/economy-a-pause-to-means-and-not-to-ends-india-may-gain-short-term-relief-from-trumps-90-day-tariff-break-but-uncertainty-persists-3810375/,2025-04-15T16:51:21+05:30,2025-04-15T11:21:21,0.2263
"Trump announces ‘major tariff’ on pharmaceuticals soon, claims China is ‘manipulating currency’",https://www.financialexpress.com/world-news/trump-announces-major-tariff-on-pharmaceuticals-soon-claims-china-is-manipulating-currency/3803718/,2025-04-09T08:19:30+05:30,2025-04-09T02:49:30,0.0
Why is the market falling today? 4 reasons…,https://www.financialexpress.com/market/why-is-the-market-falling-today-4-reasons-are-3798485/,2025-04-04T15:10:39+05:30,2025-04-04T09:40:39,-0.1531
Trump tariff to come into effect soon: Here’s what has unfolded till now and what can be expected,https://www.financialexpress.com/business/industry-trump-tariff-to-come-into-effect-soon-heres-what-has-unfolded-till-now-and-what-can-be-expected-3796386/,2025-04-02T15:23:59+05:30,2025-04-02T09:53:59,0.0
Trump says he’ll announce new pharmaceutical tariff soon,https://www.financialexpress.com/world-news/trump-says-hell-announce-new-pharmaceutical-tariff-soon/3792227/,2025-03-29T07:44:03+05:30,2025-03-29T02:14:03,0.0
Three reasons why pharma stocks are falling today?,https://www.financialexpress.com/market/three-reasons-why-pharma-stocks-are-falling-today-3787976/,2025-03-25T14:45:39+05:30,2025-03-25T09:15:39,-0.1531
"Trump signals auto tariffs in ‘near future’, might give breaks to ‘a lot of countries’ on April 2",https://www.financialexpress.com/world-news/trump-signals-auto-tariffs-in-near-future-might-give-breaks-to-a-lot-of-countries-on-april-2/3787444/,2025-03-25T07:07:17+05:30,2025-03-25T01:37:17,0.0
16% cut in Zydus Lifesciences target: 4 big worries for Nuvama are…,https://www.financialexpress.com/market/16-cut-in-zydus-lifesciences-target-4-big-worries-for-nuvama-are-3776367/,2025-03-13T09:53:45+05:30,2025-03-13T04:23:45,-0.5994
India’s pharma industry betting big on CDMO opportunity – All you need to know,https://www.financialexpress.com/business/industry-indias-pharma-industry-betting-big-on-cdmo-opportunity-all-you-need-to-know-3775800/,2025-03-12T17:43:14+05:30,2025-03-12T12:13:14,0.4215
"Poverty of ambition: To thrive, Indian pharma needs R&D investment, not just tariff cuts",https://www.financialexpress.com/opinion/poverty-of-ambition-to-thrive-indian-pharma-needs-rd-investment-not-just-tariff-cuts/3773745/,2025-03-11T06:00:00+05:30,2025-03-11T00:30:00,-0.3425
Jefferies bets big on these 3 pharma stocks- Find out why,https://www.financialexpress.com/market/jefferies-bets-big-on-these-3-pharma-stocks-find-out-why-3766798/,2025-03-04T14:31:37+05:30,2025-03-04T09:01:37,0.0
Trump tariff unlikely to be a bitter pill for pharma – Everything you need to know,https://www.financialexpress.com/business/industry-trump-tariff-to-unlikely-have-a-grim-outcome-for-pharma-sector-whats-the-base-and-worst-case-scenarionbsp-3763390/,2025-02-28T15:18:02+05:30,2025-02-28T09:48:02,-0.4215
India becoming an attractive option for global pharmaceutical supply chain: Macquarie Report,https://www.financialexpress.com/business/healthcare-india-becoming-an-attractive-option-for-global-pharmaceutical-supply-chain-macquarie-report-3755170/,2025-02-20T13:00:00+05:30,2025-02-20T07:30:00,0.4404
Pharma stocks are down as much as 10%. Read to know why…,https://www.financialexpress.com/market/pharma-stocks-are-down-as-much-as-10-read-to-know-why-3753628/,2025-02-19T10:10:39+05:30,2025-02-19T04:40:39,0.0
"Trump likely to impose 25% tariffs on imported automobiles, chips and pharmaceuticals",https://www.financialexpress.com/world-news/trump-announces-25-tariffs-on-imported-automobiles-chips-and-pharmaceuticals/3753465/,2025-02-19T09:50:07+05:30,2025-02-19T04:20:07,-0.296
Indian pharma and the case for tempered take on tariff gains for US,https://www.financialexpress.com/business/healthcare-indian-pharma-and-the-case-for-tempered-take-on-tariff-gains-for-us-3752772/,2025-02-18T14:12:59+05:30,2025-02-18T08:42:59,0.34
Q3FY25 Results: Dr. Reddy’s Laboratories reports over 2 percent rise in profit YoY; Revenue at Rs 8358.6 crore,https://www.financialexpress.com/business/healthcare-q3fy25-results-dr-reddys-laboratories-reports-2-percent-in-profit-yoy-revenue-at-rs-83586-crore-3724071/,2025-01-23T17:17:54+05:30,2025-01-23T11:47:54,0.4404
Sweet pill! Pharma sector expects 10% revenue growth in FY25 says CRISIL,https://www.financialexpress.com/business/healthcare-sweet-pill-pharma-sector-expects-10-revenue-growth-in-fy25-says-crisil-3619141/,2024-09-23T14:19:33+05:30,2024-09-23T08:49:33,0.7088
"Bitter pill for pharma: Growth worries plague most companies in August, green shoots expected in FY25",https://www.financialexpress.com/business/industry-bitter-pill-for-pharma-growth-worries-plague-most-companies-in-august-green-shoots-expected-in-fy25-3607858/,2024-09-11T12:05:00+05:30,2024-09-11T06:35:00,-0.4588
Acceleration in China+1 trend in Pharmaceuticals sector!,https://www.financialexpress.com/business/industry-acceleration-in-china1-trend-in-pharmaceuticals-sector-3597636/,2024-08-31T13:29:23+05:30,2024-08-31T07:59:23,0.0
Nichepharm acquires 24% remaining shares from Recipharm AB to restore 100% ownership,https://www.financialexpress.com/business/healthcare-nichepharm-acquires-24-remaining-shares-from-recipharm-ab-to-restore-100-ownership-3570301/,2024-07-31T21:21:23+05:30,2024-07-31T15:51:23,0.5267
"Mankind Pharma Q1 Results: Profit rises by 10.2% to Rs 536.49 crore, revenue at Rs 2,893.42 crore",https://www.financialexpress.com/business/industry-mankind-pharma-q1-results-profit-rises-by-10-2-to-rs-53649-crore-revenue-at-rs-289342-crore-3569956/,2024-07-31T15:58:40+05:30,2024-07-31T10:28:40,0.4404
"Ajanta Pharma Q1 Results: Profit rises by 18.1% to Rs 245.77 crore, revenue up 12.1% on-year",https://www.financialexpress.com/business/industry-ajanta-pharma-q1-results-profit-rises-by-18-1-to-rs-24577-crore-revenue-up-121-on-year-3569011/,2024-07-30T16:17:38+05:30,2024-07-30T10:47:38,0.4404
Kushal Pal Singh with $18.9 billion to Kishore Mariwala with $3.0 billion: The oldest billionaires in India,https://www.financialexpress.com/life/lifestyle-kushal-pal-singh-with-18-9-billion-to-kishore-mariwala-with-30-billion-the-oldest-billionaires-in-india-3517902/,2024-06-12T00:11:00+05:30,2024-06-11T18:41:00,0.0
Can India’s life sciences industry transform from ‘pharmacy of the world’ to ‘innovation hub’?,https://www.financialexpress.com/business/healthcare-can-indias-life-sciences-industry-transform-from-pharmacy-of-the-world-to-innovation-hub-3510024/,2024-06-02T14:43:15+05:30,2024-06-02T09:13:15,0.0
USFDA gives tentative approval to Lupin’s drug for treatment of rare genetic disorder,https://www.financialexpress.com/business/healthcare-usfda-gives-tentative-approval-to-lupins-drug-for-treatment-of-rare-genetic-disorder-3443030/,2024-04-01T16:12:18+05:30,2024-04-01T10:42:18,0.1027
"Indian pharma companies to post revenue growth of 8-10% in FY2025; US & Europe growth momentum to moderate, says ICRA",https://www.financialexpress.com/business/industry-indian-pharma-companies-to-post-revenue-growth-of-8-10-in-fy2025-us-europe-growth-momentum-to-moderate-says-icra-3439518/,2024-03-28T16:11:14+05:30,2024-03-28T10:41:14,0.6369
Suven Pharmaceuticals to merge with Cohance Lifesciences for integrated Pharma CDMO Leadership in India,https://www.financialexpress.com/business/healthcare-suven-pharmaceuticals-to-merge-with-cohance-lifesciences-for-integrated-pharma-cdmo-leadership-in-india-3410009/,2024-03-01T09:23:14+05:30,2024-03-01T03:53:14,0.0
Zydus gets WHO prequalification for its key formulation to treat Kala Azar,https://www.financialexpress.com/business/healthcare-zydus-gets-who-prequalification-for-its-key-formulation-to-treat-kala-azar-3404561/,2024-02-25T13:40:21+05:30,2024-02-25T08:10:21,0.4019
AstraZeneca’s DKD pipeline highlights potential to differentiate in kidney disease space,https://www.financialexpress.com/business/healthcare-astrazenecas-dkd-pipeline-highlights-potential-to-differentiate-in-kidney-disease-space-3399066/,2024-02-20T07:03:00+05:30,2024-02-20T01:33:00,0.0
"Natco Pharma Q3 profit jumps 241.4% to Rs 212.70 crore, interim dividend announced",https://www.financialexpress.com/business/industry-natco-pharma-q3-profit-jumps-241-4-to-rs-21270-crore-interim-dividend-announced-3394169/,2024-02-14T15:08:35+05:30,2024-02-14T09:38:35,0.4404
"We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences",https://www.financialexpress.com/business/healthcare-we-will-continue-to-deepen-our-presence-in-segments-like-diabetes-through-product-portfolio-expansion-krishnakumar-vaidyanathan-executive-director-eris-lifesciences-3390447/,2024-02-13T16:05:38+05:30,2024-02-13T10:35:38,0.3612
USFDA gives nod to Lupin’s generic formulation to treat ocular pain,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-formulation-to-treat-ocular-pain-3386668/,2024-02-07T12:13:40+05:30,2024-02-07T06:43:40,-0.1531
"Piramal Pharma posts Q3FY24 profit at Rs 10.11 crore, revenue up 14.1% on double digit growth across all three biz",https://www.financialexpress.com/business/industry-piramal-pharma-posts-q3fy24-profit-at-rs-10-11-crore-revenue-up-141-on-double-digit-growth-across-all-three-biz-3379614/,2024-01-31T11:26:02+05:30,2024-01-31T05:56:02,0.6705
"Dr Reddy’s Labs Q3 Results: Profit rises 11% to Rs 1380.90 crore, revenue up 6.6% on-year; beats estimates",https://www.financialexpress.com/business/industry-dr-reddys-labs-q3-results-profit-rises-11-to-rs-1380-90-crore-revenue-up-66-on-year-beats-estimates-3378980/,2024-01-30T16:46:59+05:30,2024-01-30T11:16:59,0.4404
"Strides Pharma posts Q3 profit at Rs 49.67 crore, revenue up 20% on-year at Rs 1037.67 crore",https://www.financialexpress.com/business/industry-strides-pharma-posts-q3-profit-at-rs-49-67-crore-revenue-up-20-on-year-at-rs-103767-crore-3378885/,2024-01-30T15:03:16+05:30,2024-01-30T09:33:16,0.4404
Orchid Pharma’s drug to treat major bacterial infection gets EMA approval,https://www.financialexpress.com/business/healthcare-orchid-pharmas-drug-to-treat-major-bacterial-infection-gets-ema-approval-3378610/,2024-01-30T12:38:31+05:30,2024-01-30T07:08:31,0.7003
"J&J slides as device margins droop, drug sales seen falling",https://www.financialexpress.com/business/healthcare-jj-slides-as-device-margins-droop-drug-sales-seen-falling-3374062/,2024-01-24T16:48:57+05:30,2024-01-24T11:18:57,-0.1531
CDSCO grants permission to AstraZeneca to import and market anticoagulant drug in India,https://www.financialexpress.com/business/healthcare-cdsco-grants-permission-to-astrazeneca-to-import-and-market-anticoagulant-drug-in-india-3373031/,2024-01-23T17:56:09+05:30,2024-01-23T12:26:09,0.2263
Novartis’ innovative drug shows significant positive outcomes in Phase III trial for patients with gastrointestinal cancers,https://www.financialexpress.com/business/healthcare-novartis-innovative-drug-shows-significant-positive-outcomes-in-phase-iii-trial-for-patients-with-gastrointestinal-cancers-3371416/,2024-01-22T12:23:02+05:30,2024-01-22T06:53:02,0.8074
"ADHD field presents significant opportunity for drug developers in 7MM, says GlobalData",https://www.financialexpress.com/business/healthcare-adhd-field-presents-significant-opportunity-for-drug-developers-in-7mm-says-globaldata-3368522/,2024-01-19T11:00:00+05:30,2024-01-19T05:30:00,0.5574
Hyd pharma leaders urge UP to position state as hub for Chinese-dependent raw materials,https://www.financialexpress.com/business/healthcare-hyd-pharma-leaders-urge-up-to-position-state-as-hub-for-chinese-dependent-raw-materials-3368888/,2024-01-19T09:51:57+05:30,2024-01-19T04:21:57,0.0
Q3FY24 Results Preview: Strong numbers likely from Aurobindo Pharma & Gland Pharma; US sales to improve QoQ for all relevant companies,https://www.financialexpress.com/business/healthcare-q3fy24-results-preview-strong-numbers-likely-from-aurobindo-pharma-gland-pharma-us-sales-to-improve-qoq-for-all-relevant-companies-3362049/,2024-01-11T17:08:35+05:30,2024-01-11T11:38:35,0.7351
GSK to buy Asthma drug owner Aiolos for up to $1.4 billion,https://www.financialexpress.com/business/healthcare-gsk-to-buy-asthma-drug-owner-aiolos-for-up-to-1-4-billion-3359880/,2024-01-09T17:09:11+05:30,2024-01-09T11:39:11,0.0
"Boehringer Ingelheim, Kyowa Kirin enter license agreement to develop novel treatment for fibro-inflammatory diseases",https://www.financialexpress.com/business/healthcare-boehringer-ingelheim-kyowa-kirin-enter-license-agreement-to-develop-novel-treatment-for-fibro-inflammatory-diseases-3358362/,2024-01-08T11:44:45+05:30,2024-01-08T06:14:45,0.6705
CitiusTech appoints Sudhir Kesavan as Chief Operating Officer,https://www.financialexpress.com/business/healthcare-citiustech-appoints-sudhir-kesavan-as-chief-operating-officer-3355561/,2024-01-04T17:22:35+05:30,2024-01-04T11:52:35,0.0
This low-cost pill can help to quit smoking; Read on to know all about it,https://www.financialexpress.com/business/healthcare-this-low-cost-pill-can-help-to-quit-smoking-read-on-to-know-all-about-it-3353309/,2024-01-02T17:14:40+05:30,2024-01-02T11:44:40,0.4019
‘M&A and investing activity in Indian healthcare sector likely to continue at strong levels’,https://www.financialexpress.com/business/healthcare-ma-and-investing-activity-in-the-indian-healthcare-sector-likely-to-continue-at-strong-levels-3349695/,2023-12-28T15:18:14+05:30,2023-12-28T09:48:14,0.5106
Akums launches extended-release tablets for severe morning sickness,https://www.financialexpress.com/business/healthcare-akums-launches-extended-release-tablets-for-severe-morning-sickness-3349029/,2023-12-28T09:00:00+05:30,2023-12-28T03:30:00,-0.3818
Lupin gets USFDA approval for suspension to treat allergic conjunctivitis,https://www.financialexpress.com/business/healthcare-lupin-gets-usfda-approval-for-suspension-to-treat-allergic-conjunctivitis-3348989/,2023-12-28T07:00:00+05:30,2023-12-28T01:30:00,0.5574
Biocon Biologics partners with Sandoz for distribution of its biosimilar to treat immune-related diseases in Japan,https://www.financialexpress.com/business/healthcare-biocon-biologics-partners-with-sandoz-for-distribution-of-its-biosimilar-to-treat-immune-related-diseases-in-japan-3345770/,2023-12-22T21:59:42+05:30,2023-12-22T16:29:42,0.4019
Bristol to pay SystImmune up to $8.4 billion in cancer-drug deal,https://www.financialexpress.com/business/healthcare-bristol-to-pay-systimmune-up-to-8-4-billion-in-cancer-drug-deal-3336763/,2023-12-13T09:00:00+05:30,2023-12-13T03:30:00,-0.1027
Sanofi drops rare disease drug purchase after FTC files suit,https://www.financialexpress.com/business/healthcare-sanofi-drops-rare-disease-drug-purchase-after-ftc-files-suit-3336644/,2023-12-12T16:47:33+05:30,2023-12-12T11:17:33,0.0
Bengaluru doctors remove live insect larvae woman’s scalp; Read on to know all about this bizarre case,https://www.financialexpress.com/business/healthcare-bengaluru-doctors-remove-live-insect-larvae-womans-scalp-read-on-to-know-all-about-this-bizarre-case-3335914/,2023-12-12T09:00:00+05:30,2023-12-12T03:30:00,-0.3869
Merck KGaA plunges as multiple sclerosis drug fails in trial,https://www.financialexpress.com/business/healthcare-merck-kgaa-plunges-as-multiple-sclerosis-drug-fails-in-trial-3333587/,2023-12-08T17:12:45+05:30,2023-12-08T11:42:45,-0.4215
"Govt needs to take some concrete measures to demonstrate that they value intellectual property: Anil Matai, Director-General, OPPI",https://www.financialexpress.com/business/healthcare-govt-needs-to-take-some-concrete-measures-to-demonstrate-that-they-value-intellectual-property-anil-matai-director-general-oppi-3330852/,2023-12-08T07:00:00+05:30,2023-12-08T01:30:00,0.6908
Commonly used painkiller Meftal can lead to DRESS Syndrome; Govt issues alert,https://www.financialexpress.com/business/healthcare-commonly-used-painkiller-meftal-can-lead-to-dress-syndrome-govt-issues-alert-3330770/,2023-12-07T15:13:38+05:30,2023-12-07T09:43:38,0.296
Blockchain technology in pharmaceutical industry,https://www.financialexpress.com/business/blockchain-blockchain-technology-in-pharmaceutical-industry-2907920/,2022-12-10T11:30:00+05:30,2022-12-10T06:00:00,0.0
"Gland Pharma shares fall 4% on Cenexi acquisition report; should you buy, hold or sell?",https://www.financialexpress.com/market/gland-pharma-shares-fall-4-on-cenexi-acquisition-report-should-you-buy-hold-or-sell-2896465/,2022-11-30T12:11:15+05:30,2022-11-30T06:41:15,0.296
Gambia deaths: Why experts feel WHO alert is way past a wake up call on Indian drug regulatory revamp,https://www.financialexpress.com/business/healthcare-gambia-deaths-why-experts-feel-who-alert-is-way-past-a-wake-up-call-on-indian-drug-regulatory-revamp-2708295/,2022-10-13T08:26:32+05:30,2022-10-13T02:56:32,0.296
Novartis appoints Fiona Marshall as President of Novartis Institutes for Biomedical Research,https://www.financialexpress.com/business/healthcare-novartis-appoints-fiona-marshall-as-president-of-novartis-institutes-for-biomedical-research-2652438/,2022-09-01T21:28:17+05:30,2022-09-01T15:58:17,0.0
Orchid Pharma to spend up to Rs 500 cr to set up unit under PLI scheme,https://www.financialexpress.com/business/industry-orchid-pharma-to-spend-up-to-rs-500-cr-to-set-up-unit-under-pli-scheme-2649830/,2022-08-31T00:20:00+05:30,2022-08-30T18:50:00,0.0
Natco Pharma Q1 net profit rise multifold to Rs 320.4 cr,https://www.financialexpress.com/business/industry-natco-pharma-q1-net-profit-rise-multifold-to-rs-320-4-cr-2623180/,2022-08-09T15:19:02+05:30,2022-08-09T09:49:02,0.4404
Driving innovation and R&D in the Indian pharma sector,https://www.financialexpress.com/business/healthcare-driving-innovation-and-rd-in-the-indian-pharma-sector-2613326/,2022-08-01T14:03:19+05:30,2022-08-01T08:33:19,0.3818
"Dr Reddy’s share price falls 4% despite more than double Q1 net profit; should you buy, hold or sell?",https://www.financialexpress.com/market/dr-reddys-share-price-falls-4-despite-more-than-double-q1-net-profit-should-you-buy-hold-or-sell-2610339/,2022-07-29T10:01:46+05:30,2022-07-29T04:31:46,0.6249
Indian pharma firms likely to see muted revenue growth from US generics market in FY23: Icra,https://www.financialexpress.com/business/industry-indian-pharma-firms-likely-to-see-muted-revenue-growth-from-us-generics-market-in-fy23-icra-2607067/,2022-07-26T18:22:27+05:30,2022-07-26T12:52:27,0.3818
Liminal BioSciences discontinues development of fezagepras,https://www.financialexpress.com/business/healthcare-liminal-biosciences-discontinues-development-of-fezagepras-2605598/,2022-07-25T18:19:23+05:30,2022-07-25T12:49:23,0.0
"Govt to launch scheme for pharma MSMEs to support tech upgradation, improve productivity and quality",https://www.financialexpress.com/business/sme-msme-eodb-govt-to-launch-scheme-for-pharma-msmes-clusters-to-support-tech-upgradation-improve-productivity-and-quality-2599245/,2022-07-19T19:21:48+05:30,2022-07-19T13:51:48,0.6808
Online pharmacies to oppose licensing bill,https://www.financialexpress.com/business/industry-online-pharmacies-to-oppose-licensing-bill-2596745/,2022-07-18T05:45:00+05:30,2022-07-18T00:15:00,0.0
"With significant contributions to generics, India’s Pharma sector is all set to further extend its R&D capabilities: Nikkhil Masurkar, Executive Director, Entod Pharmaceuticals",https://www.financialexpress.com/business/healthcare-with-significant-contributions-to-generics-indias-pharma-sector-is-all-set-to-further-extend-its-rd-capabilities-nikkhil-masurkar-executive-director-entod-pharmaceuticals-2589135/,2022-07-10T14:36:00+05:30,2022-07-10T09:06:00,0.3612
Lupin’s Somerset Manufacturing Plant Receives EIR from US FDA,https://www.financialexpress.com/business/healthcare-lupins-somerset-manufacturing-plant-receives-eir-from-us-fda-2-2586329/,2022-07-07T16:10:10+05:30,2022-07-07T10:40:10,0.0
"Time has come for pharma industry to move to value leadership, says Mandaviya",https://www.financialexpress.com/business/industry-time-has-come-for-pharma-industry-to-move-to-value-leadership-says-mandaviya-2580704/,2022-07-02T22:13:28+05:30,2022-07-02T16:43:28,0.34
Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania,https://www.financialexpress.com/business/healthcare-sun-pharma-acquires-uractiv-portfolio-from-fiterman-pharma-in-romania-2539726/,2022-05-27T12:41:32+05:30,2022-05-27T07:11:32,0.0
India-Mali: Synergy in pharmaceuticals sector,https://www.financialexpress.com/business/healthcare-india-mali-synergy-in-pharmaceuticals-sector-2535015/,2022-05-23T18:40:10+05:30,2022-05-23T13:10:10,0.0
GlaxoSmithKline Pharma reports Q4 net loss at Rs 55 crore,https://www.financialexpress.com/business/industry-glaxosmithkline-pharma-reports-q4-net-loss-at-rs-55-cr-2527055/,2022-05-16T20:42:26+05:30,2022-05-16T15:12:26,-0.3182
Oman to fast-track approval for Indian pharma products,https://www.financialexpress.com/policy/economy-oman-to-fast-track-approval-for-indian-pharma-products-2521430/,2022-05-12T08:45:29+05:30,2022-05-12T03:15:29,0.4767
"Oman to fast-track approval of Indian pharma products registered by USFDA, UKMHRA, EMA",https://www.financialexpress.com/business/healthcare-oman-to-fast-track-approval-of-indian-pharma-products-registered-by-usfda-ukmhra-ema-2521132/,2022-05-11T21:21:47+05:30,2022-05-11T15:51:47,0.4767
"Domestic manufacturing of key ingredients must be ramped up to reduce dependence on other countries: Sudarshan Jain, IPA",https://www.financialexpress.com/business/healthcare-domestic-manufacturing-of-key-ingredients-must-be-ramped-up-to-reduce-dependence-on-other-countries-sudarshan-jain-ipa-2520046/,2022-05-11T11:36:42+05:30,2022-05-11T06:06:42,0.0
"Driven by big pharma needs, Syngene to focus on expanding breadth of services & capabilities",https://www.financialexpress.com/business/healthcare-driven-by-big-pharma-needs-syngene-to-focus-on-expanding-breadth-of-services-capabilities-2511519/,2022-05-05T15:13:30+05:30,2022-05-05T09:43:30,0.0
Alembic gets USFDA nod to market generic drug,https://www.financialexpress.com/business/healthcare-alembic-gets-usfda-nod-to-market-generic-drug-2497776/,2022-04-20T14:13:46+05:30,2022-04-20T08:43:46,0.0
How biotechnology can contribute to the development of a country,https://www.financialexpress.com/life/science-how-biotechnology-can-contribute-to-the-development-of-a-country-2494956/,2022-04-18T14:18:50+05:30,2022-04-18T08:48:50,0.0
FE Pharma Summit 2022 Day 2: Indian Pharma – The Opportunity In Adversity Story,https://www.financialexpress.com/videos/business-video/2476369/fe-pharma-summit-2022-day-2-indian-pharma-the-opportunity-in-adversity-story/,2022-03-30T16:07:59+05:30,2022-03-30T10:37:59,0.0
FE Pharma Summit 2022 Day 1: From Pharmacy Of the World To Being Its Innovation Hub,https://www.financialexpress.com/videos/business-video/2476343/fe-pharma-summit-2022-day-1-from-pharmacy-of-the-world-to-being-its-innovation-hub/,2022-03-30T15:48:20+05:30,2022-03-30T10:18:20,0.3818
"FE Pharma Summit: DoP has drafted policy to catalyze R&D in pharma sector: S Aparna, Secretary, DoP",https://www.financialexpress.com/business/healthcare-fe-pharma-summit-dop-has-drafted-policy-to-catalyze-rd-in-pharma-sector-s-aparna-secretary-dop-2471101/,2022-03-24T21:31:45+05:30,2022-03-24T16:01:45,0.0
Deadline for proposals under PLI scheme for bulk drugs extended till March-end,https://www.financialexpress.com/business/healthcare-deadline-for-proposals-under-pli-scheme-for-bulk-drugs-extended-till-march-end-2460523/,2022-03-14T17:38:12+05:30,2022-03-14T12:08:12,0.0
Pharma cos can’t claim IT deduction on freebies to doctors to promote sales of medicines prohibited by law: SC,https://www.financialexpress.com/business/healthcare-pharma-cos-cant-claim-it-deduction-on-freebies-to-doctors-to-promote-sales-of-medicines-prohibited-by-law-sc-2442275/,2022-02-23T11:57:25+05:30,2022-02-23T06:27:25,0.6597
Binnopharm Group inks deal to acquire two anti-bacterial brands from Dr. Reddy’s in the Russia & CIS region,https://www.financialexpress.com/business/healthcare-binnopharm-group-inks-deal-to-acquire-two-anti-bacterial-brands-from-dr-reddys-in-the-russia-cis-region-2439964/,2022-02-21T11:45:42+05:30,2022-02-21T06:15:42,0.0
"Dr Reddy’s, Sun Pharma shares rise a day after India approves COVID-19 vaccines for emergency use",https://www.financialexpress.com/market/dr-reddys-sun-pharma-shares-rise-after-india-approves-covid-19-vaccines-for-emergency-use-2393031/,2021-12-29T15:54:39+05:30,2021-12-29T10:24:39,0.3182
"Pharma shares regaining momentum, resuming up-trend; here’s how to shape your stock portfolio",https://www.financialexpress.com/market/pharma-shares-regaining-momentum-resuming-up-trend-heres-how-to-shape-your-stock-portfolio-2187771/,2021-02-04T13:54:50+05:30,2021-02-04T08:24:50,0.296
"Gland Pharma shares gain 36% over issue price; neat USFDA record, strong sales to further aid growth",https://www.financialexpress.com/market/gland-pharma-shares-gain-38-over-issue-price-neat-usfda-record-strong-sales-to-further-aid-growth-2135150/,2020-11-24T16:28:47+05:30,2020-11-24T10:58:47,0.926
JM Financial India Portfolio: Why large caps look cheaper than small and midcaps,https://www.financialexpress.com/market/jm-financial-india-portfolio-why-large-caps-look-cheaper-than-small-and-midcaps-3845610/,2025-05-15T12:58:12+05:30,2025-05-15T07:28:12,0.0
Bitter pill: 2 reasons why Nuvama retains ‘Hold’ on Cipla,https://www.financialexpress.com/market/bitter-pill-2-reasons-wny-nuvama-retains-hold-on-cipla-3845422/,2025-05-15T09:56:39+05:30,2025-05-15T04:26:39,-0.4215
"Why are pharma stocks falling despite 2,200-point Sensex rally? Nifty Pharma slides 2%",https://www.financialexpress.com/market/why-are-pharma-stocks-falling-despite-2200-point-sensex-rally-nifty-pharma-slides-2-3841134/,2025-05-12T10:49:19+05:30,2025-05-12T05:19:19,0.2732
Market master Vijay Kedia’s 2 favourite stocks: Must-know holdings for smart investors,https://www.financialexpress.com/market/stock-insights/market-master-vijay-kedias-2-favourite-stocks-must-know-holdings-for-smart-investors/3840593/,2025-05-12T06:00:00+05:30,2025-05-12T00:30:00,0.4019
"India’s CDMO sector to post 13-15% revenue growth in FY26 amid US tariff concerns, says Crisil",https://www.financialexpress.com/business/industry-indias-crdmo-sector-to-post-13-15-revenue-growth-in-fy26-amid-us-tariff-concerns-says-crisil-3837181/,2025-05-08T13:58:52+05:30,2025-05-08T08:28:52,0.3818
Tariff Panic! 3 crucial concerns as pharma stocks plunge on Trump’s big claims,https://www.financialexpress.com/market/tariff-panic-3-crucial-concerns-as-pharma-stocks-plunge-on-trumps-big-claims-3803992/,2025-04-09T12:29:59+05:30,2025-04-09T06:59:59,-0.5562
"Exclusive | ‘Prefer banks, metals present big opportunity, tech to disappoint ’: Anand Shah, ICICI Prudential",https://www.financialexpress.com/market/exclusive-prefer-banks-metals-present-big-opportunity-tech-to-disappoint-anand-shah-icici-prudential-3800437/,2025-04-06T08:52:36+05:30,2025-04-06T03:22:36,0.1531
Pharma stocks tank as Trump signals steep tariffs,https://www.financialexpress.com/market/pharma-stocks-tank-as-trump-signals-steep-tariffs-3799324/,2025-04-04T21:37:42+05:30,2025-04-04T16:07:42,0.0
"Indian pharma products may be subject to duties in future actions under US Trade Expansion Act, reveals report",https://www.financialexpress.com/business/healthcare-indian-pharma-products-may-be-subject-to-duties-in-future-actions-under-us-trade-expansion-act-reveals-report-3797565/,2025-04-03T14:40:28+05:30,2025-04-03T09:10:28,0.0
"Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst",https://www.financialexpress.com/business/healthcare-pharma-tariff-exemption-temporary-relief-but-higher-tariffs-may-be-imposed-later-warns-analyst-3797429/,2025-04-03T12:52:14+05:30,2025-04-03T07:22:14,0.0
Novartis gets USFDA nod for its therapy to treat Berger’s disease,https://www.financialexpress.com/business/healthcare-novartis-gets-usfda-nod-for-its-therapy-to-treat-bergers-disease-3797316/,2025-04-03T11:19:29+05:30,2025-04-03T05:49:29,0.4019
India’s pharma sector secures tariff exemption; IPA lauds boost for affordable medicines,https://www.financialexpress.com/business/healthcare-indias-pharma-sector-secures-tariff-exemption-ipa-lauds-boost-for-affordable-medicines-3797246/,2025-04-03T10:26:24+05:30,2025-04-03T04:56:24,0.6124
Hims & Hers to sell Lilly’s weight-loss drug on its telehealth platform,https://www.financialexpress.com/business/healthcare-hims-hers-to-sell-lillys-weight-loss-drug-on-its-telehealth-platform-3796664/,2025-04-02T17:46:02+05:30,2025-04-02T12:16:02,0.0
US tariffs on pharma: THESE companies could be hit the hardest – All you need to know,https://www.financialexpress.com/business/healthcare-us-tariffs-on-pharma-these-companies-could-be-hit-the-hardest-all-you-need-to-know-3796636/,2025-04-02T17:25:05+05:30,2025-04-02T11:55:05,0.0
"Bayer Pharma to expand cardiology, women’s health portfolios with new drugs this year",https://www.financialexpress.com/business/healthcare-bayer-pharma-to-expand-cardiology-womens-health-portfolios-with-new-drugs-this-year-3796210/,2025-04-02T11:37:38+05:30,2025-04-02T06:07:38,0.3182
Gennova partners with CEPI to develop saRNA vaccine for Nipah virus,https://www.financialexpress.com/business/healthcare-gennova-partners-with-cepi-to-develop-sarna-vaccine-for-nipah-virus-3795565/,2025-04-01T17:43:40+05:30,2025-04-01T12:13:40,0.0
Pharma majors expand US manufacturing amid tariff pressures as BRICS boost biosimilar access: GlobalData,https://www.financialexpress.com/business/healthcare-pharma-majors-expand-us-manufacturing-amid-tariff-pressures-as-brics-boost-biosimilar-access-globaldata-3795419/,2025-04-01T16:12:16+05:30,2025-04-01T10:42:16,0.4019
Pharma industry lobbies US President Trump for phased tariffs: Report,https://www.financialexpress.com/business/healthcare-pharma-industry-lobbies-us-president-trump-for-phased-tariffs-report-3795388/,2025-04-01T15:48:12+05:30,2025-04-01T10:18:12,0.0
Eli Lilly sues two companies over illegal copies of weight-loss drugs,https://www.financialexpress.com/business/healthcare-eli-lilly-sues-two-companies-over-illegal-copies-of-weight-loss-drugs-3795346/,2025-04-01T15:26:06+05:30,2025-04-01T09:56:06,-0.5574
Akums launches combination formulation for glaucoma and ocular hypertension treatment,https://www.financialexpress.com/business/healthcare-akums-launches-combination-formulation-for-glaucoma-and-ocular-hypertension-treatment-3795130/,2025-04-01T11:43:32+05:30,2025-04-01T06:13:32,0.0
Medicine Price Hike: Over 900 essential medicines to get costlier from April 1,https://www.financialexpress.com/business/medicine-price-hike-over-900-essential-medicines-to-get-costlier-from-april-1-3794322/,2025-03-31T15:26:03+05:30,2025-03-31T09:56:03,0.0
CDSCO flags 103 popular drugs like Azithromycin & Paracetamol for quality issues; Fake batch of BP medication found,https://www.financialexpress.com/business/healthcare-cdsco-flags-103-popular-drugs-like-azithromycin-paracetamol-for-quality-issues-fake-batch-of-bp-medication-found-3794211/,2025-03-31T13:44:32+05:30,2025-03-31T08:14:32,0.296
USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months,https://www.financialexpress.com/business/healthcare-usfda-approves-novel-treatment-for-hemophilia-medication-can-be-given-up-to-once-every-2-months-3793245/,2025-03-30T11:43:33+05:30,2025-03-30T06:13:33,0.6124
USFDA grants marketing authorisation of first home test for sexually transmitted infections,https://www.financialexpress.com/business/healthcare-usfda-grants-marketing-authorisation-of-first-home-test-for-sexually-transmitted-infections-3793188/,2025-03-30T10:55:14+05:30,2025-03-30T05:25:14,0.2263
Merck signs deal with Jiangsu Hengrui for access to heart drug,https://www.financialexpress.com/business/healthcare-merck-signs-deal-with-jiangsu-hengrui-for-access-to-heart-drug-3788243/,2025-03-25T16:39:35+05:30,2025-03-25T11:09:35,0.0
"Cell and gene therapy market set to grow at 44% CAGR through 2030, reveals GlobalData",https://www.financialexpress.com/business/healthcare-cell-and-gene-therapy-market-set-to-grow-at-44-cagr-through-2030-reveals-globaldata-3787649/,2025-03-25T10:23:28+05:30,2025-03-25T04:53:28,0.0
"FDA drug approvals drop 15.44 percent, but smaller pharma leads innovation: GlobalData",https://www.financialexpress.com/business/healthcare-fda-drug-approvals-drop-15-44-percent-but-smaller-pharma-leads-innovation-globaldata-3786818/,2025-03-24T16:17:49+05:30,2025-03-24T10:47:49,0.431
"As Eli Lilly’s popular weight loss drug enters India, doctors warn of potential misuse",https://www.financialexpress.com/business/healthcare-as-eli-lillys-popular-weight-loss-drug-enters-india-doctors-warn-of-potential-misuse-3783663/,2025-03-21T09:41:24+05:30,2025-03-21T04:11:24,0.0258
Bharat Biotech launches integrated Cell and Gene Therapy facility in India,https://www.financialexpress.com/business/healthcare-bharat-biotech-launches-integrated-cell-and-gene-therapy-in-india-3783074/,2025-03-20T16:51:03+05:30,2025-03-20T11:21:03,0.0
Eli Lilly launches its blockbuster weight loss drug Mounjaro in India,https://www.financialexpress.com/business/healthcare-eli-lilly-launches-its-blockbuster-weight-loss-drug-mounjaro-in-india-3782702/,2025-03-20T12:21:06+05:30,2025-03-20T06:51:06,0.3818
Strides Pharma approves demerger from Arco Labs,https://www.financialexpress.com/business/healthcare-strides-pharma-approves-demerger-from-arco-labs-3781626/,2025-03-19T12:04:17+05:30,2025-03-19T06:34:17,0.4019
Cipla signs multi-regional licensing deal with Formosa for eye disorder,https://www.financialexpress.com/business/healthcare-cipla-signs-multi-regional-licensing-deal-with-formosa-for-eye-disorder-3780747/,2025-03-18T15:23:18+05:30,2025-03-18T09:53:18,-0.4019
Incyte’s skin disease drug meets main goal in late-stage studies,https://www.financialexpress.com/business/healthcare-incytes-skin-disease-drug-meets-main-goal-in-late-stage-studies-3779754/,2025-03-17T17:25:29+05:30,2025-03-17T11:55:29,0.0
Govt set to rollout key TB drug Rifampicin in India this year,https://www.financialexpress.com/business/healthcare-govt-set-to-rollout-key-tb-drug-rifampicin-in-india-this-year-3779326/,2025-03-17T12:30:18+05:30,2025-03-17T07:00:18,0.0
"Gilead Sciences’ annual HIV prevention injection shows promise in clinical trial, Lancet study reveals",https://www.financialexpress.com/business/healthcare-gilead-sciences-annual-hiv-prevention-injection-shows-promise-in-clinical-trial-lancet-study-reveals-3775743/,2025-03-12T17:05:09+05:30,2025-03-12T11:35:09,0.3182
"IPA defends Indian generics, dismisses US study questioning drug quality",https://www.financialexpress.com/business/healthcare-ipa-defends-indian-generics-dismisses-us-study-questioning-drug-quality-3775584/,2025-03-12T15:26:16+05:30,2025-03-12T09:56:16,-0.1027
"Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja",https://www.financialexpress.com/business/healthcare-empagliflozin-generic-to-be-sold-at-90-discount-expecting-50-volume-growth-mankinds-md-rajeev-juneja-3775475/,2025-03-12T13:56:46+05:30,2025-03-12T08:26:46,0.3818
Alkem Labs launches generic formulation of Boehringer’s diabetes drug in India,https://www.financialexpress.com/business/healthcare-alkem-labs-launches-generic-formulation-of-boehringers-diabetes-drug-in-india-3775276/,2025-03-12T11:35:56+05:30,2025-03-12T06:05:56,0.0
FDA gives nod to first generics of Xarelto to treat stroke and heart disorders,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-first-generics-of-xarelto-to-treat-stroke-and-heart-disorders-3774099/,2025-03-11T11:23:47+05:30,2025-03-11T05:53:47,0.4019
Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India?,https://www.financialexpress.com/business/healthcare-boehringer-ingelheims-blockbuster-diabetes-drug-goes-off-patent-todaywill-it-lower-treatment-costs-in-india-3774052/,2025-03-11T10:51:26+05:30,2025-03-11T05:21:26,0.4019
Biocon Biologics partners with Civica to expand Insulin Aspart access in United States,https://www.financialexpress.com/business/healthcare-biocon-biologics-partners-with-civica-to-expand-insulin-aspart-access-in-united-states-3769655/,2025-03-06T18:12:08+05:30,2025-03-06T12:42:08,0.6249
Novo Nordisk to launch new therapies in blood and growth disorders after success in diabetes and obesity,https://www.financialexpress.com/business/healthcare-novo-nordisk-to-launch-new-therapies-in-blood-and-growth-disorders-after-success-in-diabetes-and-obesity-3769596/,2025-03-06T17:46:44+05:30,2025-03-06T12:16:44,0.743
Novo Nordisk CEO warns of drug shortages and price hikes in US,https://www.financialexpress.com/business/healthcare-novo-nordisk-ceo-warns-of-drug-shortages-and-price-hikes-in-us-3769511/,2025-03-06T16:31:04+05:30,2025-03-06T11:01:04,-0.25
Eris Lifesciences appoints Murari Ranganathan as president of Cardiometabolic Business,https://www.financialexpress.com/business/healthcare-eris-lifesciences-appoints-murari-ranganathan-as-president-of-cardiometabolic-business-3769228/,2025-03-06T12:32:34+05:30,2025-03-06T07:02:34,0.0
Zydus Lifesciences launches breakthrough drug for transplant patients in India,https://www.financialexpress.com/business/healthcare-zydus-lifesciences-launches-breakthrough-drug-for-transplant-in-india-3768259/,2025-03-05T15:59:50+05:30,2025-03-05T10:29:50,0.0
Zydus to develop the world’s first combination vaccine to offer protection against shigellosis and typhoid,https://www.financialexpress.com/business/healthcare-zydus-to-develop-the-worlds-first-combination-vaccine-to-offer-protection-against-shigellosis-and-typhoid-3766750/,2025-03-04T13:26:41+05:30,2025-03-04T07:56:41,0.0
Pfizer may soon move its overseas manufacturing to United States to counter potential tariff hit,https://www.financialexpress.com/business/healthcare-pfizer-may-soon-move-its-overseas-manufacturing-to-united-states-to-counter-potential-tariff-hit-3766635/,2025-03-04T11:58:18+05:30,2025-03-04T06:28:18,0.4215
Indian drug regulator to free up manpower for better regulatory execution,https://www.financialexpress.com/business/healthcare-indian-drug-regulator-to-free-up-manpower-for-better-regulatory-executionnbsp-3762120/,2025-02-27T14:02:09+05:30,2025-02-27T08:32:09,0.7351
"Indian pharma rises to global prominence led by export boom and better compliance rates, McKinsey report reveals",https://www.financialexpress.com/business/healthcare-indian-pharma-rises-to-global-prominence-led-by-export-boom-and-better-compliance-rates-mckinsey-report-reveals-3762058/,2025-02-27T13:19:43+05:30,2025-02-27T07:49:43,0.4404
Zydus Lifesciences launches flu vaccine in India to combat new influenza strain,https://www.financialexpress.com/business/healthcare-zydus-lifesciences-launches-flu-vaccine-in-india-to-combat-new-influenza-strain-3760841/,2025-02-26T12:11:45+05:30,2025-02-26T06:41:45,-0.6369
How will Trump’s tariff threat on pharmaceuticals impact Indian drugmakers? Dr Reddy’s reacts,https://www.financialexpress.com/business/healthcare-how-will-trumps-tariff-threat-on-pharmaceuticals-impact-indian-drugmakers-dr-reddys-reacts-3759846/,2025-02-25T13:01:27+05:30,2025-02-25T07:31:27,-0.5267
Opioid drugs row: Health secretary calls for stronger regulations to ensure quality medicines,https://www.financialexpress.com/business/healthcare-opioid-drugs-row-health-secretary-calls-for-stronger-regulations-to-ensure-quality-medicines-3759724/,2025-02-25T11:34:36+05:30,2025-02-25T06:04:36,0.6369
Biocon Biologics launches biosimilar to treat Crohn’s disease in United States,https://www.financialexpress.com/business/healthcare-biocon-biologics-launches-biosimilar-to-treat-crohns-disease-in-united-states-3759164/,2025-02-24T17:31:52+05:30,2025-02-24T12:01:52,0.6705
Government suspends Aveo Pharma operations over opioid drug scandal; firm was exporting banned drugs to West Africa,https://www.financialexpress.com/business/healthcare-government-suspends-aveo-pharma-operations-over-opioid-drug-scandal-firm-was-exporting-banned-drugs-to-west-africa-3758553/,2025-02-24T10:31:22+05:30,2025-02-24T05:01:22,-0.7096
Donald Trump pushes drugmakers to shift overseas production to US or face tariffs: Report,https://www.financialexpress.com/world-news/donald-trump-pushes-drugmakers-to-shift-overseas-production-to-us-or-face-tariffs-report/3756988/,2025-02-22T12:26:58+05:30,2025-02-22T06:56:58,0.0
Top US health agency revises definitions of ‘Female’ and ‘Male’ under Trump order,https://www.financialexpress.com/business/healthcare-top-us-health-agency-revises-definitions-of-female-and-male-under-trump-order-3755094/,2025-02-20T12:06:28+05:30,2025-02-20T06:36:28,0.2023
Trump to meet pharma leaders amid push for govt support on drug pricing,https://www.financialexpress.com/business/healthcare-trump-to-meet-pharma-leaders-amid-push-for-govt-support-on-drug-pricing-3755051/,2025-02-20T11:41:21+05:30,2025-02-20T06:11:21,0.4019
‘India supplies 47% generic medicines to US…’: IPA responds to Trump’s 25% tariff threat,https://www.financialexpress.com/business/healthcare-india-supplies-47-generic-medicines-to-us-ipa-responds-to-trumps-25-tariff-threat-3753896/,2025-02-19T13:31:42+05:30,2025-02-19T08:01:42,-0.5267
FDA Alert: Millions of granola bars recalled over metal contamination; Classified as class II risk,https://www.financialexpress.com/business/healthcare-fda-alert-millions-of-granola-bars-recalled-over-metal-contamination-classified-as-class-ii-risk-3752590/,2025-02-18T10:33:41+05:30,2025-02-18T05:03:41,0.0258
Glenmark and FDC recall products in United States over manufacturing concerns,https://www.financialexpress.com/business/healthcare-glenmark-and-fdc-recall-products-in-united-states-over-manufacturing-concerns-3751972/,2025-02-17T15:54:14+05:30,2025-02-17T10:24:14,0.4215
Q3FY25: GSK pharma’s profit surges 4X to Rs 229 crore; Revenue up 18 percent,https://www.financialexpress.com/business/healthcare-q3fy25-gsk-pharmas-profit-surges-4x-to-rs-229-crore-revenue-up-18-percent-3749451/,2025-02-14T16:42:33+05:30,2025-02-14T11:12:33,0.4404
Novo Nordisk to seek regulatory approval for obesity drug early 2026,https://www.financialexpress.com/business/healthcare-novo-nordisk-to-seek-regulatory-approval-for-obesity-drug-early-2026-3738634/,2025-02-05T14:00:22+05:30,2025-02-05T08:30:22,0.4767
Lilly India appoints Winselow Tucker as President and General Manager,https://www.financialexpress.com/business/healthcare-lilly-india-appoints-winselow-tucker-as-president-and-general-manager-3737257/,2025-02-04T12:01:06+05:30,2025-02-04T06:31:06,0.0
"Economic Survey 2025 highlights impact of Ultra-processed junk food, U-WIN’s role in immunisation effort",https://www.financialexpress.com/business/healthcare-economic-survey-2025-highlights-impact-of-ultra-processed-junk-food-u-wins-role-in-immunisation-effort-3733104/,2025-02-01T07:14:34+05:30,2025-02-01T01:44:34,0.0
Rare disease patients urge PM Modi to address delay in Rs 974 crore national programme roll-out,https://www.financialexpress.com/business/healthcare-rare-disease-patients-urge-pm-modi-to-address-delay-in-rs-974-crore-national-programme-roll-out-3730461/,2025-01-30T08:25:00+05:30,2025-01-30T02:55:00,-0.3182
FE Mental Health Series | ‘My brother’s schizophrenia showed me society’s lack of support for the mentally ill’,https://www.financialexpress.com/business/healthcare-fe-mental-health-series-my-brothers-schizophrenia-showed-me-societys-lack-of-support-for-the-mentally-ill-3730443/,2025-01-30T08:08:00+05:30,2025-01-30T02:38:00,0.1027
Budget 2025: Will Nirmala Sitharaman cut the cost of medicines and hospitalisation?,https://www.financialexpress.com/business/healthcare-budget-2025-will-nirmala-sitharaman-cut-the-cost-of-medicines-and-hospitalisation-3730185/,2025-01-29T17:44:51+05:30,2025-01-29T12:14:51,-0.2732
USFDA gives nod to Novo Nordisk’s Ozempic to reduce risk of kidney failure,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-novo-nordisks-ozempic-to-reduce-risk-of-kidney-failure-3729632/,2025-01-29T10:11:37+05:30,2025-01-29T04:41:37,-0.6597
"Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore",https://www.financialexpress.com/business/healthcare-q3fy25-mankind-pharmas-revenue-up-by-24-percent-to-rs-3230-crore-profit-at-rs-380-crore-3724252/,2025-01-23T19:39:43+05:30,2025-01-23T14:09:43,0.4404
"Q3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio",https://www.financialexpress.com/business/healthcare-q3fy25-dr-reddys-to-focus-on-continued-capex-investment-rd-and-increasing-capacity-of-existing-portfolio-3724242/,2025-01-23T19:27:55+05:30,2025-01-23T13:57:55,0.0
USFDA issues warning of serious allergic reaction with multiple sclerosis drugs; Urges patients to be cautious,https://www.financialexpress.com/business/healthcare-usfda-issues-warning-of-serious-allergic-reaction-with-multiple-sclerosis-drugs-3723649/,2025-01-23T12:31:27+05:30,2025-01-23T07:01:27,-0.6486
Immuneel Therapeutics launches CAR T-cell therapy for blood cancer in India,https://www.financialexpress.com/business/healthcare-immuneel-therapeutics-launches-global-car-t-cell-therapy-for-non-hodgkins-lymphoma-in-india-3720597/,2025-01-20T17:34:08+05:30,2025-01-20T12:04:08,-0.6597
"Biocon urges government to exempt cancer, rare-disease drugs from tax in Budget 2025",https://www.financialexpress.com/business/healthcare-biocon-urges-government-to-exempt-cancer-rare-disease-drugs-from-tax-in-budget-2025-3720537/,2025-01-20T16:52:59+05:30,2025-01-20T11:22:59,-0.6124
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation,https://www.financialexpress.com/business/healthcare-astrazenecas-fasenra-set-to-revolutionise-copd-treatment-as-phase-iii-data-builds-anticipation-3719616/,2025-01-19T15:51:39+05:30,2025-01-19T10:21:39,0.1027
Sanofi to increase competition in atopic dermatitis market after Dupixent’s success,https://www.financialexpress.com/business/healthcare-sanofi-to-increase-competition-in-atopic-dermatitis-market-after-dupixents-success-3719607/,2025-01-19T15:41:31+05:30,2025-01-19T10:11:31,0.7184
US govt grants Moderna $590 million to make bird flu vaccine,https://www.financialexpress.com/business/healthcare-us-govt-grants-moderna-590-million-to-make-bird-flu-vaccine-3719418/,2025-01-19T12:07:05+05:30,2025-01-19T06:37:05,-0.1779
"Weight loss pills Ozempic, Wegovy and Trizepatide enter Indian market",https://www.financialexpress.com/business/healthcare-weight-loss-pills-ozempic-wegovy-and-trizepatide-enter-indian-market-3719083/,2025-01-19T10:03:13+05:30,2025-01-19T04:33:13,-0.3182
Gene therapy exempted from GST; duty cuts on critical medicines for cancer and rare diseases expected,https://www.financialexpress.com/business/healthcare-gene-therapy-exempted-from-gst-duty-cuts-on-critical-medicines-for-cancer-and-rare-diseases-expected-3718804/,2025-01-18T14:21:16+05:30,2025-01-18T08:51:16,-0.836
Budget 2025 Expectations: Pharma leaders emphasise on expansion of PLI scheme to include investments in APIs,https://www.financialexpress.com/business/healthcare-budget-2025-expectations-pharma-leaders-emphasise-on-expansion-of-pli-scheme-to-include-investments-in-apis-3717953/,2025-01-17T13:27:27+05:30,2025-01-17T07:57:27,0.0
USFDA issues warning against use of anti-allergic nasal spray intravenously,https://www.financialexpress.com/business/healthcare-usfda-issues-warning-against-use-of-anti-allergic-nasal-spray-intravenously-3717917/,2025-01-17T12:50:45+05:30,2025-01-17T07:20:45,-0.34
Newron and Myung In Pharm announce license agreement for schizophrenia therapy in South Korea,https://www.financialexpress.com/business/healthcare-newron-and-myung-in-pharm-announce-license-agreement-for-schizophrenia-therapy-in-south-korea-3711864/,2025-01-10T11:57:40+05:30,2025-01-10T06:27:40,0.4939
USFDA gives nod to Lupin’s generic formulation to treat eye issues,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-formulation-to-treat-eye-issues-3711276/,2025-01-09T17:14:44+05:30,2025-01-09T11:44:44,0.4019
China’s drug regulator gives nod to HPV vaccine for men,https://www.financialexpress.com/business/healthcare-chinas-drug-regulator-gives-nod-to-hpv-vaccine-for-men-3710089/,2025-01-08T12:10:52+05:30,2025-01-08T06:40:52,0.0
Novartis gene therapy poised to expand SMA treatment landscape,https://www.financialexpress.com/business/healthcare-novartis-gene-therapy-poised-to-expand-sma-treatment-landscape-3709502/,2025-01-07T17:13:28+05:30,2025-01-07T11:43:28,0.5106
Zydus Lifesciences partners with CVS Caremark for diabetes drugs template formulary,https://www.financialexpress.com/business/healthcare-zydus-lifesciences-partners-with-cvs-caremark-for-diabetes-drugs-template-formulary-3709348/,2025-01-07T14:52:35+05:30,2025-01-07T09:22:35,0.0
"Budget 2025 Expectations: Healthcare industry leaders demand strategic reforms, standardised practices and advanced medical education",https://www.financialexpress.com/business/healthcare-budget-2025-healthcare-industry-leaders-strategic-reforms-standardised-practices-and-advanced-medical-education-3709306/,2025-01-07T14:12:38+05:30,2025-01-07T08:42:38,0.128
What’s in store for pharmaceutical sector in 2025?,https://www.financialexpress.com/business/healthcare-whats-in-store-for-pharmaceutical-sector-in-2025-3706432/,2025-01-03T12:21:12+05:30,2025-01-03T06:51:12,0.0
Can gel treat breast cancer? Indian scientists develop new injectable therapy with less side effects,https://www.financialexpress.com/life/can-gel-treat-breast-cancer-indian-scientists-develop-new-injectable-therapy-with-less-side-effects-3705832/,2025-01-02T17:05:11+05:30,2025-01-02T11:35:11,-0.4019
Type 1 diabetes market to reach $9.9 billion in 7 major markets by 2033,https://www.financialexpress.com/business/healthcare-type-1-diabetes-market-to-reach-9-9-billion-in-7-major-markets-by-2033-3705794/,2025-01-02T16:42:45+05:30,2025-01-02T11:12:45,0.0258
Akums opens new facility for lyophilised and sterile dosage manufacturing,https://www.financialexpress.com/business/healthcare-akums-opens-new-facility-for-lyophilized-and-sterile-dosage-manufacturing-3705766/,2025-01-02T15:50:39+05:30,2025-01-02T10:20:39,0.0
Eli Lilly’s Zepbound holds potential to dominate obesity market,https://www.financialexpress.com/business/healthcare-eli-lillys-zepbound-holds-potential-to-dominate-obesity-market-3704456/,2024-12-31T16:26:00+05:30,2024-12-31T10:56:00,-0.128
Novartis’ novel therapy to treat SMA Type 2 shows significant positive outcome in Phase III study,https://www.financialexpress.com/business/healthcare-novartis-novel-therapy-to-treat-sma-type-2-shows-significant-positive-outcome-in-phase-iii-study-3704254/,2024-12-31T12:58:38+05:30,2024-12-31T07:28:38,0.8555
Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio,https://www.financialexpress.com/business/healthcare-lupin-acquires-huminsulin-from-lilly-to-enhance-diabetes-portfolio-3704243/,2024-12-31T12:47:31+05:30,2024-12-31T07:17:31,0.0
Fortis Healthcare appoints Leo Puri as Chairman of the Board,https://www.financialexpress.com/business/healthcare-fortis-healthcare-appoints-leo-puri-as-chairman-of-the-board-3701533/,2024-12-27T15:26:58+05:30,2024-12-27T09:56:58,0.0
Akums enters into €200 Million partnership for European market expansion for supply of formulations,https://www.financialexpress.com/business/healthcare-akums-group-enters-into-200-million-partnership-for-european-market-expansion-for-supply-of-pharmaceutical-formulations-3700555/,2024-12-26T13:49:52+05:30,2024-12-26T08:19:52,0.0
Mankind Pharma and Innovent Biologics partner to commercialise innovative immunotherapy in India,https://www.financialexpress.com/business/healthcare-mankind-pharma-and-innovent-biologics-partner-to-commercialise-innovative-immunotherapy-in-india-3700520/,2024-12-26T12:56:06+05:30,2024-12-26T07:26:06,0.4404
Indian pharma companies focus on innovative research in foreign countries through dedicated entities,https://www.financialexpress.com/business/healthcare-indian-pharma-companies-focus-on-innovative-research-in-foreign-countries-through-dedicated-entities-3699135/,2024-12-24T15:27:53+05:30,2024-12-24T09:57:53,0.7096
Operating losses of e-pharmacies seen falling below 10 percent next fiscal: CRISIL,https://www.financialexpress.com/business/healthcare-operating-losses-of-e-pharmacies-seen-falling-below-10-percent-next-fiscal-crisil-3699104/,2024-12-24T15:05:04+05:30,2024-12-24T09:35:04,-0.5106
Kenvue India present report on hydration gap for non-diarrheal illnesses,https://www.financialexpress.com/business/healthcare-kenvue-india-present-report-on-hydration-gap-for-non-diarrheal-illnesses-3696533/,2024-12-20T17:00:13+05:30,2024-12-20T11:30:13,-0.4939
Fortis Hospitals Mumbai launches initiative to address lack of emergency contact; Launches new helpline number,https://www.financialexpress.com/business/healthcare-fortis-hospitals-mumbai-launches-initiative-to-address-lack-of-emergency-contact-launches-new-helpline-number-3696255/,2024-12-20T12:29:32+05:30,2024-12-20T06:59:32,-0.5574
Year in review: Major medical breakthroughs of 2024 that you must know,https://www.financialexpress.com/business/healthcare-year-in-review-major-medical-breakthroughs-of-2024-that-you-must-know-3695503/,2024-12-19T15:50:35+05:30,2024-12-19T10:20:35,0.0
Granules India Limited gets USFDA nod for ADHD treatment,https://www.financialexpress.com/business/healthcare-granules-india-limited-gets-usfda-nod-for-adhd-treatment-3694908/,2024-12-19T08:04:00+05:30,2024-12-19T02:34:00,-0.2263
Lupin acquires three trademarks from Boehringer Ingelheim to strengthen diabetes portfolio in India,https://www.financialexpress.com/business/healthcare-lupin-acquires-three-trademarks-from-boehringer-ingelheim-to-strengthen-diabetes-portfolio-in-india-3692274/,2024-12-16T08:03:00+05:30,2024-12-16T02:33:00,0.3182
Toripalimab to fortify Dr. Reddy’s oncology portfolio in India,https://www.financialexpress.com/business/healthcare-toripalimab-to-fortify-dr-reddys-oncology-portfolio-in-india-3689892/,2024-12-12T10:29:29+05:30,2024-12-12T04:59:29,0.0
CDSCO gives nod to Cipla for distribution and marketing of inhaled insulin in India,https://www.financialexpress.com/business/healthcare-cdsco-gives-nod-to-cipla-for-distribution-and-marketing-of-inhaled-insulin-in-india-3689553/,2024-12-11T17:31:56+05:30,2024-12-11T12:01:56,0.0
First-in-human indigenous gene therapy for Hemophilia A shows significant positive outcomes,https://www.financialexpress.com/business/healthcare-first-in-human-indigenous-gene-therapy-for-hemophilia-a-shows-significant-positive-outcomes-3689479/,2024-12-11T16:12:27+05:30,2024-12-11T10:42:27,0.6597
"Despite heavy marketing, most Americans reject new weight-loss drugs",https://www.financialexpress.com/business/healthcare-despite-heavy-marketing-most-americans-reject-new-weight-loss-drugs-3689319/,2024-12-11T13:14:30+05:30,2024-12-11T07:44:30,-0.4549
"Dr. Morepen enters wellness segment with weight management solution, focuses on India market",https://www.financialexpress.com/business/healthcare-dr-morepen-enters-wellness-segment-with-weight-management-solution-focuses-on-india-market-3688789/,2024-12-10T18:24:32+05:30,2024-12-10T12:54:32,0.6369
Cobenfy set to break dopamine dominance in schizophrenia treatment,https://www.financialexpress.com/business/healthcare-cobenfy-set-to-break-dopamine-dominance-in-schizophrenia-treatment-3687824/,2024-12-09T16:25:38+05:30,2024-12-09T10:55:38,0.2023
Kenvue India presents recommendations for managing pediatric sensitive skin,https://www.financialexpress.com/business/healthcare-kenvue-india-presents-recommendations-for-managing-pediatric-sensitive-skin-3687728/,2024-12-09T15:43:26+05:30,2024-12-09T10:13:26,0.0
USFDA gives nod to Eugia Pharma’s generic drug to treat kidney cancer,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-eugia-pharmas-generic-drug-to-treat-kidney-cancer-3685027/,2024-12-05T15:58:11+05:30,2024-12-05T10:28:11,-0.4019
Snakebites declared a ‘Notifiable Disease’ in India; Health experts anticipate improved surveillance and compliance,https://www.financialexpress.com/business/healthcare-snakebites-declared-a-notifiable-disease-in-india-health-experts-anticipate-improved-surveillance-and-compliance-3684959/,2024-12-05T15:03:18+05:30,2024-12-05T09:33:18,0.4767
Lilly’s Zepbound outshines Wegovy in weight loss head-to-head trial,https://www.financialexpress.com/business/healthcare-lillys-zepbound-outshines-wegovy-in-weight-loss-head-to-head-trial-3684128/,2024-12-04T17:34:15+05:30,2024-12-04T12:04:15,-0.3182
"We have made strategic choices for Indian market to grow, scale and meet unmet needs of consumers: Manish Anandani, MD, Kenvue India",https://www.financialexpress.com/business/healthcare-we-have-made-strategic-choices-for-indian-market-to-grow-scale-and-meet-unmet-needs-of-consumers-manish-anandani-md-kenvue-india-3683069/,2024-12-03T16:23:37+05:30,2024-12-03T10:53:37,0.0
USFDA gives nod to Gland Pharma’s generic formulation to treat glaucoma,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-gland-pharmas-generic-formulation-to-treat-glaucoma-3682823/,2024-12-03T14:40:08+05:30,2024-12-03T09:10:08,0.4019
USFDA gives nod to Biocon Biologics’ biosimilar to treat Crohn’s disease,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-biocon-biologics-biosimilar-to-treat-crohns-disease-3681406/,2024-12-01T19:49:12+05:30,2024-12-01T14:19:12,0.4019
First new treatment for asthma attacks in 50 years can reduce need for hospitalisation by 30 percent,https://www.financialexpress.com/business/healthcare-first-new-treatment-for-asthma-attacks-in-50-years-can-reduce-need-for-hospitalisation-by-30-percent-3680457/,2024-11-29T20:41:25+05:30,2024-11-29T15:11:25,-0.4404
USFDA gives tentative approval to Lupin’s generic formulation to treat type 2 diabetes,https://www.financialexpress.com/business/healthcare-usfda-gives-tentative-approval-to-lupins-generic-formulation-to-treat-type-2-diabetes-3679993/,2024-11-29T12:59:44+05:30,2024-11-29T07:29:44,0.7003
Akums partners with Caregen to launch Specialty Nutraceuticals and Differentiated Cosmeceuticals in India,https://www.financialexpress.com/business/healthcare-akums-partners-with-caregen-to-launch-specialty-nutraceuticals-and-differentiated-cosmeceuticals-in-india-3679912/,2024-11-29T12:18:52+05:30,2024-11-29T06:48:52,0.0
"India’s pharma sector set for rapid growth, 86 percent CXOs call for ecosystem collaboration: EY Parthenon-OPPI report",https://www.financialexpress.com/business/healthcare-indias-pharma-sector-set-for-rapid-growth-86-percent-cxos-call-for-ecosystem-collaboration-ey-parthenon-oppi-report-3679858/,2024-11-29T11:47:10+05:30,2024-11-29T06:17:10,0.0
Pharma leaders convene at OPPI Annual Summit 2024 to discuss India’s path to global leadership,https://www.financialexpress.com/business/healthcare-pharma-leaders-convene-at-oppi-annual-summit-2024-to-discuss-indias-path-to-global-leadership-3679616/,2024-11-28T23:31:47+05:30,2024-11-28T18:01:47,0.0
Lupin’s Humrahi diabetes support program expands to include heart health,https://www.financialexpress.com/business/healthcare-lupins-humrahi-diabetes-support-program-expands-to-include-heart-health-3679022/,2024-11-28T11:55:23+05:30,2024-11-28T06:25:23,0.4767
Dr. Reddy’s launches first immuno-oncology drug to treat rare form of head and neck cancer in India,https://www.financialexpress.com/business/healthcare-dr-reddys-launches-first-immuno-oncology-drug-to-treat-rare-form-of-head-and-neck-cancer-in-india-3678937/,2024-11-28T10:47:41+05:30,2024-11-28T05:17:41,-0.4019
Abbott launches vaccine that offers broadest protection for children against pneumococcal bacterial infections,https://www.financialexpress.com/business/healthcare-abbott-launches-vaccine-that-offers-broadest-protection-for-children-against-pneumococcal-bacterial-infections-3678572/,2024-11-27T17:18:01+05:30,2024-11-27T11:48:01,0.0
European Commission gives nod to Novartis’ novel therapy to treat breast cancer,https://www.financialexpress.com/business/healthcare-european-commission-gives-nod-to-novartis-novel-therapy-to-treat-breast-cancer-3678519/,2024-11-27T16:13:54+05:30,2024-11-27T10:43:54,-0.1027
"Indian Healthcare Market projected to reach $638 billion by 2025, report reveals",https://www.financialexpress.com/business/healthcare-indian-healthcare-market-projected-to-reach-638-billion-by-2025-report-reveals-3678354/,2024-11-27T13:18:07+05:30,2024-11-27T07:48:07,0.0258
Orchid Pharma announces strategic partnership with CAHO to tackle menace of anti-microbial resistance,https://www.financialexpress.com/business/healthcare-orchid-pharma-announces-strategic-partnership-with-caho-to-tackle-menace-of-anti-microbial-resistance-3677074/,2024-11-25T21:13:47+05:30,2024-11-25T15:43:47,-0.4939
"FE Exclusive | India is a priority market; We aim to launch tirzepatide for obesity in India by 2025: Prof Rachel Batterham, Senior VP, International Medical Affairs, Eli Lilly",https://www.financialexpress.com/business/healthcare-fe-exclusive-india-is-a-priority-market-we-aim-to-launch-tirzepatide-for-obesity-in-india-by-2025-prof-rachel-batterham-senior-vp-international-medical-affairs-eli-lilly-3675667/,2024-11-24T09:10:00+05:30,2024-11-24T03:40:00,0.128
"With superbugs on the rise, are common infections becoming untreatable?",https://www.financialexpress.com/business/healthcare-with-superbugs-on-the-rise-are-common-infections-becoming-untreatable-3675659/,2024-11-24T07:02:00+05:30,2024-11-24T01:32:00,0.0
"Novartis highlights deep pipeline in core therapeutic areas to drive long-term growth, upgrades mid-term guidance",https://www.financialexpress.com/business/healthcare-novartis-highlights-deep-pipeline-in-core-therapeutic-areas-to-drive-long-term-growth-upgrades-mid-term-guidance-3673515/,2024-11-22T13:07:59+05:30,2024-11-22T07:37:59,0.3818
Diagnosed prevalent cases of Parkinson’s disease to reach 3.15 million in seven major markets by 2033,https://www.financialexpress.com/business/healthcare-diagnosed-prevalent-cases-of-parkinsons-disease-to-reach-3-15-million-in-seven-major-markets-by-2033-3673288/,2024-11-22T11:19:26+05:30,2024-11-22T05:49:26,0.0258
Indian Chest Society criticises NMC’s decision to remove respiratory medicine departments amid rising air pollution,https://www.financialexpress.com/business/healthcare-indian-chest-society-criticises-nmcs-decision-to-remove-respiratory-medicine-departments-amid-rising-air-pollution-3672798/,2024-11-21T20:51:20+05:30,2024-11-21T15:21:20,-0.3182
Kura Oncology to partner with Japan’s Kyowa Kirin for blood cancer therapy,https://www.financialexpress.com/business/healthcare-kura-oncology-to-partner-with-japans-kyowa-kirin-for-blood-cancer-therapy-3670990/,2024-11-21T10:13:05+05:30,2024-11-21T04:43:05,-0.6597
Lupin launches drug to treat edema in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-drug-to-treat-edema-in-united-states-3669938/,2024-11-20T11:57:41+05:30,2024-11-20T06:27:41,0.6705
USFDA gives nod to Lupin’s generic formulation to treat ADHD symptoms,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-formulation-to-treat-adhd-symptoms-3669906/,2024-11-20T11:40:02+05:30,2024-11-20T06:10:02,0.4019
WHO adds new mpox vaccine to Emergency Use Listing,https://www.financialexpress.com/business/healthcare-who-adds-new-mpox-vaccine-to-emergency-use-listing-3669880/,2024-11-20T11:01:45+05:30,2024-11-20T05:31:45,-0.3818
"Rise in consultation among men aged 25-34 in 2024; Concerns in Neurology, Urology and Physiotherapy more common",https://www.financialexpress.com/business/healthcare-rise-in-consultation-among-men-aged-25-34-in-2024-concerns-in-neurology-urology-and-physiotherapy-more-common-3669289/,2024-11-19T17:40:23+05:30,2024-11-19T12:10:23,0.0
"African children with severe malaria experiencing resistance to world’s most powerful malaria drug, new study found",https://www.financialexpress.com/business/healthcare-african-children-with-severe-malaria-experiencing-resistance-to-worlds-most-powerful-malaria-drug-3666188/,2024-11-15T16:00:38+05:30,2024-11-15T10:30:38,0.1263
European Commission grants approval to Sandoz’s biosimilar to treat retinal diseases,https://www.financialexpress.com/business/healthcare-european-commission-grants-approval-to-sandozs-biosimilar-to-treat-retinal-diseases-3666104/,2024-11-15T14:40:38+05:30,2024-11-15T09:10:38,0.7717
Dr Reddy’s gets Rs 27 lakh penalty from Mexican drug regulator,https://www.financialexpress.com/business/healthcare-dr-reddys-gets-rs-27-lakh-penalty-from-mexican-drug-regulator-3665474/,2024-11-14T17:28:17+05:30,2024-11-14T11:58:17,-0.4588
Q2FY25: Global Health Limited reports rise in profit by 4.5 percent to Rs. 130.82 crore Y-o-Y,https://www.financialexpress.com/business/healthcare-q2fy25-global-health-limited-reports-rise-in-profit-by-4-5-percent-to-rs-13082-crore-y-o-y-3665337/,2024-11-14T15:23:49+05:30,2024-11-14T09:53:49,0.25
Supreme Court rejects plea to mandate doctors to inform patients about drug side-effects,https://www.financialexpress.com/business/healthcare-supreme-court-rejects-plea-to-mandate-doctors-to-inform-patients-about-drug-side-effects-3665283/,2024-11-14T14:32:01+05:30,2024-11-14T09:02:01,0.1027
AstraZeneca India partners with IAP to raise awareness on RSV in India,https://www.financialexpress.com/business/healthcare-astrazeneca-india-partners-with-iap-to-raise-awareness-on-rsv-in-india-3665262/,2024-11-14T14:16:03+05:30,2024-11-14T08:46:03,0.0
"No link between experimental weight loss drug and change in bone density, Amgen says",https://www.financialexpress.com/business/healthcare-no-link-between-experimental-weight-loss-drug-and-change-in-bone-density-amgen-says-3664274/,2024-11-13T16:54:54+05:30,2024-11-13T11:24:54,-0.5423
Q2FY25: Alkem Labs’ profit rises by 11% YoY to Rs 689 crore; revenue falls marginally,https://www.financialexpress.com/business/healthcare-q2fy25-alkem-labs-profit-rises-by-11-yoy-to-rs-689-crore-revenue-falls-marginally-3664093/,2024-11-13T14:18:18+05:30,2024-11-13T08:48:18,0.4404
EMA grants GMP certificate to CuraTeQ biosimilars’ manufacturing facility in Hyderabad,https://www.financialexpress.com/business/healthcare-ema-grants-gmp-certificate-to-curateq-biosimilars-manufacturing-facility-in-hyderabad-3663298/,2024-11-12T18:26:23+05:30,2024-11-12T12:56:23,0.2263
"To defy shrinking lifespan, companies need to stay ahead of the curve and innovate: Deepak Parekh",https://www.financialexpress.com/business/healthcare-to-defy-shrinking-lifespan-companies-need-to-stay-ahead-of-the-curve-and-innovate-deepak-parekh-3663265/,2024-11-12T18:02:10+05:30,2024-11-12T12:32:10,0.4939
USFDA gives nod to Alembic Pharma’s genetic formulation to treat heart failure,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-genetic-formulation-to-treat-heart-failure-3663150/,2024-11-12T16:44:47+05:30,2024-11-12T11:14:47,-0.1531
Q2FY25: Zydus Lifesciences reports profit rises 14% to Rs. 911 crore; R&D investments up 22% Q-o-Q,https://www.financialexpress.com/business/healthcare-q2fy25-zydus-lifesciences-reports-profit-rises-14-percent-to-rs-911-crore-rd-investments-up-22-percent-q-o-q-3662967/,2024-11-12T14:29:12+05:30,2024-11-12T08:59:12,0.4404
"Cardinal Health expands gastroenterology, diabetes segments; To buy 71 percent stake in GIA",https://www.financialexpress.com/business/healthcare-cardinal-health-expands-gastroenterology-diabetes-segments-to-buy-71-percent-stake-in-gia-3662898/,2024-11-12T13:32:37+05:30,2024-11-12T08:02:37,0.1027
Pfizer to expand manufacturing and R&D capacities; Company aims to launch more Made-in-India products,https://www.financialexpress.com/business/healthcare-pfizer-to-expand-manufacturing-and-rd-capacities-company-aims-to-launch-more-made-in-india-products-3662855/,2024-11-12T12:59:58+05:30,2024-11-12T07:29:58,0.3182
"FE Exclusive | We are planning to expand our therapeutic footprint in high-demand disease areas: Dr. Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions",https://www.financialexpress.com/business/healthcare-fe-exclusive-we-are-planning-to-expand-our-therapeutic-footprint-in-complex-molecules-and-high-demand-disease-areas-dr-abdelaziz-toumi-ceo-lupin-manufacturing-solutions-3662786/,2024-11-12T12:19:53+05:30,2024-11-12T06:49:53,0.5423
Parkinson’s disease clinical research in seven major markets focuses on disease-modifying agents,https://www.financialexpress.com/business/healthcare-parkinsons-disease-clinical-research-in-seven-major-markets-focuses-on-disease-modifying-agents-3662004/,2024-11-11T14:43:20+05:30,2024-11-11T09:13:20,0.0
USFDA grants ‘VAI’ tag to Biocon’s Bengaluru facility,https://www.financialexpress.com/business/healthcare-usfda-grants-vai-tag-to-biocons-bengaluru-facility-3661985/,2024-11-11T14:27:16+05:30,2024-11-11T08:57:16,0.2263
USFDA grants tentative approval to Lupin’s generic formulation to treat HIV infection,https://www.financialexpress.com/business/healthcare-usfda-grants-tentative-approval-to-lupins-generic-formulation-to-treat-hiv-infection-3660073/,2024-11-08T18:05:08+05:30,2024-11-08T12:35:08,0.7717
USFDA proposes removal of common decongestant from shelves after finding it ineffective,https://www.financialexpress.com/business/healthcare-usfda-proposes-removal-of-common-decongestant-from-shelves-after-finding-it-ineffective-3659695/,2024-11-08T12:44:20+05:30,2024-11-08T07:14:20,-0.128
"Spike in typhoid cases linked to prolonged monsoon, report reveals",https://www.financialexpress.com/life/spike-in-typhoid-cases-linked-to-prolonged-monsoon-report-reveals-3659067/,2024-11-07T17:13:24+05:30,2024-11-07T11:43:24,0.0
Q2FY25: Alembic Pharma’s profit rises 12 percent to Rs 153 Crores; Reports dip US sales growth,https://www.financialexpress.com/business/healthcare-q2fy25-alembic-pharmas-profit-rises-12-percent-to-rs-153-crores-reports-dip-us-sales-growth-3659042/,2024-11-07T16:49:17+05:30,2024-11-07T11:19:17,0.6705
"WHO study lists top endemic pathogens, emphasises on urgent need for new vaccines",https://www.financialexpress.com/business/healthcare-who-study-lists-top-endemic-pathogens-emphasises-on-urgent-need-for-new-vaccines-3657252/,2024-11-05T19:24:51+05:30,2024-11-05T13:54:51,0.3818
"Q2FY25: Mankind Pharma’s profit jumps 29 percent to Rs 658.88 crore; Revenue up 13.6% to Rs 3,076.51 crore",https://www.financialexpress.com/business/healthcare-q2fy25-mankind-pharmas-profit-jumps-29-percent-to-rs-658-88-crore-revenue-up-136-to-rs-307651-crore-3657129/,2024-11-05T17:23:17+05:30,2024-11-05T11:53:17,0.4404
"Q2FY25: Dr. Reddy’s net profit falls 15 percent to Rs 1,255 crore, revenue up 17 percent",https://www.financialexpress.com/business/healthcare-q2fy25-dr-reddys-profit-falls-15-percent-to-rs-1255-crore-revenue-up-17-percent-3657082/,2024-11-05T16:47:37+05:30,2024-11-05T11:17:37,0.4404
Diagnosed prevalent cases of primary open angle glaucoma to reach 10 million in 7 major markets by 2033,https://www.financialexpress.com/business/healthcare-diagnosed-prevalent-cases-of-primary-open-angle-glaucoma-to-reach-10-million-in-7-major-markets-by-2033-3654135/,2024-11-01T12:04:26+05:30,2024-11-01T06:34:26,0.0258
Asthma crisis in US marginalised communities from redlining requires more than just healthcare interventions,https://www.financialexpress.com/business/healthcare-asthma-crisis-in-us-marginalised-communities-from-redlining-requires-more-than-just-healthcare-interventions-3652767/,2024-10-30T12:10:22+05:30,2024-10-30T06:40:22,-0.6249
PM Modi Inaugurates Lyfius Pharma’s Flagship Penicillin-G Facility in Andhra Pradesh’s Kakinada,https://www.financialexpress.com/business/healthcare-pm-modi-inaugurates-lyfius-pharmas-flagship-penicillin-g-facility-in-andhra-pradeshs-kakinada-3652751/,2024-10-30T11:59:12+05:30,2024-10-30T06:29:12,0.1027
Addressing the Alarming Rise in Stroke Cases and the Unmet Rehabilitation Needs in India,https://www.financialexpress.com/business/healthcare-addressing-the-alarming-rise-in-stroke-cases-and-the-unmet-rehabilitation-needs-in-india-3652448/,2024-10-29T21:54:49+05:30,2024-10-29T16:24:49,-0.128
Q2FY25: Cipla reports 15.2% rise in net profit to Rs 1303 crore; Slow growth reported in acute category,https://www.financialexpress.com/business/healthcare-q2fy25-cipla-reports-15-2-rise-in-net-profit-to-rs-1303-crore-slow-growth-reported-in-acute-category-3652044/,2024-10-29T14:40:03+05:30,2024-10-29T09:10:03,0.6705
Dr. Reddy’s launches first-in-class drug to treat chronic constipation in India,https://www.financialexpress.com/business/healthcare-dr-reddys-launches-first-in-class-drug-to-treat-chronic-constipation-in-india-3651258/,2024-10-28T17:14:10+05:30,2024-10-28T11:44:10,0.4019
Lupin to focus on developing inhalers with near-zero global warming potential propellants,https://www.financialexpress.com/business/healthcare-lupin-to-focus-on-developing-inhalers-with-near-zero-global-warming-potential-propellants-3651241/,2024-10-28T16:50:33+05:30,2024-10-28T11:20:33,0.1531
Emcure Pharma launches Emcutix Biopharmaceuticals Limited to strengthen its Derma Portfolio,https://www.financialexpress.com/business/healthcare-emcure-pharma-launches-emcutix-biopharmaceuticals-limited-to-strengthen-its-derma-portfolio-3651144/,2024-10-28T16:01:07+05:30,2024-10-28T10:31:07,0.1027
"Q2FY25 Results: Sun Pharma’s net profit jumps 28 percent y-o-y to Rs. 3,040 crore",https://www.financialexpress.com/business/healthcare-q2fy25-results-sun-pharmas-net-profit-jumps-28-percent-y-o-y-to-rs-3040-crore-3651123/,2024-10-28T15:34:56+05:30,2024-10-28T10:04:56,0.4404
CDSCO flags 49 popular medicines like Paracetamol and Pantoprazole for failing quality test; Four drugs declared as spurious,https://www.financialexpress.com/business/healthcare-cdsco-flags-49-popular-medicines-like-paracetamol-and-pantoprazole-for-failing-quality-test-four-drugs-declared-as-spurious-3649670/,2024-10-25T20:42:50+05:30,2024-10-25T15:12:50,0.25
Jubilant Therapeutics Inc. announces first patient dosing in global clinical trials,https://www.financialexpress.com/business/healthcare-jubilant-therapeutics-inc-announces-first-patient-dosing-in-global-clinical-trials-3649433/,2024-10-25T15:33:57+05:30,2024-10-25T10:03:57,0.6124
Lilly’s donanemab could bring new hope to Alzheimer’s patients in Australia following lecanemab rejection: GlobalData,https://www.financialexpress.com/business/healthcare-lillys-donanemab-could-bring-new-hope-to-alzheimers-patients-in-australia-following-lecanemab-rejection-globaldata-3649358/,2024-10-25T13:38:11+05:30,2024-10-25T08:08:11,-0.1531
Data shows weight-loss drugs didn’t curb health costs within two years: Report,https://www.financialexpress.com/business/healthcare-data-shows-weight-loss-drugs-didnt-curb-health-costs-within-two-years-report-3648706/,2024-10-24T17:45:01+05:30,2024-10-24T12:15:01,0.0
NCCN Guidelines recognises Novartis’ ribociclib as Category 1 preferred breast cancer adjuvant treatment,https://www.financialexpress.com/business/healthcare-nccn-guidelines-recognises-novartis-ribociclib-as-category-1-preferred-breast-cancer-adjuvant-treatment-3648415/,2024-10-24T12:58:56+05:30,2024-10-24T07:28:56,-0.6597
Mankind Pharma acquires BSV to expand its portfolio in women’s health and fertility drug market,https://www.financialexpress.com/business/healthcare-mankind-pharma-acquires-bsv-to-expand-its-portfolio-in-womens-health-and-fertility-drug-market-3648299/,2024-10-24T11:34:34+05:30,2024-10-24T06:04:34,0.3182
"More people have mpox in Europe than has been reported, Roche CEO says",https://www.financialexpress.com/business/healthcare-more-people-have-mpox-in-europe-than-has-been-reported-roche-ceo-says-3647790/,2024-10-23T17:37:30+05:30,2024-10-23T12:07:30,0.0
UK regulator approves Lilly’s Alzheimer’s drug but ‘too expensive’ for wider use,https://www.financialexpress.com/business/healthcare-uk-regulator-approves-lillys-alzheimers-drug-but-too-expensive-for-wider-use-3647731/,2024-10-23T17:00:00+05:30,2024-10-23T11:30:00,0.2144
WHO prequalifies Zydus’s Typhoid vaccine,https://www.financialexpress.com/business/healthcare-who-prequalifies-zyduss-typhoid-vaccine-3647421/,2024-10-23T12:34:04+05:30,2024-10-23T07:04:04,0.0
Novo Nordisk’s oral diabetes drug reduces heart-related risks by 14 percent,https://www.financialexpress.com/business/healthcare-novo-nordisks-oral-diabetes-drug-reduces-heart-related-risks-by-14-percent-3645905/,2024-10-21T18:26:28+05:30,2024-10-21T12:56:28,-0.2732
"Lupin Appoints Claus Jepsen as President, Global Specialty",https://www.financialexpress.com/business/healthcare-lupin-appoints-claus-jepsen-as-president-global-specialty-3645858/,2024-10-21T17:43:08+05:30,2024-10-21T12:13:08,0.0
Johnson & Johnson’s subcutaneous Tremfya holds potential to set new standard in Crohn’s disease treatment,https://www.financialexpress.com/business/healthcare-johnson-johnsons-subcutaneous-tremfya-holds-potential-to-set-new-standard-in-crohns-disease-treatment-3645772/,2024-10-21T16:56:10+05:30,2024-10-21T11:26:10,0.0
Novartis gets positive CHMP opinion for its breast cancer drug to reduce risk of recurrence,https://www.financialexpress.com/business/healthcare-novartis-gets-positive-chmp-opinion-for-its-breast-cancer-drug-to-reduce-risk-of-recurrence-3643813/,2024-10-18T18:08:17+05:30,2024-10-18T12:38:17,-0.4404
USFDA gives nod to Granules India’s generic formulation to treat depression,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-granules-indias-generic-formulation-to-treat-depression-2-3643492/,2024-10-18T13:26:10+05:30,2024-10-18T07:56:10,-0.25
"US, Europe key export destinations for drug formulations, biologicals, surgical goods, Ministry data reveals",https://www.financialexpress.com/business/healthcare-us-europe-key-export-destinations-for-drug-formulations-biologicals-surgical-goods-ministry-data-reveals-3642695/,2024-10-17T16:33:32+05:30,2024-10-17T11:03:32,0.0
"COPD market to reach $30.8 billion in 7 major markets by 2033, forecasts GlobalData",https://www.financialexpress.com/business/healthcare-copd-market-to-reach-30-8-billion-in-7-major-markets-by-2033-forecasts-globaldata-3642566/,2024-10-17T14:51:50+05:30,2024-10-17T09:21:50,0.0258
Akums Drugs inks licensing pact with Canadian firm Triple Hair Inc,https://www.financialexpress.com/business/healthcare-akums-drugs-inks-licensing-pact-with-canadian-firm-triple-hair-inc-3641683/,2024-10-16T17:02:48+05:30,2024-10-16T11:32:48,0.0
mRNA licensing agreements surge 800 percent in value as confidence grows beyond vaccines,https://www.financialexpress.com/business/healthcare-mrna-licensing-agreements-surge-800-percent-in-value-as-confidence-grows-beyond-vaccines-3641515/,2024-10-16T15:33:56+05:30,2024-10-16T10:03:56,0.7783
IsomAb announces Development Candidate nomination with Pfizer for Peripheral Arterial Disease,https://www.financialexpress.com/business/healthcare-isomab-announces-development-candidate-nomination-with-pfizer-for-peripheral-arterial-disease-3641489/,2024-10-16T15:22:04+05:30,2024-10-16T09:52:04,0.0
"Tuberculosis, Asthma, Glaucoma and Bipolar Disorder medicines to get costlier by 50 percent as NPPA announces price hike",https://www.financialexpress.com/business/healthcare-tuberculosis-asthma-glaucoma-and-bipolar-disorder-medicines-to-get-costlier-by-50-percent-as-nppa-announces-price-hike-3641256/,2024-10-16T12:50:38+05:30,2024-10-16T07:20:38,-0.4019
Lupin launches first generic formulation of Abbie’s drug to treat eye disorder,https://www.financialexpress.com/business/healthcare-lupin-launches-first-generic-formulation-of-abbies-drug-to-treat-eye-disorder-3640355/,2024-10-15T15:53:51+05:30,2024-10-15T10:23:51,0.0
11 countries already recognise Indian pharmacopoeia as their standard: DCGI,https://www.financialexpress.com/business/healthcare-11-countries-already-recognise-indian-pharmacopoeia-as-their-standard-dcgi-3639307/,2024-10-14T16:23:56+05:30,2024-10-14T10:53:56,0.0
USFDA gives nod to Pfizer’s drug therapy for patients with Hemophilia,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-pfizers-drug-therapy-for-patients-with-hemophilia-3638808/,2024-10-14T11:34:41+05:30,2024-10-14T06:04:41,0.0
Alkem Labs enters into licensing agreement with Sonnet BioTherapeutics for its diabetic peripheral neuropathy drug in India,https://www.financialexpress.com/business/healthcare-alkem-laboratories-enters-into-licensing-agreement-with-sonnet-biotherapeutics-for-its-diabetic-peripheral-neuropathy-drug-in-india-3637019/,2024-10-11T10:46:04+05:30,2024-10-11T05:16:04,0.4939
Sage Therapeutics stops Alzheimer’s drug development after trial fails,https://www.financialexpress.com/business/healthcare-sage-therapeutics-stops-alzheimers-drug-development-after-trial-fails-3634599/,2024-10-08T17:59:41+05:30,2024-10-08T12:29:41,-0.5267
USFDA gives nod to first over-the-counter home Flu and COVID-19 combination test,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-first-over-the-counter-home-flu-and-covid-19-combination-test-3634475/,2024-10-08T16:55:52+05:30,2024-10-08T11:25:52,-0.3818
Aurigene Oncology reports positive outcomes of Phase 1 trial for CAR-T cell therapy in India,https://www.financialexpress.com/business/healthcare-aurigene-oncology-reports-positive-outcomes-of-phase-1-trial-for-car-t-cell-therapy-in-india-3634454/,2024-10-08T16:35:39+05:30,2024-10-08T11:05:39,0.5574
Ebglyss FDA approval intensifies competition in atopic dermatitis market: GlobalData,https://www.financialexpress.com/business/healthcare-ebglyss-fda-approval-intensifies-competition-in-atopic-dermatitis-market-globaldata-3634412/,2024-10-08T16:11:52+05:30,2024-10-08T10:41:52,0.4767
"Need to strengthen national policies to increase access and adoption of biosimilars, reveals new report",https://www.financialexpress.com/business/healthcare-need-to-strengthen-national-policies-to-increase-access-and-adoption-of-biosimilars-reveals-new-report-3634349/,2024-10-08T15:40:37+05:30,2024-10-08T10:10:37,0.5574
Mylan settles patent litigation with Novo Nordisk over generic Ozempic in United States,https://www.financialexpress.com/business/healthcare-mylan-settles-patent-litigation-with-novo-nordisk-over-generic-ozempic-in-united-states-3632655/,2024-10-07T13:06:47+05:30,2024-10-07T07:36:47,0.25
WHO adds HPV vaccine for single-dose use to tackle burden of cervical cancer,https://www.financialexpress.com/business/healthcare-who-adds-hpv-vaccine-for-single-dose-use-to-tackle-burden-of-cervical-cancer-3632478/,2024-10-07T11:10:04+05:30,2024-10-07T05:40:04,-0.8074
Lupin acquires nine brands of Medical Nutritional Institute in South Africa,https://www.financialexpress.com/business/healthcare-lupin-acquires-nine-brands-of-medical-nutritional-institute-in-south-africa-3630573/,2024-10-04T15:22:44+05:30,2024-10-04T09:52:44,0.0
Biocon Biologics refinances $1.1 Billion long term debt,https://www.financialexpress.com/business/healthcare-biocon-biologics-refinances-1-1-billion-long-term-debt-3629559/,2024-10-03T15:49:51+05:30,2024-10-03T10:19:51,-0.3612
Hetero enters into agreement with Gilead to manufacture and distribute HIV drug,https://www.financialexpress.com/business/healthcare-hetero-enters-into-agreement-with-gilead-to-manufacture-and-distribute-multi-drug-resistant-hiv-3629287/,2024-10-03T12:49:05+05:30,2024-10-03T07:19:05,0.4939
Dr. Reddy’s enters into licensing agreement with Gilead Sciences for HIV drug,https://www.financialexpress.com/business/healthcare-dr-reddys-enters-into-licensing-agreement-with-gilead-sciences-for-hiv-drug-3629137/,2024-10-03T11:54:16+05:30,2024-10-03T06:24:16,0.4939
Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited,https://www.financialexpress.com/business/healthcare-mankind-pharma-transfers-otc-business-to-subsidiary-mankind-consumer-products-private-limited-3627577/,2024-10-01T13:57:21+05:30,2024-10-01T08:27:21,-0.2263
Sun Pharma and Philogen enter into exclusive agreement for commercialising anti-cancer immunotherapy,https://www.financialexpress.com/business/healthcare-sun-pharma-and-philogen-enter-into-exclusive-agreement-for-commercialising-anti-cancer-immunotherapy-3627342/,2024-10-01T12:49:22+05:30,2024-10-01T07:19:22,0.5719
"After CDSCO flagged 53 commonly used medicines for failing quality test, pharma body defends its member companies",https://www.financialexpress.com/business/healthcare-after-cdsco-flagged-53-commonly-used-medicines-for-failing-quality-test-pharma-body-defends-its-member-companies-3626382/,2024-09-30T16:00:25+05:30,2024-09-30T10:30:25,-0.5106
Bristol Myers gets USFDA nod for new type of schizophrenia drug,https://www.financialexpress.com/business/healthcare-bristol-myers-gets-usfda-nod-for-new-type-of-schizophrenia-drug-3624116/,2024-09-27T18:26:04+05:30,2024-09-27T12:56:04,0.0
"CDSCO flags 53 popular medicines of poor quality; Alkem labs denies claims of Pan-D, Clavam 625 being not-of-standard quality",https://www.financialexpress.com/business/healthcare-cdsco-flags-53-popular-medicines-of-poor-quality-alkem-labs-denies-claims-of-pan-d-clavam-625-being-not-of-standard-quality-3624093/,2024-09-27T18:10:37+05:30,2024-09-27T12:40:37,-0.4767
AstraZeneca’s FluMist approval for self-administration could increase flu vaccine uptake,https://www.financialexpress.com/business/healthcare-astrazenecas-flumist-approval-for-self-administration-could-increase-flu-vaccine-uptake-globaldata-3623524/,2024-09-27T10:38:27+05:30,2024-09-27T05:08:27,0.4215
53 commonly used medicines flagged for failing CDSCO test; Torrent Pharma defends quality of Shelcal 500,https://www.financialexpress.com/business/healthcare-53-commonly-used-medicines-flagged-for-failing-cdsco-test-torrent-pharma-defends-quality-of-shelcal-500-3623142/,2024-09-26T19:18:25+05:30,2024-09-26T13:48:25,-0.5106
50 new plants will be completed in two years under the PLI scheme: Govt,https://www.financialexpress.com/business/healthcare-50-new-plants-will-be-completed-in-two-years-under-the-pli-scheme-govt-3623081/,2024-09-26T17:53:42+05:30,2024-09-26T12:23:42,0.0
Bhushan Akshikar appointed as President of OPPI,https://www.financialexpress.com/business/healthcare-bhushan-akshikar-appointed-as-oppi-president-3622957/,2024-09-26T16:53:12+05:30,2024-09-26T11:23:12,0.0
Entod Pharma meets DCGI following suspension of approval for its eye drops; Issues clarification,https://www.financialexpress.com/business/healthcare-entod-pharma-meets-dcgi-following-suspension-of-approval-for-its-eye-drops-issues-clarification-3622708/,2024-09-26T13:38:08+05:30,2024-09-26T08:08:08,0.4767
"Viral and mosquito-borne pathogens are priority concerns for disease outbreaks, epidemiologists warn",https://www.financialexpress.com/business/healthcare-viral-and-mosquito-borne-pathogens-are-priority-concerns-for-disease-outbreaks-epidemiologists-warn-3621554/,2024-09-25T14:31:10+05:30,2024-09-25T09:01:10,-0.1027
AstraZeneca India gets CDSCO nod for its chemotherapy drug additional indications,https://www.financialexpress.com/business/healthcare-astrazeneca-india-gets-cdsco-nod-for-its-chemotherapy-drug-additional-indications-3619996/,2024-09-24T11:41:29+05:30,2024-09-24T06:11:29,0.0
mRNA vaccines lead next-generation efforts to combat H5N1 amid global outbreaks: GlobalData,https://www.financialexpress.com/business/healthcare-mrna-vaccines-lead-next-generation-efforts-to-combat-h5n1-amid-global-outbreaks-globaldata-3619451/,2024-09-23T18:01:33+05:30,2024-09-23T12:31:33,-0.34
Bajaj Healthcare enters into development and supply agreement for API with European entity,https://www.financialexpress.com/business/healthcare-bajaj-healthcare-enters-into-development-and-supply-agreement-for-api-with-european-entity-3619152/,2024-09-23T14:21:48+05:30,2024-09-23T08:51:48,0.4939
"FE Exclusive | Supradyn Naturals Calcium for calcium, vitamin D deficiencies to be launched soon: Sandeep Verma, India Country Head, Bayer Consumer Health",https://www.financialexpress.com/business/healthcare-fe-exclusive-supradyn-naturals-calcium-for-calcium-vitamin-d-deficiencies-to-be-launched-soon-sandeep-verma-india-country-head-bayer-consumer-health-3617791/,2024-09-21T20:28:40+05:30,2024-09-21T14:58:40,0.4939
Rise in lymphoma cases in India highlights importance of early diagnosis and treatment,https://www.financialexpress.com/business/healthcare-rise-in-lymphoma-cases-in-india-highlights-importance-of-early-diagnosis-and-treatment-3617669/,2024-09-21T16:49:12+05:30,2024-09-21T11:19:12,0.3612
WHO prequalifies first vaccine against mpox; Data shows over 76 percent effectiveness,https://www.financialexpress.com/business/healthcare-who-prequalifies-first-vaccine-against-mpox-data-shows-over-76-percent-effectiveness-3610543/,2024-09-13T18:20:29+05:30,2024-09-13T12:50:29,0.0
"Popular medicine to treat menopause-related hot flashes can lead to serious liver injury, FDA warns",https://www.financialexpress.com/business/healthcare-popular-medicine-to-treat-menopause-related-hot-flashes-can-lead-to-serious-liver-injury-fda-warns-3610471/,2024-09-13T17:23:49+05:30,2024-09-13T11:53:49,0.25
Akums Drugs and Pharma secures patent for its formulation to manage Sickle Cell Disease,https://www.financialexpress.com/business/healthcare-akums-drugs-and-pharma-secures-patent-for-its-formulation-to-manage-sickle-cell-disease-3610284/,2024-09-13T14:06:04+05:30,2024-09-13T08:36:04,0.3182
"Healthcare, manufacturing sector to benefit most from Fed rate cuts, reveals Motilal Oswal report",https://www.financialexpress.com/business/healthcare-healthcare-manufacturing-sector-to-benefit-most-from-fed-rate-cuts-reveals-motilal-oswal-report-3610150/,2024-09-13T12:42:26+05:30,2024-09-13T07:12:26,0.2023
Bavarian Nordic sees potential to supply 13 million doses of its mpox vaccine by 2025,https://www.financialexpress.com/business/healthcare-bavarian-nordic-sees-potential-to-supply-13-million-doses-of-its-mpox-vaccine-by-2025-3609433/,2024-09-12T17:10:28+05:30,2024-09-12T11:40:28,0.0
GSK moves mRNA flu vaccine to late-stage trials following positive outcomes,https://www.financialexpress.com/business/healthcare-gsk-moves-mrna-flu-vaccine-to-late-stage-trials-following-positive-outcomes-3609304/,2024-09-12T15:49:14+05:30,2024-09-12T10:19:14,0.25
Indian Immunologicals Limited partners with ICMR for clinical development of Zika vaccine,https://www.financialexpress.com/business/healthcare-indian-immunologicals-limited-partners-with-icmr-for-clinical-development-of-zika-vaccine-3609145/,2024-09-12T13:38:33+05:30,2024-09-12T08:08:33,-0.2263
Bharat Biotech collaborates with Alopexx for broad-spectrum anti-microbial vaccine,https://www.financialexpress.com/business/healthcare-bharat-biotech-collaborates-with-alopexx-for-broad-spectrum-anti-microbial-vaccine-3608457/,2024-09-11T18:49:51+05:30,2024-09-11T13:19:51,0.0
DCGI suspends approval of Entod Pharmaceuticals’ eye drop after it claimed to reduce dependency on reading glasses,https://www.financialexpress.com/business/healthcare-dcgi-suspends-approval-of-entod-pharmaceuticals-eye-drop-that-claimed-to-reduce-dependency-on-reading-glasses-3608324/,2024-09-11T17:03:42+05:30,2024-09-11T11:33:42,0.25
"Weight-loss drug Saxenda effective for obese children as young as 6, study reveals",https://www.financialexpress.com/business/healthcare-weight-loss-drug-saxenda-effective-for-obese-children-as-young-as-6-study-reveals-3607729/,2024-09-11T10:52:26+05:30,2024-09-11T05:22:26,0.4767
Novo Nordisk experimental obesity pill found to be safe and tolerable in early trial,https://www.financialexpress.com/business/healthcare-novo-nordisk-experimental-obesity-pill-found-to-be-safe-and-tolerable-in-early-trial-3607688/,2024-09-11T10:15:38+05:30,2024-09-11T04:45:38,0.4404
Zydus Lifesciences completes Phase II clinical trial of Usnoflast to treat ALS,https://www.financialexpress.com/business/healthcare-zydus-lifesciences-completes-phase-ii-clinical-trial-of-usnoflast-to-treat-als-3607304/,2024-09-10T19:26:45+05:30,2024-09-10T13:56:45,0.4019
China’s drug regulator clears mpox vaccine; Clinical trials to begin soon,https://www.financialexpress.com/business/healthcare-chinas-drug-regulator-clears-mpox-vaccine-clinical-trials-to-begin-soon-3607250/,2024-09-10T18:07:42+05:30,2024-09-10T12:37:42,0.0772
"Global migraine market to reach $16.4 billion in 7 major markets by 2033, forecasts GlobalData",https://www.financialexpress.com/business/healthcare-global-migraine-market-to-reach-16-4-billion-in-7-major-markets-by-2033-forecasts-globaldata-3605956/,2024-09-09T17:56:55+05:30,2024-09-09T12:26:55,0.0258
Boehringer Ingelheim announces plans to advance potential new treatment for geographic atrophy,https://www.financialexpress.com/business/healthcare-boehringer-ingelheim-announces-plans-to-advance-potential-new-treatment-for-geographic-atrophy-3605925/,2024-09-09T17:39:56+05:30,2024-09-09T12:09:56,0.0
GSK’s COPD drug candidate shows significantly positive outcome in Phase III trial,https://www.financialexpress.com/business/healthcare-gsks-copd-drug-candidate-shows-significantly-positive-outcome-in-phase-iii-trial-3605912/,2024-09-09T17:26:34+05:30,2024-09-09T11:56:34,0.5574
Health Ministry approves new and more efficient treatment regimen for drug-resistant TB in India,https://www.financialexpress.com/business/healthcare-health-ministry-approves-new-and-more-efficient-treatment-regimen-for-drug-resistant-tb-in-india-3603646/,2024-09-06T16:48:37+05:30,2024-09-06T11:18:37,0.6997
Indian Immunologicals Limited launches made-in-India Hepatitis A vaccine for children,https://www.financialexpress.com/business/healthcare-indian-immunologicals-limited-launches-made-in-india-hepatitis-a-vaccine-for-children-3603483/,2024-09-06T15:49:20+05:30,2024-09-06T10:19:20,-0.2263
Entod Pharmaceuticals presented “unethical and false presentation of facts” on PresVu eye drops: Report,https://www.financialexpress.com/business/healthcare-entod-pharmaceuticals-presented-unethical-and-false-presentation-of-facts-on-presvu-eye-drops-report-3602492/,2024-09-05T15:30:02+05:30,2024-09-05T10:00:02,0.0
Entod Pharmaceuticals gets DCGI nod for its eye drops to treat Presbyopia,https://www.financialexpress.com/business/healthcare-entod-pharmaceuticals-gets-dcgi-nod-for-its-eye-drops-to-treat-presbyopia-3600558/,2024-09-03T17:22:47+05:30,2024-09-03T11:52:47,0.4019
Sanofi’s Multiple sclerosis drug misses goal in trials for relapsing disease forms,https://www.financialexpress.com/business/healthcare-sanofis-multiple-sclerosis-drug-misses-goal-in-trials-for-relapsing-disease-forms-3599139/,2024-09-02T16:28:35+05:30,2024-09-02T10:58:35,-0.2263
USFDA gives nod to Lupin’s generic formulation for eye disorder treatment,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-formulation-for-eye-disorder-treatment-3594597/,2024-08-28T12:55:56+05:30,2024-08-28T07:25:56,-0.4019
USFDA grants tentative approval to Zydus’ drug to treat Parkinson’s Disease,https://www.financialexpress.com/business/healthcare-usfda-grants-tentative-approval-to-zydus-drug-to-treat-parkinsons-disease-3594508/,2024-08-28T11:51:47+05:30,2024-08-28T06:21:47,0.7717
USFDA gives nod to Alembic Pharma’s generic formulation to treat skin disorders,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembic-pharmas-generic-formulation-to-treat-skin-disorders-3593485/,2024-08-27T13:16:44+05:30,2024-08-27T07:46:44,0.4019
AstraZeneca threatens to move UK vaccine production to US: Report,https://www.financialexpress.com/business/healthcare-astrazeneca-threatens-to-move-uk-vaccine-production-to-us-report-3590822/,2024-08-23T17:21:34+05:30,2024-08-23T11:51:34,-0.3818
Pharma stable: Strong US business the right prescription for robust Q1,https://www.financialexpress.com/business/industry-pharma-stable-strong-us-business-the-right-prescription-for-robust-q1-3590609/,2024-08-23T14:13:57+05:30,2024-08-23T08:43:57,0.7845
Health Canada gives nod to Lupin’s biosimilar to treat infection in cancer patients,https://www.financialexpress.com/business/healthcare-health-canada-gives-nod-to-lupins-biosimilar-to-treat-infection-in-cancer-patients-3590605/,2024-08-23T14:11:51+05:30,2024-08-23T08:41:51,-0.4019
Govt bans 156 commonly used combination medicines—Check full list here,https://www.financialexpress.com/business/healthcare-govt-bans-156-commonly-used-combination-medicinescheck-full-list-here-3590492/,2024-08-23T12:43:43+05:30,2024-08-23T07:13:43,0.0
USFDA gives nod to Indoco Remedies to market generic formulation for withdrawal treatment,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-indoco-remedies-to-market-generic-formulation-for-withdrawal-treatment-3588645/,2024-08-21T15:40:58+05:30,2024-08-21T10:10:58,0.0258
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA,https://www.financialexpress.com/business/healthcare-indian-api-companies-to-grow-by-7-8-and-operating-profit-margin-to-improve-to-12-14-in-fy2025-icra-3580803/,2024-08-12T16:12:47+05:30,2024-08-12T10:42:47,0.7003
Eli Lilly obesity drug approval in China strengthens market position amid GLP-1 agonist competition: GlobalData,https://www.financialexpress.com/business/healthcare-eli-lilly-obesity-drug-approval-in-china-strengthens-market-position-amid-glp-1-agonist-competition-globaldata-3578452/,2024-08-09T13:55:29+05:30,2024-08-09T08:25:29,0.7269
USFDA gives nod to Granules India’s generic formulation to treat depression,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-granules-indias-generic-formulation-to-treat-depression-3578377/,2024-08-09T13:02:29+05:30,2024-08-09T07:32:29,-0.25
These 70 medicines may get cheaper in India as NPPA fixes price,https://www.financialexpress.com/business/healthcare-these-70-medicines-may-get-cheaper-in-india-as-nppa-fixes-price-3577618/,2024-08-08T17:51:10+05:30,2024-08-08T12:21:10,0.0
CDSCO waives local clinical trials for new drugs approved in developed countries,https://www.financialexpress.com/business/healthcare-cdsco-waives-local-clinical-trials-for-new-drugs-approved-in-developed-countries-3577506/,2024-08-08T16:03:50+05:30,2024-08-08T10:33:50,0.4215
USFDA gives nod to Alembic’s generic formulation for treatment of severe psoriasis,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-alembics-generic-formulation-for-treatment-of-severe-psoriasis-3576374/,2024-08-07T17:27:25+05:30,2024-08-07T11:57:25,-0.3818
"Centre spent Rs 36,397 crore on procurement of COVID-19 vaccines: Govt tells Lok Sabha",https://www.financialexpress.com/business/healthcare-centre-spent-rs-36397-crore-on-procurement-of-covid-19-vaccines-govt-tells-lok-sabha-3572370/,2024-08-02T17:33:04+05:30,2024-08-02T12:03:04,0.0
"India needs increased surveillance, more focus on drug discovery to combat AMR: Dr. Jaideep Gogtay, Global CMO, Cipla",https://www.financialexpress.com/business/healthcare-india-needs-increased-surveillance-more-focus-on-drug-discovery-to-combat-amr-dr-jaideep-gogtay-global-cmo-cipla-3572304/,2024-08-02T17:04:08+05:30,2024-08-02T11:34:08,-0.0772
Sanofi gets marketing authorisation for its vaccine to treat RSV in India,https://www.financialexpress.com/business/healthcare-sanofi-get-marketing-authorisation-for-its-vaccine-to-treat-rsv-in-india-3571054/,2024-08-01T15:35:18+05:30,2024-08-01T10:05:18,0.4019
Mexican regulatory authority gives nod to Zydus’ Trastuzumab biosimilar to treat cancers,https://www.financialexpress.com/business/healthcare-mexican-regulatory-authority-gives-nod-to-zydus-trastuzumab-biosimilar-to-treat-cancers-3570005/,2024-07-31T16:36:30+05:30,2024-07-31T11:06:30,0.4588
Centaur launches chronic heart failure generic drug in United States,https://www.financialexpress.com/business/healthcare-centaur-launches-chronic-heart-failure-generic-drug-in-united-states-3557456/,2024-07-22T14:34:01+05:30,2024-07-22T09:04:01,-0.128
USFDA red-flags desi Viagra! Indian pharmas’ erectile dysfunction drug in question over ‘fake’ data,https://www.financialexpress.com/business/healthcare-us-fda-red-flags-desi-viagra-indian-pharmas-erectile-dysfunction-drug-in-question-over-fake-data-3550769/,2024-07-11T17:21:50+05:30,2024-07-11T11:51:50,-0.4753
"India set to witness obesity pill revolution? As patents near expiry, pharma giants gear up for market boom",https://www.financialexpress.com/business/healthcare-india-set-to-witness-obesity-pill-revolution-as-patents-near-expiry-pharma-giants-gear-up-for-market-boom-3547071/,2024-07-08T12:55:02+05:30,2024-07-08T07:25:02,0.0
"GSK takes full rights to COVID-19, influenza vaccines from CureVac",https://www.financialexpress.com/business/healthcare-gsk-takes-full-rights-to-covid-19-influenza-vaccines-from-curevac-3544339/,2024-07-05T10:46:44+05:30,2024-07-05T05:16:44,0.0
"Budget 2024: Pharma sector demands substantial R&D incentives, tax relief and strong IP framework",https://www.financialexpress.com/budget/budget-2024-pharma-sector-demands-substantial-rampd-incentives-tax-relief-and-strong-ip-framework-3543082/,2024-07-04T10:39:10+05:30,2024-07-04T05:09:10,0.8591
USFDA approves Eli Lilly’s drug to treat Alzheimer’s in adults,https://www.financialexpress.com/business/healthcare-usfda-approves-eli-lillys-drug-to-treat-alzheimers-in-adults-3542109/,2024-07-03T11:49:01+05:30,2024-07-03T06:19:01,0.6597
EU grants fast-track assessment to AstraZeneca’s COVID-19 prevention drug,https://www.financialexpress.com/business/healthcare-eu-grants-fast-track-assessment-to-astrazenecas-covid-19-prevention-drug-3540380/,2024-07-01T14:43:57+05:30,2024-07-01T09:13:57,0.2263
Orchid Pharma partners with Cipla to launch new antibiotic in India,https://www.financialexpress.com/business/healthcare-orchid-pharma-partners-with-cipla-to-launch-new-antibiotic-in-india-3540128/,2024-07-01T11:32:31+05:30,2024-07-01T06:02:31,0.0
USFDA gives nod to Lupin’s generic formulation to treat eye condition,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-formulation-to-treat-eye-condition-3536936/,2024-06-27T17:24:02+05:30,2024-06-27T11:54:02,0.4019
Chronic kidney disease market to grow at 19.6 percent CAGR in seven major markets during 2023-33: GlobalData,https://www.financialexpress.com/business/healthcare-chronic-kidney-disease-market-to-grow-at-19-6-percent-cagr-in-seven-major-markets-during-2023-33-globaldata-3535447/,2024-06-26T15:11:36+05:30,2024-06-26T09:41:36,0.0
"Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd.",https://www.financialexpress.com/business/healthcare-our-primary-goal-is-to-double-our-revenue-enter-higher-margin-niche-segments-and-increase-footprint-dr-saloni-wagh-director-supriya-lifescience-ltd-3533944/,2024-06-25T09:04:28+05:30,2024-06-25T03:34:28,0.3182
"We are working on reviving its R&D strengths; To launch new products 1-2 months: Rajnish Rohatgi, CEO, Orchid Pharma",https://www.financialexpress.com/business/healthcare-we-are-working-on-reviving-its-rd-strengths-to-launch-new-products-1-2-months-rajnish-rohatgi-ceo-orchid-pharma-3532739/,2024-06-24T10:54:11+05:30,2024-06-24T05:24:11,0.4019
USFDA advisors back Eli Lilly’s Alzheimer’s drug ahead of its expected approval,https://www.financialexpress.com/business/healthcare-usfda-advisors-back-eli-lillys-alzheimers-drug-ahead-of-its-expected-approval-3521763/,2024-06-11T16:22:53+05:30,2024-06-11T10:52:53,0.4767
USFDA gives nod to Genfit and Ipsen’s liver disease drug,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-genfit-and-ipsens-liver-disease-drug-3521571/,2024-06-11T15:08:49+05:30,2024-06-11T09:38:49,0.0
Skye Bioscience to halt eye disease drug development after failing trial,https://www.financialexpress.com/business/healthcare-skye-bioscience-to-halt-eye-disease-drug-development-after-failing-trial-3520636/,2024-06-10T17:43:56+05:30,2024-06-10T12:13:56,-0.5106
Akums launches novel formulations for patients with gastrointestinal disorders in India,https://www.financialexpress.com/business/healthcare-akums-launches-novel-formulations-for-patients-with-gastrointestinal-disorders-in-india-3520238/,2024-06-10T14:05:11+05:30,2024-06-10T08:35:11,0.3182
Seres Therapeutics to sell bacterial infection drug to Nestle Health,https://www.financialexpress.com/business/healthcare-seres-therapeutics-to-sell-bacterial-infection-drug-to-nestle-health-3516861/,2024-06-06T16:54:04+05:30,2024-06-06T11:24:04,0.0
CDSCO approves Orchid Pharma’s antibiotic combination to treat serious bacterial infections in India,https://www.financialexpress.com/business/healthcare-cdsco-approves-orchid-pharmas-antibiotic-combination-to-treat-serious-bacterial-infections-in-india-3516471/,2024-06-06T12:50:04+05:30,2024-06-06T07:20:04,0.6249
Aurigene opens its biologics facility to offer process development and clinical scale manufacturing capabilities,https://www.financialexpress.com/business/healthcare-aurigene-opens-its-biologics-facility-to-offer-process-development-and-clinical-scale-manufacturing-capabilities-3515583/,2024-06-05T16:02:33+05:30,2024-06-05T10:32:33,0.0
Strides Pharma gets USFDA approval for its generic formulation to treat GERD,https://www.financialexpress.com/business/healthcare-strides-pharma-gets-usfda-approval-for-its-generic-formulation-to-treat-gerd-3497461/,2024-05-22T15:13:33+05:30,2024-05-22T09:43:33,0.7003
Takeda Biopharma appoints Annapurna Das as General Manager for its India Operations,https://www.financialexpress.com/business/healthcare-takeda-biopharma-appoints-annapurna-das-as-general-manager-for-its-india-operations-3490538/,2024-05-16T15:01:38+05:30,2024-05-16T09:31:38,0.0
French drugmaker Sanofi to invest over €1 billion in production sites,https://www.financialexpress.com/business/healthcare-french-drugmaker-sanofi-to-invest-over-1-billion-in-production-sites-3486977/,2024-05-14T10:58:10+05:30,2024-05-14T05:28:10,0.0
Strides Pharma gets USFDA nod for its drug to treat elevated phosphorous levels,https://www.financialexpress.com/business/healthcare-strides-pharma-gets-usfda-nod-for-its-drug-to-treat-elevated-phosphorous-levels-3486090/,2024-05-13T15:16:51+05:30,2024-05-13T09:46:51,0.4019
mRNA vaccines could reduce preventable illness across multiple disease areas: GlobalData,https://www.financialexpress.com/business/healthcare-mrna-vaccines-could-reduce-preventable-illness-across-multiple-disease-areas-globaldata-3466641/,2024-04-24T10:32:28+05:30,2024-04-24T05:02:28,-0.4019
Roche’s therapy shows promise in slowing Parkinson’s disease motor progression: GlobalData,https://www.financialexpress.com/business/healthcare-roches-therapy-shows-promise-in-slowing-parkinsons-disease-motor-progression-globaldata-3465965/,2024-04-23T15:40:49+05:30,2024-04-23T10:10:49,0.3182
Doctors lack consensus on patient choice between branded and generic drugs: GlobalData,https://www.financialexpress.com/business/healthcare-doctors-lack-consensus-on-patient-choice-between-branded-and-generic-drugs-globaldata-3461965/,2024-04-19T12:06:15+05:30,2024-04-19T06:36:15,-0.3182
Can aspirin prevent colorectal cancer? New study reveals shocking effects of the painkiller,https://www.financialexpress.com/business/healthcare-can-aspirin-prevent-colorectal-cancer-new-study-reveals-shocking-effects-of-the-medicine-3461915/,2024-04-19T11:35:58+05:30,2024-04-19T06:05:58,-0.7906
Want to get rid of reading glasses? This new medication can improve age-related vision impairment,https://www.financialexpress.com/business/healthcare-want-to-get-rid-of-reading-glasses-this-new-medication-can-improve-age-related-vision-impairment-3460654/,2024-04-18T11:49:48+05:30,2024-04-18T06:19:48,0.6369
Caplin Steriles gets USFDA approval for its eye infection treatment,https://www.financialexpress.com/business/healthcare-caplin-steriles-gets-usfda-approval-for-its-eye-infection-treatment-3458285/,2024-04-16T12:14:41+05:30,2024-04-16T06:44:41,0.4767
Commonly-used painkiller Nimesulide and antibiotic Cefuroxime can lead to serious skin disorders; Govt issues alert,https://www.financialexpress.com/business/healthcare-commonly-used-painkiller-nimesulide-and-antibiotic-cefuroxime-can-lead-to-serious-skin-disorders-govt-issues-alert-3454719/,2024-04-12T12:08:55+05:30,2024-04-12T06:38:55,0.2263
Pfizer reports significant positive outcomes from phase 3 trial of its RSV vaccine,https://www.financialexpress.com/business/healthcare-pfizer-reports-significant-positive-outcomes-from-phase-3-trial-of-its-rsv-vaccine-3453730/,2024-04-11T13:51:20+05:30,2024-04-11T08:21:20,0.6597
Sun Pharma halts trial of its Parkinson’s disease drug as it fails to show “treatment benefits”,https://www.financialexpress.com/business/healthcare-sun-pharma-halts-trial-of-its-parkinsons-disease-drug-as-it-fails-to-show-treatment-benefits-3452475/,2024-04-10T14:57:22+05:30,2024-04-10T09:27:22,-0.4215
"Lupin, Glenmark and Natco Pharma recall drugs in US market due to manufacturing issues",https://www.financialexpress.com/business/healthcare-lupin-glenmark-and-natco-pharma-recall-drugs-in-us-market-due-to-manufacturing-issues-3452401/,2024-04-10T13:57:28+05:30,2024-04-10T08:27:28,0.0
Boehringer Ingelheim China gets approval for supply to EU and US markets,https://www.financialexpress.com/business/healthcare-boehringer-ingelheim-china-gets-approval-for-supply-to-eu-and-us-markets-3452190/,2024-04-10T12:19:23+05:30,2024-04-10T06:49:23,0.4767
Lupin launches generic formulation of bacterial pneumonia drug in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-generic-formulation-of-bacterial-pneumonia-drug-in-united-states-3452114/,2024-04-10T11:25:02+05:30,2024-04-10T05:55:02,0.4215
USFDA issues warning letter to Natco Pharma for Telangana Plant; Shares dip over 2 percent,https://www.financialexpress.com/business/healthcare-usfda-issues-warning-letter-to-natco-pharma-for-telangana-plant-shares-dip-over-2-percent-3451112/,2024-04-09T13:08:46+05:30,2024-04-09T07:38:46,-0.0516
Health Ministry’s Drugs Advisory Board recommends prohibition of Emcure Pharma’s pain relief drug combination in India,https://www.financialexpress.com/business/healthcare-health-ministrys-drugs-advisory-board-recommends-prohibition-of-emcure-pharmas-pain-relief-drug-combination-in-india-3451064/,2024-04-09T12:38:36+05:30,2024-04-09T07:08:36,0.1779
USFDA grants approval to Strides Pharma for its anti-depressant drug,https://www.financialexpress.com/business/healthcare-usfda-grants-approval-to-strides-pharma-for-its-anti-depressant-drug-3450936/,2024-04-09T11:47:49+05:30,2024-04-09T06:17:49,0.6124
India’s pharma market reports 9.5 percent growth in March 2024: Pharmatrac data,https://www.financialexpress.com/business/healthcare-indias-pharma-market-reports-9-5-percent-growth-in-march-2024-pharmatrac-data-3450871/,2024-04-09T10:56:53+05:30,2024-04-09T05:26:53,0.3818
AstraZeneca and Daiichi Sankyo’s drug gets USFDA nod for people with HER2-positive solid tumours,https://www.financialexpress.com/business/healthcare-astrazeneca-and-daiichi-sankyos-drug-gets-usfda-nod-for-people-with-her2-positive-solid-tumours-3450145/,2024-04-08T15:21:31+05:30,2024-04-08T09:51:31,0.1531
Lupin gets USFDA nod for its drug to treat movement disorders,https://www.financialexpress.com/business/healthcare-lupin-gets-usfda-nod-for-its-drug-to-treat-movement-disorders-3450121/,2024-04-08T14:54:06+05:30,2024-04-08T09:24:06,0.4019
Sanofi’s new polio vaccine gets nod in India amid speculations of potential shortage,https://www.financialexpress.com/business/healthcare-sanofis-new-polio-vaccine-gets-nod-in-india-amid-speculations-of-potential-shortage-3449806/,2024-04-08T11:12:27+05:30,2024-04-08T05:42:27,-0.25
Biocon leads generic race for blockbuster weight loss drugs as patents set to expire soon,https://www.financialexpress.com/business/healthcare-biocon-leads-generic-race-for-blockbuster-weight-loss-drugs-as-patents-set-to-expire-soon-3449767/,2024-04-08T10:51:11+05:30,2024-04-08T05:21:11,0.3818
"French drugmaker Sanofi agrees to settle 4,000 Zantac cancer lawsuits in US state courts",https://www.financialexpress.com/business/healthcare-french-drugmaker-sanofi-agrees-to-settle-4000-zantac-cancer-lawsuits-in-us-state-courts-3446050/,2024-04-04T12:38:19+05:30,2024-04-04T07:08:19,-0.6369
Lupin appoints Dr. Ranjana Pathak as Chief Quality Officer,https://www.financialexpress.com/business/healthcare-lupin-appoints-dr-ranjana-pathak-as-chief-quality-officer-3445146/,2024-04-03T16:10:13+05:30,2024-04-03T10:40:13,0.0
China develops first biosimilar of globally popular weight loss drug Ozempic; Application submitted for approval,https://www.financialexpress.com/business/healthcare-china-develops-first-biosimilar-of-globally-popular-weight-loss-drug-ozempic-application-submitted-for-approval-3445129/,2024-04-03T15:59:47+05:30,2024-04-03T10:29:47,0.5574
Dr. Reddy’s Laboratories’ subsidiary Aurigene launches AI/ML-assisted drug discovery platform,https://www.financialexpress.com/business/healthcare-dr-reddys-laboratories-subsidiary-aurigene-launches-aiml-assisted-drug-discovery-platform-3445072/,2024-04-03T15:33:11+05:30,2024-04-03T10:03:11,0.0
International Patients’ Union signs MoU with the Indian Pharmacopeia Commission to prioritise patient-driven healthcare solutions,https://www.financialexpress.com/business/healthcare-international-patients-union-signs-mou-with-ipc-to-prioritise-patient-driven-healthcare-solutions-3445045/,2024-04-03T15:13:30+05:30,2024-04-03T09:43:30,0.1779
Cipla to witness surge in profit due to growth in its complex respiratory portfolio: Report,https://www.financialexpress.com/business/healthcare-cipla-to-witness-surge-in-profit-due-to-growth-in-its-complex-respiratory-portfolio-report-3444951/,2024-04-03T13:40:41+05:30,2024-04-03T08:10:41,0.6705
AstraZeneca’s add-on treatment for rare blood disease gets USFDA nod,https://www.financialexpress.com/business/healthcare-astrazenecas-add-on-treatment-for-rare-blood-disease-gets-usfda-nod-3444136/,2024-04-02T16:59:12+05:30,2024-04-02T11:29:12,0.0
Eyestem to initiate human trials for its therapy to treat eye disorder,https://www.financialexpress.com/business/healthcare-eyestem-to-initiate-human-trials-for-its-formulation-to-treat-eye-disorder-3444072/,2024-04-02T16:22:51+05:30,2024-04-02T10:52:51,0.0
Urgent need for improved osteoporosis management to enhance patient outcomes: GlobalData,https://www.financialexpress.com/business/healthcare-urgent-need-for-improved-osteoporosis-management-to-enhance-patient-outcomes-globaldata-3444052/,2024-04-02T16:10:36+05:30,2024-04-02T10:40:36,0.5994
Foresee Pharma to continue phase 3 trial of its drug to treat puberty disorder,https://www.financialexpress.com/business/healthcare-foresee-pharma-to-continue-phase-3-trial-of-its-drug-to-treat-puberty-disorder-3443936/,2024-04-02T14:31:26+05:30,2024-04-02T09:01:26,0.0
Eisai submits sBLA to USFDA for its key drug to treat early Alzheimer’s disease,https://www.financialexpress.com/business/healthcare-eisai-submits-sbla-to-usfda-for-its-key-drug-to-treat-early-alzheimers-disease-3443903/,2024-04-02T14:06:39+05:30,2024-04-02T08:36:39,0.4019
Bharat Biotech to collaborate with Serum Institute’s subsidiary Bilthoven Biologicals for production and supply of oral Polio vaccines,https://www.financialexpress.com/business/healthcare-bharat-biotech-to-collaborate-with-serum-institutes-subsidiary-for-production-and-supply-of-oral-polio-vaccines-3443817/,2024-04-02T12:59:25+05:30,2024-04-02T07:29:25,0.0
Sanofi to launch key drugs from its global pipeline in India soon,https://www.financialexpress.com/business/healthcare-sanofi-to-launch-key-drugs-from-its-global-pipeline-in-india-soon-3443623/,2024-04-02T10:42:49+05:30,2024-04-02T05:12:49,0.0
Eli Lilly’s obesity drug may face shortage issue in United States; Here’s why,https://www.financialexpress.com/business/healthcare-eli-lillys-obesity-drug-may-face-shortage-issue-in-united-states-heres-why-3443009/,2024-04-01T15:57:23+05:30,2024-04-01T10:27:23,0.2023
"Data analytics can play a crucial role in connecting the right patient with right drugs: Jaswinder Chadha, President & CEO, Axtria",https://www.financialexpress.com/business/healthcare-data-analytics-can-play-a-crucial-role-in-connecting-the-right-patient-with-right-drugs-jaswinder-chadha-president-ceo-axtria-3442724/,2024-04-01T12:20:19+05:30,2024-04-01T06:50:19,0.34
Aurobindo Pharma commissions 4 plants to manufacture Penicillin-G and injectable products in Andhra Pradesh,https://www.financialexpress.com/business/healthcare-aurobindo-pharma-commissions-4-plants-to-manufacture-penicillin-g-and-injectable-products-in-andhra-pradesh-3442611/,2024-04-01T10:54:40+05:30,2024-04-01T05:24:40,0.0
"From Paracetamol to Amoxycillin, samples of 58 commonly-used drugs fail quality test; CDSCO issues alert",https://www.financialexpress.com/business/healthcare-from-paracetamol-to-amoxycillin-58-essential-drug-samples-fail-quality-test-cdsco-issues-alert-3442582/,2024-04-01T10:38:03+05:30,2024-04-01T05:08:03,-0.3182
"Paracetamol, Azithromycin and other essential medicines to get costly from April 1; Read on to know why",https://www.financialexpress.com/business/healthcare-paracetamol-azithromycin-and-other-essential-medicines-to-get-costly-from-april-1-read-on-to-know-why-3442187/,2024-03-31T17:29:40+05:30,2024-03-31T11:59:40,-0.1027
Companies protest minimal rise in drug prices for FY25,https://www.financialexpress.com/business/healthcare-companies-protest-minimal-rise-in-drug-prices-for-fy25-3441000/,2024-03-30T00:45:00+05:30,2024-03-29T19:15:00,-0.25
Lupin gets USFDA nod for its generic drug to treat seizures,https://www.financialexpress.com/business/healthcare-lupin-gets-usfda-nod-for-its-generic-drug-to-treat-seizures-3440372/,2024-03-29T12:21:47+05:30,2024-03-29T06:51:47,0.4019
New marketing code for drugs stirs debate,https://www.financialexpress.com/business/healthcare-new-marketing-code-for-drugs-stirs-debate-3437488/,2024-03-27T04:15:00+05:30,2024-03-26T22:45:00,0.0
USFDA gives nod to nonsteroidal treatment for Duchenne Muscular Dystrophy,https://www.financialexpress.com/business/healthcare-fda-gives-nod-to-nonsteroidal-treatment-for-duchenne-muscular-dystrophy-3435687/,2024-03-24T16:56:46+05:30,2024-03-24T11:26:46,0.0
"In India, CGM usage trend has seen a gradual incline since its introduction in 2015: Dr. Subramaniam, Medical Affairs Head, Abbott Diabetes Care",https://www.financialexpress.com/business/healthcare-in-india-cgm-usage-trend-has-seen-a-gradual-incline-since-its-introduction-in-2015-dr-subramaniam-medical-affairs-head-abbott-diabetes-care-3431313/,2024-03-20T12:40:08+05:30,2024-03-20T07:10:08,0.4939
Venus Remedies gets its first incentive of Rs 7.50 crore under PLI scheme,https://www.financialexpress.com/business/healthcare-venus-remedies-gets-its-first-incentive-of-rs-7-50-crore-under-pli-scheme-3415372/,2024-03-06T12:15:19+05:30,2024-03-06T06:45:19,0.3612
Sandoz gets FDA approval for first and only denosumab biosimilars,https://www.financialexpress.com/business/healthcare-sandoz-gets-fda-approval-for-first-and-only-denosumab-biosimilars-3415261/,2024-03-06T11:16:23+05:30,2024-03-06T05:46:23,0.4767
Roche launches monoclonal antibody for two critical eye diseases in India,https://www.financialexpress.com/business/healthcare-roche-launches-monoclonal-antibody-for-two-critical-eye-diseases-in-india-3414762/,2024-03-05T20:33:21+05:30,2024-03-05T15:03:21,-0.3182
Cadila Pharmaceuticals launches vaccine to prevent seasonal flu in India,https://www.financialexpress.com/business/healthcare-cadila-pharmaceuticals-launches-vaccine-to-prevent-seasonal-flu-in-india-3412962/,2024-03-04T15:30:44+05:30,2024-03-04T10:00:44,-0.3612
Garware Fulflex India acquires Avcor Health Care Products to strengthen its medical product portfolio,https://www.financialexpress.com/business/healthcare-garware-fulflex-india-acquires-avcor-health-care-products-to-strengthen-its-medical-product-portfolio-3410070/,2024-03-01T10:13:56+05:30,2024-03-01T04:43:56,0.6705
Cadila Pharmaceuticals launches Vitamin D injection to treat deficiency,https://www.financialexpress.com/business/healthcare-cadila-pharmaceuticals-launches-vitamin-d-injection-to-treat-deficiency-3406171/,2024-02-27T09:11:37+05:30,2024-02-27T03:41:37,0.5994
Emcure launches initiative to help women assess anemia risk with self-test,https://www.financialexpress.com/business/healthcare-emcure-launches-initiative-to-help-women-assess-anemia-risk-with-self-test-3406156/,2024-02-27T09:00:13+05:30,2024-02-27T03:30:13,0.1531
"Otsuka’s new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData",https://www.financialexpress.com/business/healthcare-otsukas-new-formulations-to-offset-abilify-maintena-dual-patent-expiry-impact-says-globaldata-3395815/,2024-02-16T10:05:00+05:30,2024-02-16T04:35:00,0.0
USFDA approves first medication for severe frostbite treatment,https://www.financialexpress.com/business/healthcare-usfda-approves-first-medication-for-severe-frostbite-treatment-3395812/,2024-02-16T09:30:00+05:30,2024-02-16T04:00:00,0.0258
CDSCO gives nod to Boehringer Ingelheim’s anti-diabetic drug to treat chronic kidney disease in India,https://www.financialexpress.com/business/healthcare-cdsco-gives-nod-to-boehringer-ingelheims-anti-diabetic-drug-to-treat-chronic-kidney-disease-in-india-3394339/,2024-02-14T16:49:32+05:30,2024-02-14T11:19:32,0.4019
Lupin launches generic formulation for ocular pain in US market,https://www.financialexpress.com/business/healthcare-lupin-launches-generic-formulation-for-ocular-pain-in-us-market-3393102/,2024-02-13T16:31:10+05:30,2024-02-13T11:01:10,-0.5106
Eris Lifesciences acquires 51 percent stake in Swiss Parenterals to expand its footprint in sterile injectables,https://www.financialexpress.com/business/healthcare-eris-lifesciences-acquires-51-percent-stake-in-swiss-parenterals-to-expand-its-footprint-in-sterile-injectables-3393081/,2024-02-13T16:21:15+05:30,2024-02-13T10:51:15,0.3182
"Aparna Group forays into pharma business vertical, gets USFDA clearance for manufacturing unit",https://www.financialexpress.com/business/healthcare-aparna-group-forays-into-pharma-business-vertical-gets-usfda-clearance-for-manufacturing-unit-3392225/,2024-02-13T08:00:00+05:30,2024-02-13T02:30:00,0.0
ORS remains under-prescribed in India; 50 percent of children with diarrhea did not receive this lifesaving treatment,https://www.financialexpress.com/business/healthcare-ors-remains-under-prescribed-in-india-50-percent-of-children-with-diarrhea-did-not-receive-this-lifesaving-treatment-3390732/,2024-02-12T09:00:00+05:30,2024-02-12T03:30:00,0.0
Steroid-based antifungal creams may lead to more fungal infections; Here’s how,https://www.financialexpress.com/business/healthcare-steroid-based-antifungal-creams-may-lead-to-more-fungal-infections-heres-how-3387001/,2024-02-07T16:09:59+05:30,2024-02-07T10:39:59,0.0
"Pharma companies planning to invest nearly 7 percent of revenue in establishing high-end labs by 2025, Capgemini report reveals",https://www.financialexpress.com/business/healthcare-pharma-companies-planning-to-invest-nearly-7-percent-of-revenue-in-establishing-high-end-labs-by-2025-capgemini-report-reveals-3386845/,2024-02-07T14:22:08+05:30,2024-02-07T08:52:08,0.0
Novartis to acquire MorphoSys AG to strengthen oncology pipeline,https://www.financialexpress.com/business/healthcare-novartis-to-acquire-morphosys-ag-to-strengthen-oncology-pipeline-3385330/,2024-02-06T08:53:47+05:30,2024-02-06T03:23:47,0.3182
GSK’s Arexvy label expansion will intensify competition with Pfizer’s Abrysvo in RSV space,https://www.financialexpress.com/business/healthcare-gsks-arexvy-label-expansion-will-intensify-competition-with-pfizers-abrysvo-in-rsv-space-3384409/,2024-02-05T11:46:23+05:30,2024-02-05T06:16:23,0.0
"Torrent Pharma Q3 profit up 51.7% at Rs 443 crore, revenue up 9.7% on-year",https://www.financialexpress.com/business/industry-torrent-pharma-q3-profit-up-51-7-at-rs-443-crore-revenue-up-97-on-year-3382716/,2024-02-02T15:05:48+05:30,2024-02-02T09:35:48,0.4404
USFDA gives nod to Lupin’s generic formulation for heart rhythm disorder treatment,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-formulation-for-heart-rhythm-disorder-treatment-3381757/,2024-02-01T16:04:41+05:30,2024-02-01T10:34:41,-0.4019
Sandoz launches biosimilar for multiple sclerosis in Germany,https://www.financialexpress.com/business/healthcare-sandoz-launches-biosimilar-for-multiple-sclerosis-in-germany-3379753/,2024-01-31T12:47:33+05:30,2024-01-31T07:17:33,0.0
Dr. Reddy’s Q3FY24 Results: Pharma major to focus on scaling up its consumer health segment; To launch IBS management platform soon,https://www.financialexpress.com/business/healthcare-dr-reddys-q3fy24-results-pharma-major-to-focus-on-scaling-up-its-consumer-health-segment-to-launch-ibs-management-platform-soon-3379707/,2024-01-31T12:23:22+05:30,2024-01-31T06:53:22,0.0
Pfizer beats as Paxlovid returns impact milder than feared,https://www.financialexpress.com/business/healthcare-pfizer-beats-as-paxlovid-returns-impact-milder-than-feared-3379107/,2024-01-30T18:27:55+05:30,2024-01-30T12:57:55,-0.4939
Jubilant Pharma to sell 25.8 percent stake in Sofie Biosciences,https://www.financialexpress.com/business/healthcare-jubilant-pharma-to-sell-25-8-percent-stake-in-sofie-biosciences-3379043/,2024-01-30T17:46:13+05:30,2024-01-30T12:16:13,0.6124
"Antibody drug conjugates focus draws global pharma giants attention to China, says GlobalData",https://www.financialexpress.com/business/healthcare-antibody-drug-conjugates-focus-draws-global-pharma-giants-attention-to-china-says-globaldata-3377889/,2024-01-30T08:00:00+05:30,2024-01-30T02:30:00,0.0
"Moderna leads development of mRNA vaccines in infectious diseases, reveals GlobalData",https://www.financialexpress.com/business/healthcare-moderna-leads-development-of-mrna-vaccines-in-infectious-diseases-reveals-globaldata-3377591/,2024-01-29T13:44:22+05:30,2024-01-29T08:14:22,0.0
Budget 2024: Will Nirmala Sitharaman bring down cost of medicines on February 1? Read on to find out,https://www.financialexpress.com/budget/budget-2024-will-nirmala-sitharaman-bring-down-cost-of-medicines-on-february-1-read-on-to-find-out-3376875/,2024-01-29T08:00:00+05:30,2024-01-29T02:30:00,0.0
Top 10 blockbuster drugs that will become off-patent in 2024,https://www.financialexpress.com/business/healthcare-top-10-blockbuster-drugs-that-will-become-off-patent-in-2024-3375195/,2024-01-25T16:24:40+05:30,2024-01-25T10:54:40,0.6908
Abbott bets on aging population for nutrition business growth,https://www.financialexpress.com/business/healthcare-abbott-bets-on-aging-population-for-nutrition-business-growth-3374649/,2024-01-25T11:02:40+05:30,2024-01-25T05:32:40,0.3818
USFDA grants tentative approval to Lupin’s generic tablets for stroke treatment,https://www.financialexpress.com/business/healthcare-usfda-grants-tentative-approval-to-lupins-generic-tablets-for-stroke-treatment-3373002/,2024-01-23T17:26:52+05:30,2024-01-23T11:56:52,0.6124
Sanofi to buy Inhibrx for $2.2 billion in rare disease push,https://www.financialexpress.com/business/healthcare-sanofi-to-buy-inhibrx-for-2-2-billion-in-rare-disease-push-3372794/,2024-01-23T15:21:58+05:30,2024-01-23T09:51:58,0.0
USFDA asks companies to add ‘boxed warning’ for CAR-T cancer therapies,https://www.financialexpress.com/business/healthcare-usfda-asks-companies-to-add-boxed-warning-for-car-t-cancer-therapies-3372706/,2024-01-23T14:38:09+05:30,2024-01-23T09:08:09,-0.6597
Gilead sinks after lung cancer drug fails to improve survival,https://www.financialexpress.com/business/healthcare-gilead-sinks-after-lung-cancer-drug-fails-to-improve-survival-3372692/,2024-01-23T14:01:27+05:30,2024-01-23T08:31:27,-0.6486
Indian Immunologicals rolls out indigenously developed Hepatitis A vaccine,https://www.financialexpress.com/business/healthcare-indian-immunologicals-ltd-rolls-out-indigenously-developed-hepatitis-a-vaccine-3371431/,2024-01-22T12:32:37+05:30,2024-01-22T07:02:37,0.0
Sandoz to acquire biosimilar to treat eye disorders from Coherus BioSciences,https://www.financialexpress.com/business/healthcare-sandoz-to-acquire-biosimilar-to-treat-eye-disorders-from-coherus-biosciences-3371383/,2024-01-22T12:03:57+05:30,2024-01-22T06:33:57,0.4019
USFDA gives nod to Lupin’s generic formulation to treat high uric acid,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-formulation-to-treat-high-uric-acid-3368927/,2024-01-19T10:11:54+05:30,2024-01-19T04:41:54,0.4019
India renal denervation catheter market to grow at 11% CAGR through 2033: GlobalData,https://www.financialexpress.com/business/healthcare-india-renal-denervation-catheter-market-to-grow-at-11-cagr-through-2033-globaldata-3368441/,2024-01-19T09:00:00+05:30,2024-01-19T03:30:00,0.0
Agepha Pharma and Caristo Diagnostics team up to fight coronary inflammation,https://www.financialexpress.com/business/healthcare-agepha-pharma-and-caristo-diagnostics-team-up-to-fight-coronary-inflammation-3368397/,2024-01-19T08:00:00+05:30,2024-01-19T02:30:00,-0.3818
NATCO Pharma Limited invests around US$ 2 million in Cellogen Therapeutics,https://www.financialexpress.com/business/healthcare-natco-pharma-limited-invests-around-us-2-million-in-cellogen-therapeutics-3368201/,2024-01-18T15:48:19+05:30,2024-01-18T10:18:19,-0.2263
Bayer and Sun Pharma sign marketing and distribution agreement for second brand of cardiac drug in India,https://www.financialexpress.com/business/healthcare-bayer-and-sun-pharma-sign-marketing-and-distribution-agreement-for-second-brand-of-cardiac-drug-in-india-3368157/,2024-01-18T15:18:23+05:30,2024-01-18T09:48:23,0.4939
Nearly 2 in 3 cervical cancer patients in India die every year; Here’s why,https://www.financialexpress.com/business/healthcare-nearly-2-in-3-cervical-cancer-patients-in-india-die-every-year-heres-why-3368125/,2024-01-18T14:59:44+05:30,2024-01-18T09:29:44,-0.8519
"FE Exclusive | We will be launching JADA System to combat postpartum hemorrhage in India later this year: Andreas Daugaard, MD, SEA Cluster at Organon",https://www.financialexpress.com/business/healthcare-fe-exclusive-we-will-be-launching-jada-system-to-combat-postpartum-hemorrhage-in-india-later-this-year-andreas-daugaard-md-sea-cluster-at-organon-3366866/,2024-01-17T13:02:09+05:30,2024-01-17T07:32:09,-0.2263
"Ozempic not linked to suicidal thoughts, FDA report finds",https://www.financialexpress.com/business/healthcare-ozempic-not-linked-to-suicidal-thoughts-fda-report-finds-3363168/,2024-01-12T16:42:49+05:30,2024-01-12T11:12:49,0.5559
Ozone Pharma eyes Rs 1000 crore topline in next 3 years,https://www.financialexpress.com/business/healthcare-ozone-pharma-eyes-rs-1000-crore-topline-in-next-3-years-3361861/,2024-01-11T15:13:03+05:30,2024-01-11T09:43:03,0.0
Delhi govt issues notice to GTB hospital to ‘terminate’ doctor for denying admission to patient,https://www.financialexpress.com/business/healthcare-delhi-govt-issues-notice-to-gtb-hospital-to-terminate-doctor-for-denying-admission-to-patient-3361818/,2024-01-11T15:04:43+05:30,2024-01-11T09:34:43,-0.34
Transgene and NEC extend collaboration to continue joint clinical development of neoantigen cancer vaccine,https://www.financialexpress.com/business/healthcare-transgene-and-nec-extend-collaboration-to-continue-joint-clinical-development-of-neoantigen-cancer-vaccine-3361750/,2024-01-11T13:29:58+05:30,2024-01-11T07:59:58,-0.5719
FDA allows imports of syphilis drug alternate during shortage,https://www.financialexpress.com/business/healthcare-fda-allows-imports-of-syphilis-drug-alternate-during-shortage-3361656/,2024-01-11T12:05:12+05:30,2024-01-11T06:35:12,-0.25
Lupin launches tablets to aid smoking cessation in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-tablets-to-aid-smoking-cessation-in-the-united-states-3361232/,2024-01-10T20:45:00+05:30,2024-01-10T15:15:00,0.4215
Novartis in advanced talks to buy Cytokinetics: Report,https://www.financialexpress.com/business/healthcare-novartis-in-advanced-talks-to-buy-cytokinetics-report-3359861/,2024-01-09T16:58:49+05:30,2024-01-09T11:28:49,0.25
"Bayer Pharma head sees brighter future with deals, new drugs",https://www.financialexpress.com/business/healthcare-bayer-pharma-head-sees-brighter-future-with-deals-new-drugs-3359807/,2024-01-09T16:38:13+05:30,2024-01-09T11:08:13,0.3818
Health Ministry revises Schedule M guidelines for pharma manufacturing units to quality check,https://www.financialexpress.com/business/healthcare-health-ministry-revises-schedule-m-guidelines-for-pharma-manufacturing-units-to-quality-check-3359685/,2024-01-09T14:35:35+05:30,2024-01-09T09:05:35,0.0
Cipla announces joint venture for global development and commercialisation of innovative cell therapy products,https://www.financialexpress.com/business/healthcare-cipla-announces-joint-venture-for-global-development-and-commercialisation-of-innovative-cell-therapy-products-3359462/,2024-01-09T12:13:49+05:30,2024-01-09T06:43:49,0.4404
Akums launches generic formulation to treat migraine,https://www.financialexpress.com/business/healthcare-akums-launches-generic-formulation-to-treat-migraine-3356483/,2024-01-05T14:28:16+05:30,2024-01-05T08:58:16,0.4019
USFDA grants tentative approval to Lupin’s generic formulation for type 2 diabetes,https://www.financialexpress.com/business/healthcare-usfda-grants-tentative-approval-to-lupins-generic-formulation-for-type-2-diabetes-2-3356253/,2024-01-05T12:07:30+05:30,2024-01-05T06:37:30,0.6124
Strong performance in US market to support growth of Indian pharma industry in FY24: ICRA,https://www.financialexpress.com/business/healthcare-strong-performance-in-us-market-to-support-growth-of-indian-pharma-industry-in-fy24-icra-3355517/,2024-01-04T17:05:58+05:30,2024-01-04T11:35:58,0.8225
"Healthcare & Pharma Outlook 2024: Companies to focus on quality, sustainability, and accessibility; Surge in R&D expected",https://www.financialexpress.com/business/healthcare-healthcare-pharma-outlook-2024-companies-to-focus-on-quality-sustainability-and-accessibility-surge-in-rd-expected-3355197/,2024-01-04T13:02:12+05:30,2024-01-04T07:32:12,0.0
"Navigating a New Era: India’s Drugs, Medical Devices, and Cosmetics Bill",https://www.financialexpress.com/business/healthcare-navigating-a-new-era-indias-drugs-medical-devices-and-cosmetics-bill-3354345/,2024-01-04T08:00:00+05:30,2024-01-04T02:30:00,0.0
Expiring Pfizer covid drug doses to cost Europe $2.2 billion,https://www.financialexpress.com/business/healthcare-expiring-pfizer-covid-drug-doses-to-cost-europe-2-2-billion-3354261/,2024-01-03T15:37:44+05:30,2024-01-03T10:07:44,0.0
AstraZeneca India launches innovative drug for HER-2 positive metastatic breast cancer patients in India,https://www.financialexpress.com/business/healthcare-astrazeneca-india-launches-innovative-drug-for-her-2-positive-metastatic-breast-cancer-patients-in-india-3354029/,2024-01-03T12:54:42+05:30,2024-01-03T07:24:42,0.2732
Unlocking the future of pharma: The synergy of SaaS and cloud communication with AI,https://www.financialexpress.com/business/healthcare-unlocking-the-future-of-pharma-the-synergy-of-saas-and-cloud-communication-with-ai-3353342/,2024-01-03T09:00:00+05:30,2024-01-03T03:30:00,0.0
Roche to fold struggling diabetes business into diagnostics unit,https://www.financialexpress.com/business/healthcare-roche-to-fold-struggling-diabetes-business-into-diagnostics-unit-3353273/,2024-01-02T16:51:47+05:30,2024-01-02T11:21:47,-0.4215
"China approves AstraZeneca, Sanofi shot to prevent RSV infection",https://www.financialexpress.com/business/healthcare-china-approves-astrazeneca-sanofi-shot-to-prevent-rsv-infection-3353248/,2024-01-02T16:27:06+05:30,2024-01-02T10:57:06,0.4215
Alembic Pharmaceuticals gets 8 USFDA approvals in Q3FY24,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-gets-8-usfda-approvals-in-q3fy24-3353021/,2024-01-02T14:10:06+05:30,2024-01-02T08:40:06,0.0
BDR Pharma launches oral solution for prostate cancer in India,https://www.financialexpress.com/business/healthcare-bdr-pharma-launches-oral-solution-for-prostate-cancer-in-india-3352995/,2024-01-02T12:18:02+05:30,2024-01-02T06:48:02,-0.4767
This anxiety drug can cause miscarriage if taken during pregnancy; Read on to know more,https://www.financialexpress.com/business/healthcare-this-anxiety-drug-can-cause-miscarriage-if-taken-during-pregnancy-read-on-to-know-more-3350687/,2023-12-29T14:16:33+05:30,2023-12-29T08:46:33,-0.1779
Vibrating pills for weight loss? Read on to know more about this drug,https://www.financialexpress.com/business/healthcare-vibrating-pills-for-weight-loss-read-on-to-know-more-about-this-drug-3350677/,2023-12-29T13:56:30+05:30,2023-12-29T08:26:30,-0.3182
Cell and gene therapy will be top industry trend for pharma in 2024,https://www.financialexpress.com/business/healthcare-cell-and-gene-therapy-will-be-top-industry-trend-for-pharma-in-2024-3350495/,2023-12-29T11:59:32+05:30,2023-12-29T06:29:32,0.2023
India’s fight against rare diseases needs more focus on awareness and diagnosis: GlobalData,https://www.financialexpress.com/business/healthcare-indias-fight-against-rare-diseases-needs-more-focus-on-awareness-and-diagnosis-globaldata-3350459/,2023-12-29T11:37:03+05:30,2023-12-29T06:07:03,-0.3818
"Casgevy approval unlikely to be followed up by another CRISPR drug in near future, says GlobalData",https://www.financialexpress.com/business/healthcare-casgevy-approval-unlikely-to-be-followed-up-by-another-crispr-drug-in-near-future-says-globaldata-3349959/,2023-12-29T07:00:00+05:30,2023-12-29T01:30:00,0.4767
AstraZeneca to buy cancer drug developer for up to $1.2 billion,https://www.financialexpress.com/business/healthcare-astrazeneca-to-buy-cancer-drug-developer-for-up-to-1-2-billion-3347920/,2023-12-27T09:00:00+05:30,2023-12-27T03:30:00,-0.6597
"Recap 2023: From postpartum depression to Alzheimer’s disease, here are some crucial USFDA approvals this year",https://www.financialexpress.com/business/healthcare-recap-2023-from-postpartum-depression-to-alzheimers-disease-here-are-some-crucial-usfda-approvals-this-year-3347615/,2023-12-26T13:41:11+05:30,2023-12-26T08:11:11,-0.5719
"CDSCO issues alert against 62 substandard drugs; Samples from Lupin, Jackson Laboratories flagged",https://www.financialexpress.com/business/healthcare-cdsco-issues-alert-against-62-substandard-drugs-samples-from-lupin-jackson-laboratories-flagged-3347552/,2023-12-26T12:27:14+05:30,2023-12-26T06:57:14,0.296
CDSCO to ban common cold and flu syrups for children below four years; Pharma cos asked to insert warning,https://www.financialexpress.com/business/healthcare-cdsco-to-ban-common-cold-and-flu-syrups-for-children-below-four-years-pharma-cos-asked-to-insert-warning-3343729/,2023-12-20T18:39:36+05:30,2023-12-20T13:09:36,-0.8225
AstraZeneca gets CDSCO approval to market trip drug combination for COPD treatment,https://www.financialexpress.com/business/healthcare-astrazeneca-gets-cdsco-approval-to-market-trip-drug-combination-for-copd-treatment-3339697/,2023-12-15T15:59:30+05:30,2023-12-15T10:29:30,0.4767
Cipla announces further investment in GoApptiv; To hold over 22 percent stake in the digital tech company,https://www.financialexpress.com/business/healthcare-cipla-announces-further-investment-in-goapptiv-to-hold-over-22-percent-stake-in-the-digital-tech-company-3339580/,2023-12-15T14:16:41+05:30,2023-12-15T08:46:41,0.0
Lyrus gets USFDA nod for critical UTI treatment in United States,https://www.financialexpress.com/business/healthcare-lyrus-gets-usfda-nod-for-critical-uti-treatment-in-united-states-3339386/,2023-12-15T13:31:29+05:30,2023-12-15T08:01:29,0.128
Nestle CEO sees little threat from weight-loss drugs to business,https://www.financialexpress.com/business/healthcare-nestle-ceo-sees-little-threat-from-weight-loss-drugs-to-business-3337744/,2023-12-14T08:00:00+05:30,2023-12-14T02:30:00,-0.4779
"Diversifying into biologicals could further amplify our export potential: S V Veeramani, Chairman, Pharmexcil",https://www.financialexpress.com/business/healthcare-diversifying-into-biologicals-could-further-amplify-our-export-potential-s-v-veeramani-chairman-pharmexcil-3337660/,2023-12-13T16:03:49+05:30,2023-12-13T10:33:49,0.0
Granules India gets ANDA approval for delayed-release tablets to treat GERD,https://www.financialexpress.com/business/healthcare-granules-india-gets-anda-approval-for-delayed-release-tablets-to-treat-gerd-3337621/,2023-12-13T15:19:22+05:30,2023-12-13T09:49:22,0.7003
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 billion deal,https://www.financialexpress.com/business/healthcare-astrazeneca-buys-respiratory-vaccine-developer-icosavax-in-1-1-billion-deal-3336616/,2023-12-12T16:27:37+05:30,2023-12-12T10:57:37,0.0
Hospital chain Aster to fuel India expansion through buyouts,https://www.financialexpress.com/business/healthcare-hospital-chain-aster-to-fuel-india-expansion-through-buyouts-3333614/,2023-12-08T17:23:22+05:30,2023-12-08T11:53:22,0.0
WHO flags 5 Pakistan-made contaminated syrups and medicines; Products detected in several countries,https://www.financialexpress.com/business/healthcare-who-flags-5-pakistan-made-contaminated-syrups-and-medicines-products-detected-in-several-countries-3333489/,2023-12-08T16:20:47+05:30,2023-12-08T10:50:47,0.0
Staying on Top: Unpacking 15 Years of Indian Pharma Performance Through Numbers,https://www.financialexpress.com/business/healthcare-staying-on-top-unpacking-15-years-of-indian-pharma-performance-through-numbers-3331030/,2023-12-08T09:00:00+05:30,2023-12-08T03:30:00,0.2023
"Widespread awareness about asthma and promoting better understanding of inhalation therapy crucial: Achin Gupta, CEO – One India Business, Cipla Ltd.",https://www.financialexpress.com/business/healthcare-widespread-awareness-about-asthma-and-promoting-better-understanding-of-inhalation-therapy-crucial-achin-gupta-ceo-one-india-business-cipla-ltd-3330994/,2023-12-08T08:00:00+05:30,2023-12-08T02:30:00,0.6597
Coya Therapeutics and Dr. Reddy’s Laboratories enter into exclusive collaboration for investigational combination therapy to treat ALS,https://www.financialexpress.com/business/healthcare-coya-therapeutics-and-dr-reddys-laboratories-enter-into-exclusive-collaboration-for-investigational-combination-therapy-to-treat-als-3329980/,2023-12-06T18:11:55+05:30,2023-12-06T12:41:55,0.4939
Sun Pharma inks licensing pact with Aclaris Therapeutics for autoimmune disorder drug,https://www.financialexpress.com/business/healthcare-sun-pharma-inks-licensing-pact-with-aclaris-therapeutics-for-autoimmune-disorder-drug-3329510/,2023-12-06T13:35:16+05:30,2023-12-06T08:05:16,-0.4019
USFDA approves Lupin’s generic formulation to aid in quitting smoking,https://www.financialexpress.com/business/healthcare-usfda-approves-lupins-generic-formulation-to-aid-in-quitting-smoking-3329481/,2023-12-06T13:10:53+05:30,2023-12-06T07:40:53,0.4019
USFDA gives nod to Novartis’ oral monotherapy to treat rare blood disorder,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-novartis-oral-monotherapy-to-treat-rare-blood-disorder-3329376/,2023-12-06T12:20:30+05:30,2023-12-06T06:50:30,0.0
Max Healthcare launches CAR-T cell therapy to improve cancer care in Delhi-NCR,https://www.financialexpress.com/business/healthcare-max-healthcare-launches-car-t-cell-therapy-to-improve-cancer-care-in-delhi-ncr-3328662/,2023-12-05T15:27:10+05:30,2023-12-05T09:57:10,0.1779
Statin consumption continues to remain low among at-risk patients; Here’s why,https://www.financialexpress.com/business/healthcare-statin-consumption-continues-to-remain-low-among-at-risk-patients-heres-why-3328570/,2023-12-05T13:40:08+05:30,2023-12-05T08:10:08,-0.2732
Zydus Lifesciences gets USFDA nod for generic formulation to treat heart failure,https://www.financialexpress.com/business/healthcare-zydus-lifesciences-gets-usfda-nod-for-generic-formulation-to-treat-heart-failure-3322905/,2023-12-01T16:18:22+05:30,2023-12-01T10:48:22,-0.1531
"Over-prescription, self-medication, and regulatory gaps leading causes of antimicrobial resistance in India",https://www.financialexpress.com/business/healthcare-over-prescription-self-medication-and-regulatory-gaps-leading-causes-of-antimicrobial-resistance-in-india-3322656/,2023-12-01T12:52:45+05:30,2023-12-01T07:22:45,0.0
Four reasons why India should invest in surgical care,https://www.financialexpress.com/business/healthcare-four-reasons-why-india-should-invest-in-surgical-care-3321446/,2023-12-01T11:00:00+05:30,2023-12-01T05:30:00,0.4939
Ozempic knock-offs contain an unsafe substance banned by the FDA,https://www.financialexpress.com/business/healthcare-ozempic-knock-offs-contain-an-unsafe-substance-banned-by-the-fda-3322205/,2023-12-01T08:00:00+05:30,2023-12-01T02:30:00,-0.4588
"Industry needs to move beyond a profit-driven focus, embrace sustainability as a core principle: Pharma Leaders Round Table",https://www.financialexpress.com/business/healthcare-industry-needs-to-move-beyond-a-profit-driven-focus-embrace-sustainability-as-a-core-principle-pharma-leaders-round-table-3322082/,2023-11-30T19:21:00+05:30,2023-11-30T13:51:00,0.3182
"Innovation, sustainability and growth become key highlights of 16th edition of CPHI & PMEC India",https://www.financialexpress.com/business/healthcare-innovation-sustainability-and-growth-become-key-highlights-of-16th-edition-of-cphi-pmec-india-3321501/,2023-11-30T11:22:42+05:30,2023-11-30T05:52:42,0.6369
China: Surge in respiratory infections continues—Here’s what we know so far,https://www.financialexpress.com/business/healthcare-china-surge-in-respiratory-infections-continues-heres-what-we-know-so-far-3321400/,2023-11-30T10:08:46+05:30,2023-11-30T04:38:46,0.0
Ratings and Reviews: Time for the NMC to look ahead,https://www.financialexpress.com/business/healthcare-ratings-and-reviews-time-for-the-nmc-to-look-ahead-3319073/,2023-11-28T11:00:00+05:30,2023-11-28T05:30:00,0.0
"16th edition of CPHI & PMEC India Expo to be held from November 28-30; over 1,500 leading pharma exhibitors to participate",https://www.financialexpress.com/business/healthcare-16th-edition-of-cphi-pmec-india-expo-to-be-held-from-november-28-30-over-1500-leading-pharma-exhibitors-to-participate-3319081/,2023-11-27T19:43:20+05:30,2023-11-27T14:13:20,0.0
"We have established ourselves in generics, need to increase focus on innovation: DCGI",https://www.financialexpress.com/business/healthcare-we-have-established-ourselves-in-generics-need-to-increase-focus-on-innovation-dcgi-3317837/,2023-11-25T23:02:49+05:30,2023-11-25T17:32:49,0.5994
"Need for robust innovation ecosystem, IP and regulatory support in India: EY Parthenon-OPPI report",https://www.financialexpress.com/business/healthcare-need-for-robust-innovation-ecosystem-ip-and-regulatory-support-in-india-ey-parthenon-oppi-report-3317765/,2023-11-25T19:43:08+05:30,2023-11-25T14:13:08,0.7717
Lupin launches fixed-dose triple combination drug for COPD in India,https://www.financialexpress.com/business/healthcare-lupin-launches-fixed-dose-triple-combination-drug-for-copd-in-india-3315976/,2023-11-24T11:11:41+05:30,2023-11-24T05:41:41,0.0
USFDA gives tentative approval to Lupin’s Type 2 diabetes drug,https://www.financialexpress.com/business/healthcare-usfda-gives-tentative-approval-to-lupins-type-2-diabetes-drug-3315944/,2023-11-24T10:55:14+05:30,2023-11-24T05:25:14,0.4767
Lupin gets USFDA nod for its solution to treat ocular pain,https://www.financialexpress.com/business/healthcare-lupin-gets-usfda-nod-for-its-solution-to-treat-ocular-pain-3315861/,2023-11-24T09:56:07+05:30,2023-11-24T04:26:07,0.1779
Antimicrobial Resistance in India: Navigating the crisis with strategic foresight,https://www.financialexpress.com/business/healthcare-antimicrobial-resistance-in-india-navigating-the-crisis-with-strategic-foresight-3313820/,2023-11-22T14:00:00+05:30,2023-11-22T08:30:00,-0.6249
Diluting pre-grant patent opposition will be costly for public health,https://www.financialexpress.com/business/healthcare-diluting-pre-grant-patent-opposition-will-be-costly-for-public-health-3313809/,2023-11-22T13:00:00+05:30,2023-11-22T07:30:00,-0.1027
USFDA gives nod to Lupin’s cholesterol-lowering drug,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-cholesterol-lowering-drug-3313651/,2023-11-22T08:53:42+05:30,2023-11-22T03:23:42,0.0
USFDA grants tentative approval to Lupin’s generic drug for Type 2 Diabetes,https://www.financialexpress.com/business/healthcare-usfda-grants-tentative-approval-to-lupins-generic-drug-for-type-2-diabetes-3313644/,2023-11-22T08:26:49+05:30,2023-11-22T02:56:49,0.6124
What to do and what not to do when prescribed antibiotics? Know what doctor says,https://www.financialexpress.com/business/healthcare-what-to-do-and-what-not-to-do-when-prescribed-antibiotics-know-from-doctors-3313268/,2023-11-21T17:32:14+05:30,2023-11-21T12:02:14,0.0
These common mistakes should be avoided when taking antibiotics—Read on to know more,https://www.financialexpress.com/life/these-common-mistakes-should-be-avoided-when-taking-antibiotics-read-on-to-know-more-3313240/,2023-11-21T17:03:14+05:30,2023-11-21T11:33:14,-0.5994
USFDA gives nod to Strides Pharma’s generic drug for seizures,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-strides-pharmas-generic-drug-for-seizures-3312943/,2023-11-21T13:28:39+05:30,2023-11-21T07:58:39,0.0
AstraZeneca starts health-tech business to add AI to pharma,https://www.financialexpress.com/business/healthcare-astrazeneca-starts-health-tech-business-to-add-ai-to-pharma-3312198/,2023-11-21T09:00:00+05:30,2023-11-21T03:30:00,0.0
"Bayer slumps most ever after roundup verdict, drug setback",https://www.financialexpress.com/business/healthcare-bayer-slumps-most-ever-after-roundup-verdict-drug-setback-3312184/,2023-11-21T07:00:00+05:30,2023-11-21T01:30:00,0.1531
Modi govt rebuffs WHO report that says 11 lakh children missed first dose of measles vaccines in 2022,https://www.financialexpress.com/business/healthcare-modi-govt-rebuffs-who-report-that-says-11-lakh-children-missed-first-dose-of-measles-vaccines-in-2022-3311979/,2023-11-20T15:09:01+05:30,2023-11-20T09:39:01,-0.296
"US limit on key ADHD drug is worsening shortages, Group says",https://www.financialexpress.com/business/healthcare-us-limit-on-key-adhd-drug-is-worsening-shortages-group-says-3311755/,2023-11-20T12:44:53+05:30,2023-11-20T07:14:53,-0.5574
Lupin gets USFDA approval for injection indicated for controlled ovarian hyperstimulation,https://www.financialexpress.com/business/healthcare-lupin-gets-usfda-approval-for-injection-indicated-for-controlled-ovarian-hyperstimulation-3311251/,2023-11-20T09:00:00+05:30,2023-11-20T03:30:00,0.4767
"Technological integration boosts patient engagement and control in Diabetes, reveals evidence-based India centric study",https://www.financialexpress.com/business/healthcare-technological-integration-boosts-patient-engagement-and-control-in-diabetes-reveals-evidence-based-india-centric-study-3311242/,2023-11-20T08:00:00+05:30,2023-11-20T02:30:00,0.6486
"FDA’s orphan drug designations increase for myelofibrosis drugs, reveals GlobalData",https://www.financialexpress.com/business/healthcare-fdas-orphan-drug-designations-increase-for-myelofibrosis-drugs-reveals-globaldata-3311224/,2023-11-20T07:00:00+05:30,2023-11-20T01:30:00,0.3182
United Kingdom MHRA authorised Vertex and CRISPR Therapeutics’s gene edited therapy for sickle cell disease and thalassemia,https://www.financialexpress.com/business/healthcare-united-kingdom-mhra-authorised-vertex-and-crispr-therapeuticss-gene-edited-therapy-for-sickle-cell-disease-and-thalassemia-3310191/,2023-11-17T22:32:41+05:30,2023-11-17T17:02:41,0.4215
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in cardiovascular disease: GlobalData,https://www.financialexpress.com/business/healthcare-verves-gene-editing-therapy-trial-to-lower-cholesterol-levels-opens-doors-for-use-in-cardiovascular-disease-globaldata-3308336/,2023-11-16T14:00:00+05:30,2023-11-16T08:30:00,-0.296
"Indian eyedrop maker recalls products made for CVS, Walmart",https://www.financialexpress.com/business/healthcare-indian-eyedrop-maker-recalls-products-made-for-cvs-walmart-3308303/,2023-11-16T13:00:00+05:30,2023-11-16T07:30:00,0.0
"QuidelOrtho weighs sale of transfusion medicine unit, sources say",https://www.financialexpress.com/business/healthcare-quidelortho-weighs-sale-of-transfusion-medicine-unit-sources-say-3308290/,2023-11-16T12:00:00+05:30,2023-11-16T06:30:00,0.0
"Belgium limits Novo’s Ozempic to diabetes, obesity patients",https://www.financialexpress.com/business/healthcare-belgium-limits-novos-ozempic-to-diabetes-obesity-patients-3307365/,2023-11-15T15:00:00+05:30,2023-11-15T09:30:00,0.0
Gene-edited therapy shows promising result in treating high cholesterol in human; Read on to know all about this new treatment,https://www.financialexpress.com/business/healthcare-gene-edited-therapy-shows-promising-result-in-treating-high-cholesterol-in-human-read-on-to-know-all-about-this-crispr-based-treatment-3306766/,2023-11-14T15:01:33+05:30,2023-11-14T09:31:33,0.4019
Novartis blockbuster drug Tasigna faces sales decline as US patent expiry looms: GlobalData,https://www.financialexpress.com/business/healthcare-novartis-blockbuster-drug-tasigna-faces-sales-decline-as-us-patent-expiry-looms-globaldata-3306345/,2023-11-14T10:00:00+05:30,2023-11-14T04:30:00,0.5106
Sandoz inaugurates new antibiotic production plant in Austria and new biosimilar development center in Germany,https://www.financialexpress.com/business/healthcare-sandoz-inaugurates-new-antibiotic-production-plant-in-austria-and-new-biosimilar-development-center-in-germany-3306342/,2023-11-14T09:00:00+05:30,2023-11-14T03:30:00,0.0
World’s first Chikungunya vaccine gets USFDA nod; Approval granted for 18 years and above,https://www.financialexpress.com/business/healthcare-worlds-first-chikungunya-vaccine-gets-usfda-nod-approval-granted-for-18-years-and-above-3304305/,2023-11-10T16:19:55+05:30,2023-11-10T10:49:55,0.6249
USFDA gives nod to world’s first enzyme replacement therapy for patients with rare blood clotting disorder,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-worlds-first-enzyme-replacement-therapy-for-patients-with-rare-blood-clotting-disorder-3304254/,2023-11-10T15:45:45+05:30,2023-11-10T10:15:45,-0.4019
Terumo India launches advanced therapy for liver cancer treatment in India,https://www.financialexpress.com/business/healthcare-terumo-india-launches-advanced-therapy-for-liver-cancer-treatment-in-india-3304171/,2023-11-10T14:42:26+05:30,2023-11-10T09:12:26,-0.5267
Novartis’ oral drug shows promising results for chronic hives treatment in Phase III trials,https://www.financialexpress.com/business/healthcare-novartis-oral-drug-shows-promising-results-for-chronic-hives-treatment-in-phase-iii-trials-3303928/,2023-11-10T13:08:42+05:30,2023-11-10T07:38:42,0.4019
"Suven Pharma Q2 profit at Rs 79.56 crore, revenue down 17% on inventory destocking globally",https://www.financialexpress.com/business/industry-suven-pharma-q2-profit-at-rs-79-56-crore-revenue-down-17-on-inventory-destocking-globally-3303814/,2023-11-10T11:11:33+05:30,2023-11-10T05:41:33,0.4404
USFDA gives nod to Lupin’s generic muscle relaxant formulation in United States,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-generic-muscle-relaxant-formulation-in-united-states-3302842/,2023-11-09T13:42:01+05:30,2023-11-09T08:12:01,0.5859
USFDA approves Eli Lilly’s new drug for chronic weight management,https://www.financialexpress.com/business/healthcare-usfda-approves-eli-lillys-new-drug-for-chronic-weight-management-3302750/,2023-11-09T13:06:51+05:30,2023-11-09T07:36:51,0.4019
Biocon Biologics announces divestment of India’s two non-core branded formulations,https://www.financialexpress.com/business/healthcare-biocon-biologics-announces-divestment-of-indias-two-non-core-branded-formulations-3301698/,2023-11-08T17:27:47+05:30,2023-11-08T11:57:47,0.0
"We will focus on revenue growth, cost optimisation, and debt reduction: Nandini Piramal, Chairperson, Piramal Pharma",https://www.financialexpress.com/business/healthcare-we-will-focus-on-revenue-growth-cost-optimisation-and-debt-reduction-nandini-piramal-chairperson-piramal-pharma-3301594/,2023-11-08T16:53:53+05:30,2023-11-08T11:23:53,0.4019
USV partners with Biogenomics to launch biosimilar insulin aspart for diabetes in India,https://www.financialexpress.com/business/healthcare-usv-partners-with-biogenomics-to-launch-biosimilar-insulin-apart-for-diabetes-in-india-3301246/,2023-11-08T15:18:59+05:30,2023-11-08T09:48:59,0.0
USFDA grants tentative approval to Lupin’s generic formulation for type 2 diabetes,https://www.financialexpress.com/business/healthcare-usfda-grants-tentative-approval-to-lupins-generic-formulation-for-type-2-diabetes-3300556/,2023-11-08T11:51:42+05:30,2023-11-08T06:21:42,0.6124
Roche sells $5.5 billion of bonds to fund Telavant buyout,https://www.financialexpress.com/business/healthcare-roche-sells-5-5-billion-of-bonds-to-fund-telavant-buyout-3299577/,2023-11-07T14:00:25+05:30,2023-11-07T08:30:25,0.0
Delhi’s toxic air is harming unborn children! Experts’ severe health warning to expecting mothers and other vulnerable groups,https://www.financialexpress.com/business/healthcare-delhis-toxic-air-is-harming-unborn-children-experts-severe-health-warning-to-expecting-mothers-and-other-vulnerable-groups-3299491/,2023-11-07T12:44:16+05:30,2023-11-07T07:14:16,-0.8687
USFDA grants approval to Zydus’ generic formulation to treat adult patients with type 2 diabetes,https://www.financialexpress.com/business/healthcare-usfda-grants-approval-to-zydus-generic-formulation-to-treat-adult-patients-with-type-2-diabetes-3298401/,2023-11-06T14:06:57+05:30,2023-11-06T08:36:57,0.7717
"Divi’s Laboratories Q2 profit drops by 29.4% on-year to Rs 348 crore, misses estimates",https://www.financialexpress.com/business/industry-divis-laboratories-q2-profit-drops-by-29-4-on-year-to-rs-348-crore-misses-estimates-3298306/,2023-11-06T12:52:37+05:30,2023-11-06T07:22:37,0.25
AnaptysBio’s psoriasis drug pipeline agent poses challenge to Boehringer Ingelheim’s Spevigo: GlobalData,https://www.financialexpress.com/business/healthcare-anaptysbios-psoriasis-drug-pipeline-agent-poses-challenge-to-boehringer-ingelheims-spevigo-globaldata-3296550/,2023-11-03T17:57:55+05:30,2023-11-03T12:27:55,0.0772
Zydus and Lupin sign licensing agreement for co-marketing drug to treat chronic liver diseases in India,https://www.financialexpress.com/business/healthcare-zydus-and-lupin-sign-licensing-agreement-for-co-marketing-drug-to-treat-chronic-liver-diseases-in-india-3296515/,2023-11-03T17:33:49+05:30,2023-11-03T12:03:49,0.7096
"ICMR data leak: CERT-In investigating, await its report, says Rajeev Chandrasekhar",https://www.financialexpress.com/business/healthcare-icmr-data-leak-cert-in-investigating-await-its-report-says-rajeev-chandrasekhar-3296274/,2023-11-03T16:15:50+05:30,2023-11-03T10:45:50,-0.25
Lilly beats revenue expectations as Mounjaro sales mount,https://www.financialexpress.com/business/healthcare-lilly-beats-revenue-expectations-as-mounjaro-sales-mount-3295403/,2023-11-03T08:00:00+05:30,2023-11-03T02:30:00,0.0
Novo Nordisk’s earnings surge on frenzy for obesity drugs,https://www.financialexpress.com/business/healthcare-novo-nordisks-earnings-surge-on-frenzy-for-obesity-drugs-3295168/,2023-11-02T15:45:16+05:30,2023-11-02T10:15:16,-0.3182
USFA gives tentative approval to Lupin’s injection for treating pulmonary arterial hypertension,https://www.financialexpress.com/business/healthcare-usfa-gives-tentative-approval-for-lupins-injection-to-treat-pulmonary-arterial-hypertension-3295118/,2023-11-02T15:10:04+05:30,2023-11-02T09:40:04,0.4767
AstraZeneca gets into strategic collaboration and investment agreements with Cellectis,https://www.financialexpress.com/business/healthcare-astrazeneca-gets-into-strategic-collaboration-and-investment-agreements-with-cellectis-3294880/,2023-11-02T12:48:48+05:30,2023-11-02T07:18:48,0.2732
"Bristol Myers Squibb’s Opdivo sales to reach $14 billion by 2028, forecasts GlobalData",https://www.financialexpress.com/business/healthcare-bristol-myers-squibbs-opdivo-sales-to-reach-14-billion-by-2028-forecasts-globaldata-3294726/,2023-11-02T11:42:27+05:30,2023-11-02T06:12:27,0.0258
"Sun Pharma Q2 Results: Profit rises 5% to Rs 2375.51 crore, beats estimates",https://www.financialexpress.com/business/industry-sun-pharma-q2-results-profit-rises-5-to-rs-2375-51-crore-beats-estimates-3293949/,2023-11-01T15:49:20+05:30,2023-11-01T10:19:20,0.4404
USFDA approves Novartis’ new drug for patients with chronic skin disease; Becomes first approved biologic drug for this condition in a decade,https://www.financialexpress.com/business/healthcare-usfda-approves-novartis-new-drug-for-patients-with-chronic-skin-disease-becomes-first-approved-biologic-drug-for-this-condition-in-a-decade-3293789/,2023-11-01T14:26:58+05:30,2023-11-01T08:56:58,0.6705
USFDA approves Amgen’s biosimilar for multiple inflammatory diseases,https://www.financialexpress.com/business/healthcare-usfda-approves-amgens-biosimilar-for-multiple-inflammatory-diseases-3293732/,2023-11-01T13:23:43+05:30,2023-11-01T07:53:43,0.4019
"Mankind Pharma Q2 profit rises by 19.4% to Rs 501.03 crore, revenue at Rs 2708.10 crore",https://www.financialexpress.com/business/industry-mankind-pharma-q2-profit-rises-by-19-4-to-rs-50103-crore-revenue-at-rs-270810-crore-3293448/,2023-11-01T10:17:37+05:30,2023-11-01T04:47:37,0.4404
"Ajanta Pharma Q2 profit rises 24.7% to Rs 195.30 crore, revenue up 9.6% on-year",https://www.financialexpress.com/business/industry-ajanta-pharma-q2-profit-rises-24-7-to-rs-19530-crore-revenue-up-96-on-year-3292656/,2023-10-31T15:02:59+05:30,2023-10-31T09:32:59,0.4404
NPPA revises prices of 438 drug formulations over calculation anomaly,https://www.financialexpress.com/business/healthcare-nppa-revises-prices-of-438-drug-formulations-3292276/,2023-10-31T11:33:21+05:30,2023-10-31T06:03:21,0.0
Innovent drug continues to take weight off in 48 week trial,https://www.financialexpress.com/business/healthcare-innovent-drug-continues-to-take-weight-off-in-48-week-trial-3291651/,2023-10-31T10:00:00+05:30,2023-10-31T04:30:00,0.0
"FDA rejection to delay Lebrikizumab chances to enter atopic dermatitis market, says GlobalData",https://www.financialexpress.com/business/healthcare-fda-rejection-to-delay-lebrikizumab-chances-to-enter-atopic-dermatitis-market-says-globaldata-3291639/,2023-10-31T09:00:00+05:30,2023-10-31T03:30:00,-0.6124
Research and innovation in the pharmaceutical sector,https://www.financialexpress.com/business/healthcare-research-and-innovation-in-the-pharmaceutical-sector-3291417/,2023-10-31T07:00:00+05:30,2023-10-31T01:30:00,0.3818
"Strides Pharma posts Q2 loss at Rs 131.34 crore, revenue rises 11.4% on-year",https://www.financialexpress.com/business/industry-strides-pharma-posts-q2-loss-at-rs-131-34-crore-revenue-rises-114-on-year-3291143/,2023-10-30T13:31:31+05:30,2023-10-30T08:01:31,-0.3182
Blackstone acquires CARE Hospitals and KIMSHEALTH,https://www.financialexpress.com/business/healthcare-blackstone-acquires-care-hospitals-and-kimshealth-3291069/,2023-10-30T12:58:55+05:30,2023-10-30T07:28:55,0.6037
"Novo Nordisk’s injectable GLP-1RA sales may increase upon imminent label expansion, says GlobalData",https://www.financialexpress.com/business/healthcare-novo-nordisks-injectable-glp-1ra-sales-may-increase-upon-imminent-label-expansion-says-globaldata-3290511/,2023-10-30T07:00:00+05:30,2023-10-30T01:30:00,0.3182
"Dr. Reddy’s Q2 FY24 Results: Pharma major to focus on acquisitions, bringing more generic and innovative products in oncology to India market",https://www.financialexpress.com/business/healthcare-dr-reddys-q2-fy24-results-pharma-major-to-focus-on-acquisitions-bringing-more-generic-and-innovative-products-in-ocology-for-india-market-3289354/,2023-10-28T11:17:21+05:30,2023-10-28T05:47:21,0.4877
"Dr Reddy’s Q2 Results: Profit rises 30% to Rs 1482.20 crore, beats estimates",https://www.financialexpress.com/business/industry-dr-reddys-q2-results-profit-rises-30-to-rs-1482-20-crore-beats-estimates-3288863/,2023-10-27T17:16:49+05:30,2023-10-27T11:46:49,0.4404
"Cipla Q2 Results: Profit surges 43.3% to Rs 1130.91 crore, revenue up 14.6% on-year, beats estimates",https://www.financialexpress.com/business/industry-cipla-q2-results-profit-surges-43-3-to-rs-113091-crore-revenue-up-146-on-year-beats-estimates-3288671/,2023-10-27T15:31:15+05:30,2023-10-27T10:01:15,0.4404
DCGI approves MSD India’s drug to treat triple-negative breast cancer and renal cell carcinoma,https://www.financialexpress.com/business/healthcare-dcgi-approves-msd-indias-drug-to-treat-triple-negative-breast-cancer-and-renal-cell-carcinoma-3286575/,2023-10-26T08:00:00+05:30,2023-10-26T02:30:00,0.0
Dr. Reddy’s launches direct-to-consumer e-commerce website ‘Celevida Wellness’ for diabetes,https://www.financialexpress.com/business/healthcare-dr-reddys-launches-direct-to-consumer-e-commerce-website-celevida-wellness-for-diabetes-3286569/,2023-10-26T07:00:00+05:30,2023-10-26T01:30:00,0.0
ICMR delivers medicines via drone in Himachal’s Lahaul & Spiti district,https://www.financialexpress.com/business/healthcare-icmr-delivers-medicines-via-drone-in-himachals-lahaul-spiti-district-3279114/,2023-10-19T15:12:09+05:30,2023-10-19T09:42:09,0.0
USFDA gives approval to Granules India for its delayed-release capsule to treat GERD symptoms,https://www.financialexpress.com/business/healthcare-usfda-gives-approval-to-granules-india-for-its-delayed-release-capsule-to-treat-gerd-symptoms-3278859/,2023-10-19T14:31:51+05:30,2023-10-19T09:01:51,0.7003
How the DPDP Act reshapes the healthcare sector’s compliance requirements,https://www.financialexpress.com/business/healthcare-how-the-dpdp-act-reshapes-the-healthcare-sectors-compliance-requirements-3275527/,2023-10-18T09:00:00+05:30,2023-10-18T03:30:00,0.0
E-Pharmacies: Catalysing Digital Access to Healthcare and Pharmaceutical Service Delivery in India,https://www.financialexpress.com/business/healthcare-e-pharmacies-catalysing-digital-access-to-healthcare-and-pharmaceutical-service-delivery-in-india-3275504/,2023-10-18T07:00:00+05:30,2023-10-18T01:30:00,0.0
Roche Pharma launches clinical trial excellence project in India,https://www.financialexpress.com/business/healthcare-roche-pharma-launches-clinical-trial-excellence-project-in-india-3275480/,2023-10-17T17:17:36+05:30,2023-10-17T11:47:36,0.6249
"Need for BPaL Treatment Regimen in India’s TB Control Programme, say experts",https://www.financialexpress.com/business/healthcare-need-for-bpal-treatment-regimen-in-indias-tb-control-programme-say-experts-3275018/,2023-10-17T11:47:52+05:30,2023-10-17T06:17:52,0.0
OPPI appoints Anil Matai as Director-General,https://www.financialexpress.com/business/healthcare-oppi-appoints-anil-matai-as-director-general-3274435/,2023-10-16T16:59:56+05:30,2023-10-16T11:29:56,0.0
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines,https://www.financialexpress.com/business/healthcare-venus-remedies-gets-marketing-approval-for-six-chemotherapy-drugs-from-the-philippines-3274096/,2023-10-16T13:05:30+05:30,2023-10-16T07:35:30,0.4767
"Ozempic’s impact on kidney patients limited, Dialysis Provider DaVita says",https://www.financialexpress.com/business/healthcare-ozempics-impact-on-kidney-patients-limited-dialysis-provider-davita-says-3271890/,2023-10-13T15:25:18+05:30,2023-10-13T09:55:18,-0.2263
USFDA gives tentative approval to Lupin’s generic formulation to treat excessive daytime sleepiness,https://www.financialexpress.com/business/healthcare-usfda-gives-tentative-approval-to-lupins-generic-formulation-to-treat-excessive-daytime-sleepiness-3271657/,2023-10-13T12:50:08+05:30,2023-10-13T07:20:08,0.7003
Sun Pharma’s eye drug shows promising results in Phase 4 trial,https://www.financialexpress.com/business/healthcare-sun-pharmas-eye-drug-shows-promising-results-in-phase-4-trial-3271608/,2023-10-13T12:25:40+05:30,2023-10-13T06:55:40,0.4019
Eli Lilly’s Crohn’s disease drug succeeds in late-stage study,https://www.financialexpress.com/business/healthcare-eli-lillys-crohns-disease-drug-succeeds-in-late-stage-study-3271488/,2023-10-13T11:05:18+05:30,2023-10-13T05:35:18,0.4939
"Novo Nordisk warns consumers of surge in its fake weight loss drugs Ozempic, Wegovy",https://www.financialexpress.com/business/healthcare-novo-nordisk-warns-consumers-of-surge-in-its-fake-weight-loss-drugs-ozempic-wegovy-3270911/,2023-10-12T16:55:17+05:30,2023-10-12T11:25:17,-0.7003
Novo drugs Ozempic and Wegovy are shaking up stock markets again,https://www.financialexpress.com/business/healthcare-novo-drugs-ozempic-and-wegovy-are-shaking-up-stock-markets-again-3270796/,2023-10-12T16:21:54+05:30,2023-10-12T10:51:54,-0.1779
"A generic problem: Asymmetric information in the pharma space impairs informed choice, leading to healthcare costs being unnecessarily jacked up",https://www.financialexpress.com/opinion/a-generic-problem-asymmetric-information-in-the-pharma-space-impairs-informed-choice-leading-to-healthcare-costs-being-unnecessarily-jacked-up/3270022/,2023-10-12T06:00:00+05:30,2023-10-12T00:30:00,-0.4019
"Hurun List 2023: India’s wealthiest from pharma sector;  Cyrus S Poonawalla, Dilip Shanghvi  top sectoral rankings",https://www.financialexpress.com/business/healthcare-hurun-list-2023-indias-wealthiest-from-pharma-sector-cyrus-s-poonawalla-dilip-shanghvi-top-sectoral-rankings-bkg-3269731/,2023-10-12T14:58:09+05:30,2023-10-12T09:28:09,0.6124
India allows cough syrup company linked to deaths in Uzbekistan to re-open factory: Report,https://www.financialexpress.com/business/healthcare-india-allows-cough-syrup-company-linked-to-deaths-in-uzbekistan-to-re-open-factory-report-3269463/,2023-10-11T13:07:10+05:30,2023-10-11T07:37:10,0.0
Cytiva sets up manufacturing facility for biopharma industry,https://www.financialexpress.com/business/healthcare-cytiva-sets-up-manufacturing-facility-for-biopharma-industry-3264314/,2023-10-06T05:00:00+05:30,2023-10-05T23:30:00,0.0
AstraZeneca gets CDSCO approval for preventive therapy for respiratory syncytial virus,https://www.financialexpress.com/business/healthcare-astrazeneca-gets-cdsco-approval-for-preventive-therapy-for-respiratory-syncytial-virus-3259590/,2023-09-30T21:30:22+05:30,2023-09-30T16:00:22,0.4767
Caplin Steriles gets USFDA nod for Injection to treat low blood pressure,https://www.financialexpress.com/business/healthcare-caplin-steriles-gets-usfda-nod-for-injection-to-treat-low-blood-pressure-3249142/,2023-09-20T12:15:01+05:30,2023-09-20T06:45:01,-0.1531
"Pharma sector to post revenue growth of 8-10% this fiscal on steady domestic sales, higher exports to regulated markets",https://www.financialexpress.com/business/industry-pharma-sector-to-post-revenue-growth-of-8-10-this-fiscal-on-steady-domestic-sales-higher-exports-to-regulated-markets-3239529/,2023-09-11T13:15:29+05:30,2023-09-11T07:45:29,0.3818
Serum Institute to launch malaria vaccine in India soon,https://www.financialexpress.com/business/healthcare-serum-institute-to-launch-malaria-vaccine-in-india-soon-3228914/,2023-08-31T17:23:41+05:30,2023-08-31T11:53:41,0.0
"J&J, India’s Lupin slash prices for tuberculosis drug in lower-income countries",https://www.financialexpress.com/business/healthcare-jj-indias-lupin-slash-prices-for-tuberculosis-drug-in-lower-income-countries-3228836/,2023-08-31T16:40:08+05:30,2023-08-31T11:10:08,-0.2732
World’s first 7-minute cancer treatment jab to be rolled out in England; Here’s what you need to know,https://www.financialexpress.com/business/healthcare-worlds-first-7-minute-cancer-treatment-jab-to-be-rolled-out-in-england-heres-what-you-need-to-know-3228377/,2023-08-31T11:58:59+05:30,2023-08-31T06:28:59,-0.6597
J&J’s Akeega FDA approval to heat up PARP battle with dual-action treatment for prostate cancer,https://www.financialexpress.com/business/healthcare-jjs-akeega-fda-approval-to-heat-up-parp-battle-with-dual-action-treatment-for-prostate-cancer-3228202/,2023-08-31T10:51:44+05:30,2023-08-31T05:21:44,-0.5994
"Novo Nordisk, Eli Lilly record growth in Q2 driven by obesity, diabetes drug sales, reveals GlobalData",https://www.financialexpress.com/business/healthcare-novo-nordisk-eli-lilly-record-growth-in-q2-driven-by-obesity-diabetes-drug-sales-reveals-globaldata-3228197/,2023-08-31T10:19:51+05:30,2023-08-31T04:49:51,0.3818
"South Africa expands HIV, TB Drug access by using pharmacists",https://www.financialexpress.com/business/healthcare-south-africa-expands-hiv-tb-drug-access-by-using-pharmacists-3225481/,2023-08-29T08:00:00+05:30,2023-08-29T02:30:00,0.1027
"Sandoz completes acquisition of Astellas’ antifungal agent, strengthens its global anti-infectives portfolio",https://www.financialexpress.com/business/healthcare-sandoz-completes-acquisition-of-astellas-antifungal-agent-strengthens-its-global-anti-infectives-portfolio-3224787/,2023-08-28T11:20:33+05:30,2023-08-28T05:50:33,0.4588
Adderall-Alternative Vyvanse approval set to ease ADHD drug shortage,https://www.financialexpress.com/business/healthcare-adderall-alternative-vyvanse-approval-set-to-ease-adhd-drug-shortage-3224429/,2023-08-28T10:00:00+05:30,2023-08-28T04:30:00,0.5574
Danaher is in the lead to acquire Biotech Supplier Abcam,https://www.financialexpress.com/business/healthcare-danaher-is-in-the-lead-to-acquire-biotech-supplier-abcam-3224427/,2023-08-28T09:00:00+05:30,2023-08-28T03:30:00,0.0
"Pharma sector Q1 review: Growth led by US market, gRevlimid sales; India growth slips on price cuts, muted volumes",https://www.financialexpress.com/business/industry-pharma-sector-q1-review-growth-led-by-us-market-grevlimid-sales-india-growth-slips-on-price-cuts-muted-volumes-3224544/,2023-08-28T07:20:00+05:30,2023-08-28T01:50:00,0.4588
Product Quality issues must be always top priority,https://www.financialexpress.com/business/healthcare-product-quality-issues-must-be-always-top-priority-3224434/,2023-08-28T07:00:00+05:30,2023-08-28T01:30:00,0.2023
CDSCO issues alert against 51 substandard drug samples; 3 declared as spurious,https://www.financialexpress.com/business/healthcare-cdsco-issues-alert-against-51-substandard-drug-samples-3-declared-as-spurious-3222773/,2023-08-25T15:32:30+05:30,2023-08-25T10:02:30,0.296
Sandoz gets USFDA approval for its biosimilar to treat relapsing forms of multiple sclerosis,https://www.financialexpress.com/business/healthcare-sandoz-gets-usfda-approval-for-its-biosimilar-to-treat-relapsing-forms-of-multiple-sclerosis-3222574/,2023-08-25T13:00:04+05:30,2023-08-25T07:30:04,0.7003
"Teva, Glenmark to pay $255 million over drug price-fixing",https://www.financialexpress.com/business/healthcare-teva-glenmark-to-pay-255-million-over-drug-price-fixing-3218846/,2023-08-23T10:00:00+05:30,2023-08-23T04:30:00,-0.1027
Roche’s fast-growing eye drug set to expand in top EU markets,https://www.financialexpress.com/business/healthcare-roches-fast-growing-eye-drug-set-to-expand-in-top-eu-markets-3218834/,2023-08-23T09:00:00+05:30,2023-08-23T03:30:00,0.4767
USFDA approves Pfizer’s vaccine for mothers to prevent RSV in infants,https://www.financialexpress.com/business/healthcare-usfda-approves-pfizers-vaccine-for-mothers-to-prevent-rsv-in-infants-3218528/,2023-08-22T14:10:45+05:30,2023-08-22T08:40:45,0.4215
IMA urges government to withdraw mandatory nature of NMC’s generic drug prescription regulation,https://www.financialexpress.com/business/healthcare-ima-urges-government-to-withdraw-mandatory-nature-of-nmcs-generic-drug-prescription-regulation-3218485/,2023-08-22T13:44:26+05:30,2023-08-22T08:14:26,0.0772
Top 20 global biopharmaceutical companies report 2.3% market cap growth in Q2 2023,https://www.financialexpress.com/business/healthcare-top-20-global-biopharmaceutical-companies-report-2-3-market-cap-growth-in-q2-2023-3217570/,2023-08-22T09:00:00+05:30,2023-08-22T03:30:00,0.5267
ABB India secures order for automating Reliance Life Sciences’ biopharmaceutical facilities,https://www.financialexpress.com/business/industry/abb-india-secures-order-for-automating-reliance-life-sciences-biopharmaceutical-facilities/3217850/,2023-08-22T07:45:00+05:30,2023-08-22T02:15:00,0.3182
"Industry backlash may reshape EU compulsory pharma licensing reform, says GlobalData",https://www.financialexpress.com/business/healthcare-industry-backlash-may-reshape-eu-compulsory-pharma-licensing-reform-says-globaldata-3216574/,2023-08-21T09:00:00+05:30,2023-08-21T03:30:00,0.0
Lupin acquires brands from Boehringer Ingelheim to expand Diabetes portfolio in India,https://www.financialexpress.com/business/healthcare-lupin-acquires-brands-from-boehringer-ingelheim-to-expand-diabetes-portfolio-in-india-3214892/,2023-08-18T15:51:45+05:30,2023-08-18T10:21:45,0.3182
"NMC generic drug guidelines row: Doctors, health experts emphasise on quality and prioritising patients’ interest",https://www.financialexpress.com/business/healthcare-enforcing-doctors-to-prescribe-only-generic-medicines-is-ill-advised-and-irrational-3214794/,2023-08-18T14:55:28+05:30,2023-08-18T09:25:28,0.4588
Glenmark Pharma gets sANDA approval for its immunosuppressive drug,https://www.financialexpress.com/business/healthcare-glenmark-pharma-gets-sanda-approval-for-its-immunosuppressive-drug-3214014/,2023-08-18T09:00:00+05:30,2023-08-18T03:30:00,0.4767
Lupin Launches inhaler powder for COPD in the United States,https://www.financialexpress.com/business/healthcare-lupin-launches-inhaler-powder-for-copd-in-the-united-states-3214005/,2023-08-18T08:00:00+05:30,2023-08-18T02:30:00,0.4215
Uzbekistan cough syrup death: Indian drug was on the market due to bribery,https://www.financialexpress.com/business/healthcare-uzbekistan-cough-syrup-death-indian-drug-was-on-the-market-due-to-bribery-3213974/,2023-08-17T17:41:04+05:30,2023-08-17T12:11:04,-0.5994
Aurobindo Pharma to launch HIV drug for children; Company shares surge,https://www.financialexpress.com/business/healthcare-aurobindo-pharma-to-launch-hiv-drug-for-children-company-shares-surge-3213527/,2023-08-17T14:16:29+05:30,2023-08-17T08:46:29,0.296
Lupin gets USFDA nod for its anti-inflammatory eye drop,https://www.financialexpress.com/business/healthcare-lupin-gets-usfda-nod-for-its-anti-inflammatory-eye-drop-3212621/,2023-08-17T08:00:00+05:30,2023-08-17T02:30:00,-0.2732
USFDA approves Lupin’s extended-release tablets to treat chest pain,https://www.financialexpress.com/business/healthcare-usfda-approves-lupins-extended-release-tablets-to-treat-chest-pain-3212582/,2023-08-17T07:00:00+05:30,2023-08-17T01:30:00,0.2732
Novo Nordisk’s growth camouflages weak spots in Danish economy,https://www.financialexpress.com/business/healthcare-novo-nordisks-growth-camouflages-weak-spots-in-danish-economy-3211501/,2023-08-16T10:00:00+05:30,2023-08-16T04:30:00,-0.0772
Amazon Pharmacy automates insulin discounts,https://www.financialexpress.com/business/healthcare-amazon-pharmacy-automates-insulin-discounts-3211495/,2023-08-16T08:00:00+05:30,2023-08-16T02:30:00,0.1779
"After NMC makes generic drug prescription mandatory, IMA calls move ‘injustice to doctors’",https://www.financialexpress.com/business/healthcare-after-nmc-makes-generic-drug-prescription-mandatory-ima-calls-move-injustice-to-doctors-3210253/,2023-08-14T15:24:43+05:30,2023-08-14T09:54:43,0.0772
"Doctors to be penalised for not prescribing generic drugs, says new NMC regulation",https://www.financialexpress.com/business/healthcare-doctors-to-be-penalised-for-not-prescribing-generic-drugs-says-new-nmc-regulation-3208895/,2023-08-14T09:09:36+05:30,2023-08-14T03:39:36,0.0
Untreatable Gonorrhea threat has drugmakers sprinting for new cures,https://www.financialexpress.com/business/healthcare-untreatable-gonorrhea-threat-has-drugmakers-sprinting-for-new-cures-3209730/,2023-08-14T09:00:00+05:30,2023-08-14T03:30:00,-0.5267
Pharma industry continues to play a stellar role,https://www.financialexpress.com/business/healthcare-pharma-industry-continues-to-play-a-stellar-role-3209722/,2023-08-14T08:00:00+05:30,2023-08-14T02:30:00,0.34
"Zydus Lifesciences Q1 profit surges to Rs 1086.90 crore, revenue up 29.6% on US sales growth",https://www.financialexpress.com/business/industry-zydus-lifesciences-q1-profit-surges-to-rs-1086-90-crore-revenue-up-296-on-us-sales-growth-3207595/,2023-08-11T13:15:39+05:30,2023-08-11T07:45:39,0.6705
Dr. Reddy’s Laboratories launches Saxagliptin and Metformin Hydrochloride tablets,https://www.financialexpress.com/business/healthcare-dr-reddys-laboratories-launches-saxagliptin-and-metformin-hydrochloride-tablets-3206350/,2023-08-11T09:00:00+05:30,2023-08-11T03:30:00,0.0
Boehringer Ingelheim expands animal health portfolio in India; Launches afoxolaner,https://www.financialexpress.com/business/healthcare-boehringer-ingelheim-expands-animal-health-portfolio-in-india-launches-afoxolaner-3206321/,2023-08-11T07:00:00+05:30,2023-08-11T01:30:00,0.1027
Novo struggles to meet demand for blockbuster obesity drug,https://www.financialexpress.com/business/healthcare-novo-struggles-to-meet-demand-for-blockbuster-obesity-drug-3207020/,2023-08-11T07:00:00+05:30,2023-08-11T01:30:00,0.2263
Weight-loss stocks soar after obesity-drug study spurs investor frenzy,https://www.financialexpress.com/business/healthcare-weight-loss-stocks-soar-after-obesity-drug-study-spurs-investor-frenzy-3205377/,2023-08-10T08:00:00+05:30,2023-08-10T02:30:00,-0.3182
900 cough syrup samples have been analysed so far: Govt tells Rajya Sabha,https://www.financialexpress.com/business/healthcare-900-cough-syrup-samples-have-been-analysed-so-far-govt-tells-rajya-sabha-3205359/,2023-08-09T18:12:48+05:30,2023-08-09T12:42:48,0.0
A $2.8 million miracle therapy eludes some long-suffering patients,https://www.financialexpress.com/business/healthcare-a-2-8-million-miracle-therapy-eludes-some-long-suffering-patients-3205280/,2023-08-09T17:21:31+05:30,2023-08-09T11:51:31,0.5859
CEPI enters into agreement with Gennova Biopharma to support development of mRNA vaccine against ‘Disease X’,https://www.financialexpress.com/business/healthcare-cepi-enters-into-agreement-with-gennova-biopharma-to-support-development-of-mrna-vaccine-against-disease-x-3204023/,2023-08-08T17:47:56+05:30,2023-08-08T12:17:56,0.7096
WHO issues alert against contaminated made-in-India cold syrup in Iraq,https://www.financialexpress.com/business/healthcare-who-issues-alert-against-contaminated-made-in-india-cold-syrup-in-iraq-3203330/,2023-08-08T11:02:55+05:30,2023-08-08T05:32:55,0.296
China drug-price negotiations offers glimpse into future for companies in US,https://www.financialexpress.com/business/healthcare-china-drug-price-negotiations-offers-glimpse-into-future-for-companies-in-us-3202789/,2023-08-08T10:00:00+05:30,2023-08-08T04:30:00,0.0
"Daiichi Sankyo will remain dominant in ADC market for oncology treatments, forecasts GlobalData",https://www.financialexpress.com/business/healthcare-daiichi-sankyo-will-remain-dominant-in-adc-market-for-oncology-treatments-forecasts-globaldata-3202759/,2023-08-08T08:00:00+05:30,2023-08-08T02:30:00,0.0
"Q1 Results Today: Godrej Consumer Products, Max Healthcare, Gland Pharma, Emami, Medplus Health Services, others",https://www.financialexpress.com/business/industry-q1-results-on-aug-7-here-are-major-quarter-earnings-to-watch-out-for-3202176/,2023-08-07T11:27:26+05:30,2023-08-07T05:57:26,0.0
"AstraZeneca, Sanofi RSV Drug for infants wins CDC backing",https://www.financialexpress.com/business/healthcare-astrazeneca-sanofi-rsv-drug-for-infants-wins-cdc-backing-3201773/,2023-08-07T09:00:00+05:30,2023-08-07T03:30:00,0.5859
World’s first oral pill for Postpartum Depression gets approved; Here’s what you need to know,https://www.financialexpress.com/business/healthcare-worlds-first-oral-pill-for-postpartum-depression-gets-approved-heres-what-you-need-to-know-3201764/,2023-08-07T08:00:00+05:30,2023-08-07T02:30:00,-0.2263
Granules Pharmaceuticals successfully completes USFDA’s post-marketing inspection,https://www.financialexpress.com/business/healthcare-granules-pharmaceuticals-successfully-completes-usfdas-post-marketing-inspection-3201735/,2023-08-07T07:00:00+05:30,2023-08-07T01:30:00,0.4939
32 MSMEs selected for pharma PLI schemes: MoS Chemicals and Fertilizers,https://www.financialexpress.com/business/sme-32-msmes-selected-for-pharma-pli-schemes-mos-chemicals-and-fertilizers-3200289/,2023-08-04T18:25:01+05:30,2023-08-04T12:55:01,0.0
"Lupin posts Q1 profit at Rs 453.33 crore against year-ago loss, reports growth across all key markets",https://www.financialexpress.com/business/industry-lupin-posts-q1-profit-at-rs-453-33-crore-against-year-ago-loss-reports-growth-across-all-key-markets-3199636/,2023-08-04T13:04:54+05:30,2023-08-04T07:34:54,0.4939
Sun Pharma posts Q1 profit at Rs 2022.54 cr on low profitability at Taro; MD says well positioned to meet FY24 guidance,https://www.financialexpress.com/business/industry-sun-pharma-posts-q1-profit-at-rs-2022-54-cr-on-low-profitability-at-taro-md-says-well-positioned-to-meet-fy24-guidance-3199427/,2023-08-04T11:41:41+05:30,2023-08-04T06:11:41,0.6124
GARDP collaborates with ICMR to initiate study on status of antibiotic-resistant infections in hospitals,https://www.financialexpress.com/business/healthcare-gardp-collaborates-with-icmr-to-initiate-study-on-status-of-antibiotic-resistant-infections-in-hospitals-3197122/,2023-08-03T12:01:00+05:30,2023-08-03T06:31:00,0.0
Less than Rs 250 cr turnover pharma units must adopt Good Manufacturing Practices in 12 months: Mandaviya,https://www.financialexpress.com/business/sme-pharma-companies-with-less-than-rs-250-cr-turnover-to-adopt-good-manufacturing-practices-within-12-months-mansukh-mandaviya-3197764/,2023-08-03T11:09:05+05:30,2023-08-03T05:39:05,0.5574
Lupin gets approval from USFDA for its topical oil to treat eczema,https://www.financialexpress.com/business/healthcare-lupin-gets-approval-from-usfda-for-its-topical-oil-to-treat-eczema-3197083/,2023-08-03T10:00:00+05:30,2023-08-03T04:30:00,0.7003
Centhaquine set to enter US-FDA approved Phase 3 Clinical Trial in US and Europe,https://www.financialexpress.com/business/healthcare-centhaquine-set-to-enter-us-fda-approved-phase-3-clinical-trial-in-us-and-europe-3197061/,2023-08-03T09:00:00+05:30,2023-08-03T03:30:00,0.4215
"Boehringer’s Cyltezo illustrates intersection of price and regulation in biosimilar market, says GlobalData",https://www.financialexpress.com/business/healthcare-boehringers-cyltezo-illustrates-intersection-of-price-and-regulation-in-biosimilar-market-says-globaldata-3197005/,2023-08-03T08:00:00+05:30,2023-08-03T02:30:00,0.0
Cameroon cough syrups death: Violation found at drugmaker Riemann Labs; Samples sent for testing,https://www.financialexpress.com/business/healthcare-cameroon-cough-syrups-death-violation-found-at-drugmaker-riemann-labs-samples-sent-for-testing-3196702/,2023-08-02T14:10:06+05:30,2023-08-02T08:40:06,-0.7964
"Centre prohibits production, sale of Ketoprofen and Aceclofenac for animal use",https://www.financialexpress.com/business/healthcare-centre-prohibits-production-sale-of-ketoprofen-and-aceclofenac-for-animal-use-3196606/,2023-08-02T13:21:57+05:30,2023-08-02T07:51:57,0.0
GSK gets FDA approval for Jemperli use with chemo to treat Endometrial Cancer,https://www.financialexpress.com/business/healthcare-gsk-gets-fda-approval-for-jemperli-use-with-chemo-to-treat-endometrial-cancer-3195742/,2023-08-02T10:00:00+05:30,2023-08-02T04:30:00,0.1027
"Merck raises 2023 sales forecast as cancer drug Keytruda, Gardasil vaccine surge",https://www.financialexpress.com/business/healthcare-merck-raises-2023-sales-forecast-as-cancer-drug-keytruda-gardasil-vaccine-surge-3195712/,2023-08-02T09:00:00+05:30,2023-08-02T03:30:00,-0.6597
"Janssen’s JNJ-2113 holds potential to become leading treatment for psoriasis, says GlobalData",https://www.financialexpress.com/business/healthcare-janssens-jnj-2113-holds-potential-to-become-leading-treatment-for-psoriasis-says-globaldata-3195695/,2023-08-02T08:00:00+05:30,2023-08-02T02:30:00,0.0
USFDA gives approval to Lupin’s contraceptive drug,https://www.financialexpress.com/business/healthcare-usfda-gives-approval-to-lupins-contraceptive-drug-3195670/,2023-08-02T07:00:00+05:30,2023-08-02T01:30:00,0.4767
"Venus Remedies secures marketing authorisation for key cancer drugs from Philippines, Paraguay, Georgia and Moldova",https://www.financialexpress.com/business/healthcare-venus-remedies-secures-marketing-authorisation-for-key-cancer-drugs-from-philippines-paraguay-georgia-and-moldova-3194298/,2023-08-01T07:00:00+05:30,2023-08-01T01:30:00,-0.4767
Cipla to launch respiratory drugs by the end of this quarter; Expects over 2-3% revenue growth from new products in FY24,https://www.financialexpress.com/business/healthcare-cipla-to-launch-respiratory-drugs-by-the-end-of-this-quarter-expects-over-2-3-revenue-growth-from-new-products-in-fy24-3192250/,2023-07-29T21:17:31+05:30,2023-07-29T15:47:31,0.3818
Dr Reddy’s to focus on continued growth of core businesses in FY24; Plans to increase presence in chronic segment,https://www.financialexpress.com/business/healthcare-dr-reddys-to-focus-on-continued-growth-of-core-businesses-in-fy24-plans-to-increase-presence-in-chronic-segment-3192238/,2023-07-29T20:50:34+05:30,2023-07-29T15:20:34,0.5994
"Ajanta Pharma stock jumps nearly 9% on strong Q1 results; Should you buy, sell or hold Ajanta Pharma shares?",https://www.financialexpress.com/market/ajanta-pharma-stock-jumps-nearly-9-on-strong-q1-results-should-you-buy-sell-or-hold-ajanta-pharma-shares-3190485/,2023-07-28T10:32:36+05:30,2023-07-28T05:02:36,0.6705
"Higher gRevlimid sales push Dr Reddy’s Q1FY24 profit up 18%, targets 25-30 new launches in FY24",https://www.financialexpress.com/business/industry-higher-grevlimid-sales-push-dr-reddys-q1fy24-profit-up-18-targets-25-30-new-launches-in-fy24-3189046/,2023-07-27T11:21:53+05:30,2023-07-27T05:51:53,0.4404
Novo Nordisk obesity drugs probed by UK regulator over suicidal thoughts,https://www.financialexpress.com/business/healthcare-novo-nordisk-obesity-drugs-probed-by-uk-regulator-over-suicidal-thoughts-3188704/,2023-07-27T09:00:00+05:30,2023-07-27T03:30:00,-0.6705
Lupin gets approval from TGA Australia for drug to treat COPD,https://www.financialexpress.com/business/healthcare-lupin-gets-approval-from-tga-australia-for-drug-to-treat-copd-3188608/,2023-07-27T06:33:39+05:30,2023-07-27T01:03:39,0.7003
Cipla Q1 profit surges 45.1% at Rs 995.70 crore; North America posts highest quarterly sales,https://www.financialexpress.com/business/industry-cipla-q1-results-profit-surges-at-45-1-at-rs-99570-crore-north-america-posts-highest-quarterly-sales-3188052/,2023-07-26T15:56:34+05:30,2023-07-26T10:26:34,0.4404
Akums gets approval for triple combination diabetes treatment,https://www.financialexpress.com/business/healthcare-akums-gets-approval-for-triple-combination-diabetes-treatment-3187490/,2023-07-26T12:10:06+05:30,2023-07-26T06:40:06,0.4767
Revenue of top domestic pharmaceutical firms to grow by 7-9 per cent in FY24: Icra,https://www.financialexpress.com/business/industry-revenue-of-top-domestic-pharmaceutical-firms-to-grow-by-7-9-per-cent-in-fy24-icra-3187051/,2023-07-26T09:18:03+05:30,2023-07-26T03:48:03,0.2023
"Indoco Remedies Q1FY24 profit dips 36.8% to Rs 24.39 crore, revenue up 5.5%",https://www.financialexpress.com/business/industry-indoco-remedies-q1fy24-profit-dips-36-8-to-rs-2439-crore-revenue-up-55-3185898/,2023-07-25T12:07:16+05:30,2023-07-25T06:37:16,0.4404
AstraZeneca’s anti-diabetic drug gets additional indication approval for heart failure treatment in India,https://www.financialexpress.com/business/healthcare-astrazenecas-anti-diabetic-drug-gets-additional-indication-approval-for-heart-failure-treatment-in-india-3185795/,2023-07-25T11:54:53+05:30,2023-07-25T06:24:53,-0.0516
"Preventative measures set to battle for RSV market domination, says GlobalData",https://www.financialexpress.com/business/healthcare-preventative-measures-set-to-battle-for-rsv-market-domination-says-globaldata-3184987/,2023-07-25T09:00:00+05:30,2023-07-25T03:30:00,-0.4215
"49 drugs including Aspirin, Vitamin D3 fail quality test; CDSCO issues alert",https://www.financialexpress.com/business/healthcare-49-drugs-including-asprin-vitamin-d3-fail-quality-test-cdsco-issues-alert-3184974/,2023-07-25T08:00:00+05:30,2023-07-25T02:30:00,-0.0258
Sandoz gets positive CHMP opinion for its multiple sclerosis biosimilar,https://www.financialexpress.com/business/healthcare-sandoz-gets-positive-chmp-opinion-for-its-multiple-sclerosis-biosimilar-3184077/,2023-07-24T11:09:53+05:30,2023-07-24T05:39:53,0.5574
"M&A activity of pharma CMOs will continue despite challenging borrowing environment, says GlobalData",https://www.financialexpress.com/business/healthcare-ma-activity-of-pharma-cmos-will-continue-despite-challenging-borrowing-environment-says-globaldata-3179936/,2023-07-21T08:00:00+05:30,2023-07-21T02:30:00,-0.1139
"India Inc to witness 6-8% revenue growth slowdown in Q1FY24, commodity prices decline to help profitability",https://www.financialexpress.com/business/industry-india-inc-to-witness-revenue-growth-slowdown-of-6-8-in-q1fy24-profitability-to-improve-as-commodity-prices-decline-3179365/,2023-07-20T12:52:29+05:30,2023-07-20T07:22:29,0.7506
"Pfizer, Gilead, GSK to capture 62% of $150 billion infectious diseases market",https://www.financialexpress.com/business/healthcare-pfizer-gilead-gsk-to-capture-62-of-150-billion-infectious-diseases-market-3178455/,2023-07-20T10:00:00+05:30,2023-07-20T04:30:00,0.0
"Novel pipeline therapies to drive Parkinson’s disease market to $6.4 billion in 2029, says GlobalData",https://www.financialexpress.com/business/healthcare-novel-pipeline-therapies-to-drive-parkinsons-disease-market-to-6-4-billion-in-2029-says-globaldata-3178439/,2023-07-20T09:00:00+05:30,2023-07-20T03:30:00,0.3182
"2022 saw decade-high immuno-oncology approvals, finds GlobalData",https://www.financialexpress.com/business/healthcare-2022-saw-decade-high-immuno-oncology-approvals-finds-globaldata-3178404/,2023-07-20T08:00:00+05:30,2023-07-20T02:30:00,0.0
This new drug delays the progression of Alzheimer’s; read on to know more,https://www.financialexpress.com/business/healthcare-this-new-drug-delays-the-progression-of-alzheimers-read-on-to-know-more-3177269/,2023-07-19T09:45:59+05:30,2023-07-19T04:15:59,0.0
USFDA approves Sanofi and AstraZeneca’s drug to prevent RSV in babies and toddlers,https://www.financialexpress.com/business/healthcare-usfda-approves-sanofi-and-astrazenecas-drug-to-prevent-rsv-in-babies-and-toddlers-3175927/,2023-07-18T12:38:54+05:30,2023-07-18T07:08:54,0.4215
Lupin gets EIR from USFDA for its Pithampur Unit-2 Manufacturing Facility,https://www.financialexpress.com/business/healthcare-lupin-gets-eir-from-usfda-for-its-pithampur-unit-2-manufacturing-facility-3165722/,2023-07-12T08:00:00+05:30,2023-07-12T02:30:00,0.0
‘Stringent action to be taken against companies that make spurious drugs’,https://www.financialexpress.com/business/healthcare-stringent-action-to-be-taken-against-companies-that-make-spurious-drugs-3165013/,2023-07-11T14:00:13+05:30,2023-07-11T08:30:13,0.0
Sanofi India gets marketing authorization for drug to treat atopic dermatitis,https://www.financialexpress.com/business/healthcare-sanofi-india-gets-marketing-authorization-for-drug-to-treat-atopic-dermatitis-3164982/,2023-07-11T13:42:00+05:30,2023-07-11T08:12:00,0.4019
FDA allows more cancer drug imports from China as US faces shortages,https://www.financialexpress.com/business/healthcare-fda-allows-more-cancer-drug-imports-from-china-as-us-faces-shortages-3164608/,2023-07-11T11:30:12+05:30,2023-07-11T06:00:12,-0.7425
Poisoned cough syrup killed kids. Authorities cut the investigation short,https://www.financialexpress.com/business/healthcare-poisoned-cough-syrup-killed-kids-authorities-cut-the-investigation-short-3164587/,2023-07-11T11:18:45+05:30,2023-07-11T05:48:45,-0.8689
NMPA approval for first BCMA CAR-T Therapy paves way for more multiple myeloma cell therapies,https://www.financialexpress.com/business/healthcare-nmpa-approval-for-first-bcma-car-t-therapy-paves-way-for-more-multiple-myeloma-cell-therapies-3163706/,2023-07-11T10:00:00+05:30,2023-07-11T04:30:00,0.4767
"Hepatitis B burden places China at an elevated risk of liver cancer, forecasts GlobalData",https://www.financialexpress.com/business/healthcare-hepatitis-b-burden-places-china-at-an-elevated-risk-of-liver-cancer-forecasts-globaldata-3163698/,2023-07-11T09:00:00+05:30,2023-07-11T03:30:00,-0.8555
"This common blood pressure drug may extend your lifespan, slow aging; here’s what you need to know",https://www.financialexpress.com/business/healthcare-this-common-blood-pressure-drug-may-extend-your-lifespan-slow-aging-heres-what-you-need-to-know-3163057/,2023-07-10T12:57:32+05:30,2023-07-10T07:27:32,-0.128
Eli Lilly obesity drug retatrutide trials set to challenge weight loss results seen with other drugs,https://www.financialexpress.com/business/healthcare-eli-lilly-obesity-drug-retatrutide-trials-set-to-challenge-weight-loss-results-seen-with-other-drugs-3162146/,2023-07-10T10:00:00+05:30,2023-07-10T04:30:00,-0.25
Rating: neutral; Pharma sector: Poised for strong growth in Q1FY24,https://www.financialexpress.com/market/rating-neutral-pharma-sector-poised-for-strong-growth-in-q1fy24-3162176/,2023-07-10T01:15:00+05:30,2023-07-09T19:45:00,0.7845
Alkem Laboratories forays into Ophthalmology with launch of eye care products,https://www.financialexpress.com/business/healthcare-alkem-laboratories-forays-into-ophthalmology-with-launch-of-eye-care-products-3159369/,2023-07-06T17:29:38+05:30,2023-07-06T11:59:38,0.4939
BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia,https://www.financialexpress.com/business/healthcare-bdr-pharma-launches-new-drug-for-philadelphia-chromosome-positive-leukemia-3157778/,2023-07-06T10:00:00+05:30,2023-07-06T04:30:00,0.0
Venus Remedies oncology wing gets marketing approvals from 4 key markets,https://www.financialexpress.com/business/healthcare-venus-remedies-oncology-wing-gets-marketing-approvals-from-4-key-markets-3157754/,2023-07-06T09:00:00+05:30,2023-07-06T03:30:00,0.0
Biocon Biologics expands its footprint in Emerging Markets; takes over commercialization of Biosimilars Business from Viatris,https://www.financialexpress.com/business/healthcare-biocon-biologics-expands-its-footprint-in-emerging-markets-takes-over-commercialization-of-biosimilars-business-from-viatris-3157733/,2023-07-06T07:00:00+05:30,2023-07-06T01:30:00,0.1027
"Inflation law drives biologic drugs to outpace small molecules in venture financing in US, finds GlobalData",https://www.financialexpress.com/business/healthcare-inflation-law-drives-biologic-drugs-to-outpace-small-molecules-in-venture-financing-in-us-finds-globaldata-3155288/,2023-07-05T09:00:00+05:30,2023-07-05T03:30:00,0.0
Soliris approval for MG will allow AstraZeneca to play a key role rare disease treatment space in China,https://www.financialexpress.com/business/healthcare-soliris-approval-for-mg-will-allow-astrazeneca-to-play-a-key-role-rare-disease-treatment-space-in-china-3155268/,2023-07-05T08:00:00+05:30,2023-07-05T02:30:00,0.7506
USFDA gives tentative approval to Lupin’s HIV/AIDS drug,https://www.financialexpress.com/business/healthcare-usfda-gives-tentative-approval-to-lupins-hivaids-drug-3155441/,2023-07-04T17:15:51+05:30,2023-07-04T11:45:51,0.4767
USFDA gives final nod to Zydus’ tablets for treatment of seizures,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-zydus-tablets-for-treatment-of-seizures-3154959/,2023-07-04T13:47:33+05:30,2023-07-04T08:17:33,0.0
Biocon Biologics’ biosimilar of Humira is now available in United States,https://www.financialexpress.com/business/healthcare-biocon-biologics-biosimilar-of-humira-is-now-available-in-united-states-3154596/,2023-07-04T11:37:42+05:30,2023-07-04T06:07:42,0.4215
USFDA gives nod to Lupin’s nasal spray for Vitamin B12 deficiency,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-nasal-spray-for-vitamin-b12-deficiency-3153712/,2023-07-03T17:12:03+05:30,2023-07-03T11:42:03,0.296
Alembic Pharmaceuticals gets 5 USFDA approvals in Q1FY24,https://www.financialexpress.com/business/healthcare-alembic-pharmaceuticals-gets-5-usfda-approvals-in-q1fy24-3153335/,2023-07-03T14:32:15+05:30,2023-07-03T09:02:15,0.0
NPPA fixes ceiling prices of 53 medicines; drugs for anxiety and diabetes to get cheaper,https://www.financialexpress.com/business/healthcare-nppa-fixes-ceiling-prices-of-53-medicines-drugs-for-anxiety-and-diabetes-to-get-cheaper-3152885/,2023-07-03T11:37:54+05:30,2023-07-03T06:07:54,-0.1779
How to live a better life after Prostate Cancer?,https://www.financialexpress.com/life/how-to-live-a-better-life-after-prostate-cancer-3150247/,2023-07-01T12:00:00+05:30,2023-07-01T06:30:00,-0.3612
"After BCG, a new TB vaccine enters the final trial phase; read on to know all about this ‘promising’ shot",https://www.financialexpress.com/business/healthcare-after-bcg-a-new-tb-vaccine-enters-the-final-trial-phase-read-on-to-know-all-about-this-promising-shot-3149891/,2023-06-30T15:21:28+05:30,2023-06-30T09:51:28,0.0
Eli Lilly’s new drug shows never-seen-before results; Boosts weight loss by up to 24 percent,https://www.financialexpress.com/business/healthcare-eli-lillys-new-drug-shows-never-seen-before-results-boosts-weight-loss-by-up-to-24-percent-3147978/,2023-06-29T15:08:42+05:30,2023-06-29T09:38:42,0.0
From Pills to Promise: Unleashing India’s Pharma Potential through Quality Standards,https://www.financialexpress.com/business/healthcare-from-pills-to-promise-unleashing-indias-pharma-potential-through-quality-standards-3146455/,2023-06-29T09:00:00+05:30,2023-06-29T03:30:00,0.3182
Encouraging the manufacture of made in India drugs for rare disease treatment,https://www.financialexpress.com/business/healthcare-encouraging-the-manufacture-of-made-in-india-drugs-for-rare-disease-treatment-3146422/,2023-06-29T08:00:00+05:30,2023-06-29T02:30:00,0.5267
Uzbekistan cough syrup row: Indian company used toxic industrial-grade ingredients in medicines,https://www.financialexpress.com/business/healthcare-uzbekistan-cough-syrup-row-indian-company-used-toxic-industrial-grade-ingredients-in-medicines-3145679/,2023-06-28T11:02:26+05:30,2023-06-28T05:32:26,0.0
TPG-Backed Inova agrees to acquire Mundipharma’s OTC business,https://www.financialexpress.com/business/healthcare-tpg-backed-inova-agrees-to-acquire-mundipharmas-otc-business-3144670/,2023-06-27T15:12:12+05:30,2023-06-27T09:42:12,0.2023
DCGI approves Akums’ seizure drug for patients with epilepsy aged 12 years and older in India,https://www.financialexpress.com/business/healthcare-dcgi-approves-akums-seizure-drug-for-patients-with-epilepsy-aged-12-years-and-older-in-india-3144436/,2023-06-27T13:16:23+05:30,2023-06-27T07:46:23,0.4019
"Former AstraZeneca MD, Gagandeep Singh joins Boehringer Ingelheim Managing Director and Head of Human Pharma for India",https://www.financialexpress.com/business/healthcare-former-astrazeneca-md-gagandeep-singh-joins-boehringer-ingelheim-managing-director-and-head-of-human-pharma-for-india-3143319/,2023-06-26T17:05:56+05:30,2023-06-26T11:35:56,0.0
"Quality is a top priority today, regulators are working closely to ensure this: Health Minister Mandaviya",https://www.financialexpress.com/business/healthcare-quality-is-a-top-priority-today-regulators-are-working-closely-to-ensure-this-health-minister-mandaviya-3140227/,2023-06-23T20:41:17+05:30,2023-06-23T15:11:17,0.5267
Dr. Reddy’s enters trade generics business in India,https://www.financialexpress.com/business/healthcare-dr-reddys-enters-trade-generics-business-in-india-3139586/,2023-06-23T15:28:34+05:30,2023-06-23T09:58:34,0.0
Lupin launches oral suspension for treatment of seizure disorder in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-oral-suspension-for-treatment-of-seizure-disorder-in-united-states-3139209/,2023-06-23T13:32:44+05:30,2023-06-23T08:02:44,0.0258
Venus Remedies gets approval to market its blockbuster generic drug in Spain,https://www.financialexpress.com/business/healthcare-venus-remedies-gets-approval-to-market-its-blockbuster-generic-drug-in-spain-3137418/,2023-06-22T13:50:46+05:30,2023-06-22T08:20:46,0.7906
Study indicating bacterial infection could cause endometriosis suggests antibiotics as potential treatment: GlobalData,https://www.financialexpress.com/business/healthcare-study-indicating-bacterial-infection-could-cause-endometriosis-suggests-antibiotics-as-potential-treatment-globaldata-3137277/,2023-06-22T12:59:43+05:30,2023-06-22T07:29:43,0.0
Aspirin can lead to anemia among older adults; here’s how,https://www.financialexpress.com/business/healthcare-aspirin-can-lead-to-anemia-among-older-adults-heres-how-3136042/,2023-06-21T16:48:02+05:30,2023-06-21T11:18:02,0.0
USFDA gives nod to Lupin’s inhaler for treatment of COPD,https://www.financialexpress.com/business/healthcare-usfda-gives-nod-to-lupins-inhaler-for-treatment-of-copd-3135635/,2023-06-21T13:57:05+05:30,2023-06-21T08:27:05,0.0
"After cough syrup-linked deaths, Gambia tightens rules for Indian drugs",https://www.financialexpress.com/business/healthcare-after-cough-syrup-linked-deaths-gambia-tightens-rules-for-indian-drugs-3135406/,2023-06-21T12:34:21+05:30,2023-06-21T07:04:21,0.0
Pharma exports expected to touch $28 billion in FY 24: Pharmexcil chief,https://www.financialexpress.com/business/healthcare-pharma-exports-expected-to-touch-28-billion-in-fy-24-pharmexcil-chief-3135354/,2023-06-21T12:14:30+05:30,2023-06-21T06:44:30,0.0
"WHO investigates contaminated cough syrup; Flags 20 products originating from India, Indonesia",https://www.financialexpress.com/business/healthcare-who-investigates-contaminated-cough-syrup-flags-20-products-originating-from-india-indonesia-3135269/,2023-06-21T11:47:05+05:30,2023-06-21T06:17:05,0.0
DCGI approves India’s first mRNA based Omicron-specific booster vaccine,https://www.financialexpress.com/business/healthcare-dcgi-approves-indias-first-mrna-based-omicron-specific-booster-vaccine-3134054/,2023-06-20T15:54:50+05:30,2023-06-20T10:24:50,0.4019
"Zero tolerance on spurious medicines, 71 firms issued notices: Mansukh Mandaviya on cough syrup row",https://www.financialexpress.com/business/healthcare-zero-tolerance-on-spurious-medicines-71-firms-issued-notices-mansukh-mandaviya-on-cough-syrup-row-3133950/,2023-06-20T15:41:43+05:30,2023-06-20T10:11:43,0.296
This nasal drop can help your brain recover from stroke; here are the details,https://www.financialexpress.com/business/healthcare-this-nasal-drop-can-help-your-brain-recover-from-stroke-here-are-the-details-3132660/,2023-06-19T17:15:28+05:30,2023-06-19T11:45:28,0.1531
Lupin gets EIR from USFDA for its API Manufacturing Facility in Vizag,https://www.financialexpress.com/business/healthcare-lupin-gets-eir-from-usfda-for-its-api-manufacturing-facility-in-vizag-3132389/,2023-06-19T15:36:08+05:30,2023-06-19T10:06:08,0.0
Lupin launches injection for treating Vitamin B1 Deficiency in the United States,https://www.financialexpress.com/business/healthcare-lupin-launches-injection-for-treating-vitamin-b1-deficiency-in-the-united-states-3131770/,2023-06-19T11:17:39+05:30,2023-06-19T05:47:39,0.6124
"It is important to accelerate clinical trials to enable faster access to new drugs: Vikas Jain, Global Head, Life Sciences & Healthcare, TCS",https://www.financialexpress.com/business/healthcare-it-is-important-to-accelerate-clinical-trials-to-enable-faster-access-to-new-drugs-vikas-jainnbspglobal-head-life-sciences-amp-healthcare-tcsnbsp-3121562/,2023-06-11T10:45:22+05:30,2023-06-11T05:15:22,0.2023
Long-lasting swine flu vaccine to be a reality soon; here are the details,https://www.financialexpress.com/business/healthcare-long-last-swine-flu-vaccine-will-be-a-reality-soon-here-are-the-details-3119728/,2023-06-09T16:27:10+05:30,2023-06-09T10:57:10,-0.3818
European Commission gives final nod to GSK’s RSV vaccine,https://www.financialexpress.com/business/healthcare-european-commission-gives-final-nod-to-gsks-rsv-vaccine-3116942/,2023-06-07T14:50:58+05:30,2023-06-07T09:20:58,0.0
UK looks to expand obesity-drug access with pilot program,https://www.financialexpress.com/business/healthcare-uk-looks-to-expand-obesity-drug-access-with-pilot-program-3116914/,2023-06-07T14:26:52+05:30,2023-06-07T08:56:52,0.3182
"Takeda, Eli Lilly must defend racketeering suit over Diabetes drug, judge rules",https://www.financialexpress.com/business/healthcare-takeda-eli-lilly-must-defend-racketeering-suit-over-diabetes-drug-judge-rules-3116894/,2023-06-07T14:18:08+05:30,2023-06-07T08:48:08,0.0
AstraZeneca’s Japan partner to go solo on future cancer drugs,https://www.financialexpress.com/business/healthcare-astrazenecas-japan-partner-to-go-solo-on-future-cancer-drugs-3116862/,2023-06-07T14:07:47+05:30,2023-06-07T08:37:47,-0.6597
This pill can halve the risk of death among people with lung cancer; here are the details,https://www.financialexpress.com/business/healthcare-this-pill-can-halve-the-risk-of-death-among-people-with-lung-cancer-here-are-the-details-3115439/,2023-06-06T13:30:39+05:30,2023-06-06T08:00:39,-0.886
Redefining the pharmaceutical industry’s role in combating climate change,https://www.financialexpress.com/business/healthcare-redefining-the-pharmaceutical-industrys-role-in-combating-climate-change-3114495/,2023-06-05T17:44:35+05:30,2023-06-05T12:14:35,0.0
Why novel drug delivery systems are taking centre stage in the pharmaceutical industry?,https://www.financialexpress.com/business/healthcare-why-novel-drug-delivery-systems-are-taking-centre-stage-in-the-pharmaceutical-industry-3114186/,2023-06-05T14:51:25+05:30,2023-06-05T09:21:25,0.3182
Dr. Reddy’s successfully completes Phase I study of its proposed biosimilar of immunosuppressive drug,https://www.financialexpress.com/business/healthcare-dr-reddys-successfully-completes-phase-i-study-of-its-proposed-biosimilar-of-immunosuppressive-drug-3114132/,2023-06-05T14:09:13+05:30,2023-06-05T08:39:13,0.4939
This medicated eye drop can prevent myopia among kids; Read on to find out more,https://www.financialexpress.com/business/healthcare-this-medicated-eye-drop-can-prevent-myopia-among-kids-read-on-to-find-out-more-3113971/,2023-06-05T12:46:24+05:30,2023-06-05T07:16:24,-0.25
AstraZeneca India appoints Bhavana Agrawal as Chief Financial Officer with effect from October,https://www.financialexpress.com/business/healthcare-astrazeneca-india-appoints-bhavana-agrawal-as-chief-financial-officer-with-effect-from-october-3109030/,2023-05-31T15:27:47+05:30,2023-05-31T09:57:47,0.0
"Sun Pharma and Philogen enter into exclusive agreement for commercialising skin cancer drug in Europe, Australia and New Zealand",https://www.financialexpress.com/business/healthcare-sun-pharma-and-philogen-enter-into-exclusive-agreement-for-commercialising-skin-cancer-drug-in-europe-australia-and-new-zealand-3108510/,2023-05-31T11:13:44+05:30,2023-05-31T05:43:44,-0.1779
Enzene Biosciences launches first biosimilar of Cancer treatment drug Erbitux,https://www.financialexpress.com/business/healthcare-enzene-biosciences-launches-first-biosimilar-of-cancer-treatment-drug-erbitux-3106555/,2023-05-29T18:14:10+05:30,2023-05-29T12:44:10,-0.6597
Pharma sector can be a dark horse,https://www.financialexpress.com/business/industry-pharma-sector-can-be-a-dark-horse-3105132/,2023-05-29T03:30:00+05:30,2023-05-28T22:00:00,0.0
Will mandatory testing of cough syrups from govt labs before export hurt small exporters?,https://www.financialexpress.com/business/sme-msme-exim-will-mandatory-testing-of-cough-syrups-before-export-from-govt-labs-hurt-small-exporters-3103324/,2023-05-26T17:08:05+05:30,2023-05-26T11:38:05,-0.4767
Lupin Diagnostics launches Satellite Laboratory in Vijayawada,https://www.financialexpress.com/business/healthcare-lupin-diagnostics-launches-satellite-laboratory-in-vijayawada-3101815/,2023-05-25T16:10:53+05:30,2023-05-25T10:40:53,0.0
This drug works better than caffeine in keeping daytime sleepiness at bay; Here are the details,https://www.financialexpress.com/business/healthcare-this-drug-works-better-than-caffeine-in-keeping-daytime-sleepiness-at-bay-here-are-the-details-3101769/,2023-05-25T15:44:21+05:30,2023-05-25T10:14:21,0.4404
Govt seeks to address issue of chemists forcing consumers to buy entire strip of tablets,https://www.financialexpress.com/business/healthcare-govt-seeks-to-address-issue-of-chemists-forcing-consumers-to-buy-entire-strip-of-tablets-3100704/,2023-05-24T20:34:21+05:30,2023-05-24T15:04:21,0.0
Now cough syrups in India to undergo mandatory tests before export,https://www.financialexpress.com/business/healthcare-now-cough-syrups-in-india-to-undergo-mandatory-tests-before-export-3098514/,2023-05-23T13:17:36+05:30,2023-05-23T07:47:36,0.0772
"New weight-loss drug found to be effective in pill form, Wegovy maker says",https://www.financialexpress.com/business/healthcare-new-weight-loss-drug-found-to-be-effective-in-pill-form-wegovy-maker-says-3098398/,2023-05-23T12:05:14+05:30,2023-05-23T06:35:14,0.4767
How do the right manufacturers ensure contamination-free high-value non-oral drugs?,https://www.financialexpress.com/business/healthcare-how-do-the-right-manufacturers-ensure-contamination-free-high-value-non-oral-drugs-3097626/,2023-05-23T10:00:00+05:30,2023-05-23T04:30:00,0.3818
Takeda India partners with Bal Raksha Bharat to strengthen maternal and child health,https://www.financialexpress.com/business/healthcare-takeda-india-partners-with-bal-raksha-bharat-to-strengthen-maternal-and-child-health-3097510/,2023-05-22T16:14:16+05:30,2023-05-22T10:44:16,0.3182
Here’s why cough syrups are dangerous for children,https://www.financialexpress.com/business/healthcare-heres-why-cough-syrups-are-deadly-and-dangerous-for-children-3094048/,2023-05-19T15:37:07+05:30,2023-05-19T10:07:07,-0.4767
Pharma major Pfizer asks doctors to stop using these life-saving antibiotics; Here’s why,https://www.financialexpress.com/business/healthcare-pharma-major-pfizer-asks-doctors-to-stop-using-these-life-saving-antibiotics-heres-why-3092611/,2023-05-18T15:23:40+05:30,2023-05-18T09:53:40,-0.296
Breaking Down Silos: Collaborative Strategies to Combat Hypertension and Its Burden in India,https://www.financialexpress.com/business/healthcare-breaking-down-silos-collaborative-strategies-to-combat-hypertension-and-its-burden-in-india-3091572/,2023-05-17T17:59:00+05:30,2023-05-17T12:29:00,-0.6486
Emcure Pharmaceuticals launches injectable to treat iron deficiency in India,https://www.financialexpress.com/business/healthcare-emcure-pharmaceuticals-launches-injectable-to-treat-iron-deficiency-in-india-3091363/,2023-05-17T15:25:22+05:30,2023-05-17T09:55:22,0.4019
"Meet Hasmukh Chudgar, founder of Intas Pharmaceuticals: Know about his journey, net worth, and more",https://www.financialexpress.com/life/lifestyle-meet-hasmukh-chudgar-founder-of-intas-pharmaceuticals-know-about-his-journey-net-worth-and-more-3089348/,2023-05-17T12:01:28+05:30,2023-05-17T06:31:28,0.2263
This obesity drug also has cancer-killing properties; here’s how,https://www.financialexpress.com/business/healthcare-this-obesity-drug-also-has-cancer-killing-properties-heres-how-3088104/,2023-05-15T12:24:24+05:30,2023-05-15T06:54:24,0.0
Cipla plans to grow higher than industry growth rate in FY24,https://www.financialexpress.com/business/healthcare-q4fy23-cipla-plans-to-grow-higher-than-industry-growth-rate-in-fy24-3087528/,2023-05-15T09:00:00+05:30,2023-05-15T03:30:00,0.3818
"As Dr. Reddy’s Q4 profit soars to Rs. 959 crore, licensing deals, innovative products and consumer health to be priority in FY24",https://www.financialexpress.com/business/healthcare-as-dr-reddys-q4-profit-soars-to-rs-959-crore-licensing-deals-innovative-products-and-consumer-health-to-be-priority-in-fy24-3083439/,2023-05-11T16:41:43+05:30,2023-05-11T11:11:43,0.7003
"National Medical Devices Policy, 2023 – A job half done",https://www.financialexpress.com/business/healthcare-national-medical-devices-policy-2023-a-job-half-done-3081992/,2023-05-10T17:02:37+05:30,2023-05-10T11:32:37,0.0
"Sandoz strengthens pipeline expansion through partnership with Just-Evotec Biologics to develop, manufacture multiple biosimilars",https://www.financialexpress.com/business/healthcare-sandoz-strengthens-pipeline-expansion-through-partnership-with-just-evotec-biologics-to-develop-manufacture-multiple-biosimilars-3081856/,2023-05-10T16:04:14+05:30,2023-05-10T10:34:14,0.4588
French drugmaker Sanofi to demerge its consumer business in India,https://www.financialexpress.com/business/healthcare-french-drugmaker-sanofi-to-spin-off-its-consumer-business-in-india-3081816/,2023-05-10T15:14:08+05:30,2023-05-10T09:44:08,0.0
"Mankind Pharma share falls 6% today after gaining 32% over IPO price; should you buy, sell or hold?",https://www.financialexpress.com/market/ipo-news-mankind-pharma-share-falls-6-today-after-gaining-32-over-ipo-price-should-you-buy-sell-or-hold-3081514/,2023-05-10T12:46:56+05:30,2023-05-10T07:16:56,0.6124
"Lupin reports Q4FY23 profit at Rs 235.9 crore, revenue up 14% at Rs 4,430 crore; 200% dividend announced",https://www.financialexpress.com/business/industry-lupin-reports-q4fy23-profit-at-rs-235-9-crore-revenue-up-14-at-rs-4430-crore-200-dividend-announced-3081366/,2023-05-10T11:26:57+05:30,2023-05-10T05:56:57,0.4404
IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export to European Market,https://www.financialexpress.com/business/healthcare-iol-chemicals-and-pharmaceuticals-receives-cep-for-paracetamol-to-export-to-european-market-3078696/,2023-05-08T13:22:03+05:30,2023-05-08T07:52:03,0.0
Dr. Reddy’s Laboratories launches injection to test coronary artery disease in United States,https://www.financialexpress.com/business/healthcare-dr-reddys-laboratories-launches-injection-to-test-coronary-artery-disease-in-united-states-3075568/,2023-05-05T15:48:13+05:30,2023-05-05T10:18:13,0.4215
USFDA approves world’s first vaccine against life-threatening respiratory illness,https://www.financialexpress.com/business/healthcare-usfda-approves-worlds-first-vaccine-against-life-threatening-respiratory-illness-3075138/,2023-05-05T12:07:03+05:30,2023-05-05T06:37:03,0.0
DCGI approves AstraZeneca’s drug for treatment of HER-2 positive breast cancer,https://www.financialexpress.com/business/healthcare-dcgi-approves-astrazenecas-drug-for-treatment-of-her-2-positive-breast-cancer-3074420/,2023-05-04T17:28:21+05:30,2023-05-04T11:58:21,0.2263
Sandoz to exclusively commercialise six products from key therapeutic areas in United States,https://www.financialexpress.com/business/healthcare-sandoz-to-exclusively-commercialise-six-product-from-key-therapeutic-areas-in-united-states-3073872/,2023-05-04T12:16:16+05:30,2023-05-04T06:46:16,0.4215
Oncology drug sales to generate $2.2 trillion between 2023 and 2029,https://www.financialexpress.com/business/healthcare-oncology-drug-sales-to-generate-2-2-trillion-between-2023-and-2029-3072786/,2023-05-03T14:38:09+05:30,2023-05-03T09:08:09,0.0
"After WHO’s alert on Punjab-made cough syrup, CDSCO confirms presence of contaminants",https://www.financialexpress.com/business/healthcare-after-whos-alert-on-punjab-made-cough-syrup-cdsco-confirms-presence-of-contaminants-in-the-medicine-3072622/,2023-05-03T13:11:01+05:30,2023-05-03T07:41:01,0.296
ENTOD Pharmaceuticals launches drops for inflammatory dry eye disease,https://www.financialexpress.com/business/healthcare-entod-pharmaceuticals-launches-drops-for-inflammatory-dry-eye-disease-3072541/,2023-05-03T12:27:33+05:30,2023-05-03T06:57:33,0.0
Amgen sues Sandoz to block generic version of bone cancer and osteoporosis drugs,https://www.financialexpress.com/business/healthcare-amgen-sues-sandoz-to-block-generic-version-of-bone-cancer-and-osteoporosis-drugs-3072497/,2023-05-03T12:05:56+05:30,2023-05-03T06:35:56,-0.8074
AstraZeneca to set up five centers of excellence for severe asthma across India,https://www.financialexpress.com/business/healthcare-astrazeneca-to-set-up-five-centers-of-excellence-for-severe-asthma-across-india-3071874/,2023-05-02T19:30:05+05:30,2023-05-02T14:00:05,0.3612
"India has made significant progress in increasing access to vaccines in recent years: Vivek Sehgal, DG, OPPI",https://www.financialexpress.com/business/healthcare-india-has-made-significant-progress-in-increasing-access-to-vaccines-in-recent-years-vivek-sehgal-dg-oppi-3069170/,2023-04-30T13:43:36+05:30,2023-04-30T08:13:36,0.5574
Biocon Biologics’ new monoclonal antibodies manufacturing facility receives EU GMP certification for cancer biosimilar,https://www.financialexpress.com/business/healthcare-biocon-biologics-new-monoclonal-antibodies-manufacturing-facility-receives-eu-gmp-certification-for-cancer-biosimilar-3067646/,2023-04-28T18:12:27+05:30,2023-04-28T12:42:27,-0.6597
Abbott recalls thyroid tablets from Madhya Pradesh and Telangana; issues public notice,https://www.financialexpress.com/business/healthcare-abbott-recalls-thyroid-tablets-from-madhya-pradesh-and-telangana-issues-public-notice-3065715/,2023-04-27T17:36:06+05:30,2023-04-27T12:06:06,0.0
48 commonly-used drugs fail latest quality test; CDSCO issues alert,https://www.financialexpress.com/business/healthcare-48-commonly-used-drugs-fail-latest-quality-test-cdsco-issues-alert-3064417/,2023-04-26T21:01:42+05:30,2023-04-26T15:31:42,-0.3182
Venus Remedies gets marketing authorisation for its chemotherapy drug in UK,https://www.financialexpress.com/business/healthcare-venus-remedies-gets-marketing-authorisation-for-its-chemotherapy-drug-in-uk-3062085/,2023-04-25T16:00:17+05:30,2023-04-25T10:30:17,0.0
Sun Pharma launches novel therapy for Dry Eye Disease in India,https://www.financialexpress.com/business/healthcare-sun-pharma-launches-novel-therapy-for-dry-eye-disease-in-india-3062054/,2023-04-25T15:48:48+05:30,2023-04-25T10:18:48,0.3182
GSK launches vaccine for herpes zoster,https://www.financialexpress.com/business/healthcare-gsk-launches-vaccine-for-herpes-zoster-3061068/,2023-04-25T05:15:00+05:30,2023-04-24T23:45:00,0.0
Dr. Reddy’s Laboratories launches injection for lung disorder treatment in United States,https://www.financialexpress.com/business/healthcare-dr-reddys-laboratories-launches-injection-for-lung-disorder-treatment-in-united-states-3058558/,2023-04-22T21:45:46+05:30,2023-04-22T16:15:46,0.0258
Combining antibiotics with antidote can reduce drugs’ harmful side effects,https://www.financialexpress.com/business/healthcare-combining-antibiotics-with-antidote-can-reduce-drugs-harmful-side-effects-3050492/,2023-04-17T15:14:24+05:30,2023-04-17T09:44:24,0.0
Merck to acquire Prometheus Bioscience for around $10.8 billion,https://www.financialexpress.com/business/healthcare-merck-to-acquire-prometheus-bioscience-for-around-10-8-billion-3050338/,2023-04-17T13:39:52+05:30,2023-04-17T08:09:52,0.0
Why are patients turning to gummies as the next best thing?,https://www.financialexpress.com/business/healthcare-why-are-patients-turning-to-gummies-as-the-next-best-thing-3042700/,2023-04-12T08:00:00+05:30,2023-04-12T02:30:00,0.6369
IOL Chemicals and Pharmaceuticals appoints Vikas Vij as CEO,https://www.financialexpress.com/business/healthcare-iol-chemicals-and-pharmaceuticals-appoints-vikas-vij-as-ceo-3034517/,2023-04-05T11:23:41+05:30,2023-04-05T05:53:41,0.0
Govt extends date implementation of track and trace system for exports of drug formulations till August 1,https://www.financialexpress.com/business/healthcare-govt-extends-date-implementation-of-track-and-trace-system-for-exports-of-drug-formulations-till-august-1-3033520/,2023-04-04T17:22:51+05:30,2023-04-04T11:52:51,0.128
Cost of 651 essential medicines down 6.7 percent as govt caps ceiling prices,https://www.financialexpress.com/business/healthcare-cost-of-651-essential-medicines-down-6-7-percent-as-govt-caps-ceiling-prices-3031685/,2023-04-03T16:00:38+05:30,2023-04-03T10:30:38,0.0
Can partnerships with CRDMOs boost biosimilar manufacturing?,https://www.financialexpress.com/business/healthcare-can-partnerships-with-crdmos-boost-biosimilar-manufacturing-3028898/,2023-04-02T12:00:00+05:30,2023-04-02T06:30:00,0.4019
USFDA approves Lupin’s tablets for Hepatitis B infection treatment,https://www.financialexpress.com/business/healthcare-usfda-approves-lupins-tablets-for-hepatitis-b-infection-treatment-3028562/,2023-03-31T15:25:55+05:30,2023-03-31T09:55:55,0.4019
Pfizer’s COVID-19 drug Paxlovid is less effective against viral infection,https://www.financialexpress.com/business/healthcare-pfizers-covid-19-drug-paxlovid-is-less-effective-against-viral-infection-3027085/,2023-03-30T14:43:59+05:30,2023-03-30T09:13:59,0.4228
"Prices of painkillers, antibiotics, and cardiac medicines to go up by 12 percent from April 1",https://www.financialexpress.com/business/healthcare-prices-of-painkillers-antibiotics-and-cardiac-medicines-to-go-up-by-12-percent-from-april-1-3025828/,2023-03-29T15:01:05+05:30,2023-03-29T09:31:05,0.0
Biocon Biologics Wins ‘ABEA : Bioprocessing Excellence in South Asia’ Award,https://www.financialexpress.com/business/healthcare-biocon-biologics-wins-abea-bioprocessing-excellence-in-south-asia-award-3025715/,2023-03-29T14:00:11+05:30,2023-03-29T08:30:11,0.9062
18 Pharmaceutical companies lose their license over poor quality medicines; Here are the details,https://www.financialexpress.com/business/healthcare-18-pharmaceutical-companies-lose-their-license-over-poor-quality-medicines-here-are-the-details-3025556/,2023-03-29T13:01:09+05:30,2023-03-29T07:31:09,-0.7003
NPPA puts cap on trade margin of 42 anti-cancer drugs: Govt to Rajya Sabha,https://www.financialexpress.com/business/healthcare-nppa-puts-cap-on-trade-margin-of-42-anti-cancer-drugs-govt-to-rajya-sabha-3025605/,2023-03-29T12:54:32+05:30,2023-03-29T07:24:32,0.0
Sanofi receives marketing approval for its diabetes drug in India,https://www.financialexpress.com/business/healthcare-sanofi-receives-marketing-approval-for-its-diabetes-drug-in-india-3023536/,2023-03-27T15:49:38+05:30,2023-03-27T10:19:38,0.4767
Dr. Reddy’s focuses on differentiated portfolio in key therapy areas as part of India growth strategy: GlobalData,https://www.financialexpress.com/business/healthcare-dr-reddys-focuses-on-differentiated-portfolio-in-key-therapy-areas-as-part-of-india-growth-strategy-globaldata-3020758/,2023-03-24T11:53:47+05:30,2023-03-24T06:23:47,0.3818
Janssen’s tuberculosis drug patent application gets rejected; Generics to be available soon,https://www.financialexpress.com/business/healthcare-janssens-tuberculosis-drug-patent-application-gets-rejected-generics-to-be-soon-available-3020205/,2023-03-23T19:11:32+05:30,2023-03-23T13:41:32,-0.5106
Companies explore M&A opportunities to navigate volatile market conditions: GlobalData,https://www.financialexpress.com/business/healthcare-companies-explore-ma-opportunities-to-navigate-volatile-market-conditions-globaldata-3016342/,2023-03-20T16:29:55+05:30,2023-03-20T10:59:55,0.3818
USFDA approves Novartis’ combination targeted therapy for pediatric brain cancer,https://www.financialexpress.com/business/healthcare-usfda-approves-novartis-combination-targeted-therapy-for-pediatric-brain-cancer-3012897/,2023-03-17T11:36:00+05:30,2023-03-17T06:06:00,-0.4019
Dr. Reddy’s divests certain non-core brands in dermatology in India; To focus on strengthening core,https://www.financialexpress.com/business/healthcare-dr-reddys-divests-certain-non-core-brands-in-dermatology-in-india-to-focus-on-strengthening-core-3011950/,2023-03-16T15:58:21+05:30,2023-03-16T10:28:21,0.6486
Janssen’s novel Dengue antiviral demonstrates ‘strong protection’ in pre-clinical data,https://www.financialexpress.com/business/healthcare-janssens-novel-dengue-antiviral-demonstrates-strong-protection-in-pre-clinical-data-3011789/,2023-03-16T14:26:51+05:30,2023-03-16T08:56:51,0.3182
5 harmful effects of going overboard with antibiotics,https://www.financialexpress.com/business/healthcare-5-harmful-effects-of-going-overboard-with-antibiotics-3010615/,2023-03-16T09:00:00+05:30,2023-03-16T03:30:00,0.0
All you need to know about weight loss drug ‘Ozempic’ that Jimmy Kimmel joked about during Oscars 2023,https://www.financialexpress.com/life/all-you-need-to-know-about-weight-loss-drug-ozempic-that-jimmy-kimmel-joked-about-on-oscars-2023-3009102/,2023-03-14T17:10:02+05:30,2023-03-14T11:40:02,0.0
"Eli Lilly forays into dermatological space in India, launches psoriasis drug",https://www.financialexpress.com/business/healthcare-eli-lilly-forays-into-the-dermatological-space-in-india-launches-psoriasis-drug-3008603/,2023-03-14T12:31:25+05:30,2023-03-14T07:01:25,0.0
"Price cap move will help Eli Lilly remain dominant player in insulin market, says GlobalData",https://www.financialexpress.com/business/healthcare-price-cap-move-will-help-eli-lilly-remain-dominant-player-in-insulin-market-says-globaldata-3007384/,2023-03-13T14:19:09+05:30,2023-03-13T08:49:09,0.4019
"We plan to bring more innovative products to India in 2023 and beyond: Rishubh Gupta, General Manager, Baxter India",https://www.financialexpress.com/business/healthcare-we-plan-to-bring-more-innovative-products-to-india-in-2023-and-beyond-rishubh-gupta-general-manager-baxter-india-3006378/,2023-03-12T15:15:10+05:30,2023-03-12T09:45:10,0.4927
Sandoz signs MoU to build new biologics production plant in Slovenia; To support increasing global demand for biosimilar medicines,https://www.financialexpress.com/business/healthcare-sandoz-signs-mou-to-build-new-biologics-production-plant-in-slovenia-to-support-increasing-global-demand-for-biosimilar-medicines-3004543/,2023-03-10T12:54:49+05:30,2023-03-10T07:24:49,0.296
Venus Remedies joins India AMR Innovation Hub to combat antimicrobial resistance,https://www.financialexpress.com/business/healthcare-venus-remedies-joins-india-amr-innovation-hub-to-combat-antimicrobial-resistance-3001041/,2023-03-06T15:05:50+05:30,2023-03-06T09:35:50,0.0516
Akums enters Global Gummies market by setting-up US NSF approved plant and innovative formulations,https://www.financialexpress.com/business/healthcare-akums-enters-global-gummies-market-by-setting-up-us-nsf-approved-plant-and-innovative-formulations-2997351/,2023-03-02T13:06:02+05:30,2023-03-02T07:36:02,0.6908
Generics dominate lupus marketplace but new biologics will drive growth in coming years: GlobalData,https://www.financialexpress.com/business/healthcare-generics-dominate-lupus-marketplace-but-new-biologics-will-drive-growth-in-coming-years-globaldata-2997301/,2023-03-02T12:24:34+05:30,2023-03-02T06:54:34,0.4854
Terran Biosciences novel PCT patent application shows growing interest in psilocin therapies: GlobalData,https://www.financialexpress.com/business/healthcare-terran-biosciences-novel-pct-patent-application-shows-growing-interest-in-psilocin-therapies-globaldata-2997242/,2023-03-02T11:58:15+05:30,2023-03-02T06:28:15,0.7184
Explainer: Maiden Pharma & Drug regulation,https://www.financialexpress.com/business/healthcare-explainer-maiden-pharma-drug-regulation-2996858/,2023-03-02T07:14:02+05:30,2023-03-02T01:44:02,0.0
AstraZeneca expands its portfolio by bringing rare disease therapy for patients in India,https://www.financialexpress.com/business/healthcare-astrazeneca-expands-its-portfolio-by-bringing-rare-disease-therapy-for-patients-in-india-2995289/,2023-02-28T16:16:51+05:30,2023-02-28T10:46:51,0.1027
‘Clinical trial participation should be offered as a care option by physicians in India’,https://www.financialexpress.com/business/healthcare-clinical-trial-participation-should-be-offered-as-a-care-option-by-physicians-in-india-2993921/,2023-02-27T14:00:35+05:30,2023-02-27T08:30:35,0.4939
Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData,https://www.financialexpress.com/business/healthcare-biliary-tract-cancer-drug-durvalumab-approval-key-opportunity-for-astrazeneca-in-india-globaldata-2993894/,2023-02-27T13:31:44+05:30,2023-02-27T08:01:44,0.128
Venus Remedies gets Saudi GMP approval for all its production facilities in Baddi,https://www.financialexpress.com/business/healthcare-venus-remedies-gets-saudi-gmp-approval-for-all-its-production-facilities-in-baddi-2993723/,2023-02-27T11:42:45+05:30,2023-02-27T06:12:45,0.4767
Dr. Reddy’s Laboratories to acquire Mayne Pharma’s U.S. generic prescription product portfolio,https://www.financialexpress.com/business/healthcare-dr-reddys-laboratories-to-acquire-mayne-pharmas-us-generic-prescription-product-portfolio-2993687/,2023-02-27T11:24:21+05:30,2023-02-27T05:54:21,0.0
"FE Exclusive | Global pharma cos are looking at India as potential site for global clinical trials: Sanjay Vyas, Country Head, Parexel India",https://www.financialexpress.com/business/healthcare-fe-exclusive-global-pharma-cos-are-looking-at-india-as-potential-site-for-global-clinical-trials-sanjay-vyas-country-head-parexel-2992666/,2023-02-25T15:45:42+05:30,2023-02-25T10:15:42,0.128
Orchid Pharma working on products going off-patent in next few years,https://www.financialexpress.com/business/industry-orchid-pharma-working-on-products-going-off-patent-in-next-few-years-2990946/,2023-02-24T02:40:00+05:30,2023-02-23T21:10:00,0.0
Akums partners with Lyrus Life Sciences to develop patented technologies and manufacturing products for global markets,https://www.financialexpress.com/business/healthcare-akums-partners-with-lyrus-life-sciences-to-develop-patented-technologies-and-manufacturing-products-for-global-markets-2990246/,2023-02-23T13:37:05+05:30,2023-02-23T08:07:05,0.0
"Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine",https://www.financialexpress.com/business/healthcare-venus-remedies-gets-marketing-approval-for-cancer-drugs-from-uzbekistan-palestine-2990155/,2023-02-23T11:58:43+05:30,2023-02-23T06:28:43,-0.3182
Flipkart in talks to acquire Bangalore-based online pharmacy Pharmallama,https://www.financialexpress.com/business/healthcare-flipkart-in-talks-to-acquire-bangalore-based-online-pharmacy-pharmallama-2987955/,2023-02-21T15:41:33+05:30,2023-02-21T10:11:33,0.0
Lupin launches generic tablets for mental disorders in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-tablets-for-mental-disorders-in-united-states-2987866/,2023-02-21T14:46:22+05:30,2023-02-21T09:16:22,0.4215
USFDA tentatively approves Zydus’ tablets for seizures treatment,https://www.financialexpress.com/business/healthcare-usfda-tentatively-approves-zydus-tablets-for-seizures-treatment-2987828/,2023-02-21T14:20:10+05:30,2023-02-21T08:50:10,0.4019
AstraZeneca’s drug receives CDSCO approval in India for Biliary Tract Cancer,https://www.financialexpress.com/business/healthcare-astrazenecas-drug-receives-cdsco-approval-in-india-for-biliary-tract-cancer-2984982/,2023-02-17T20:25:41+05:30,2023-02-17T14:55:41,-0.3182
"FE Exclusive | There is still a lot of untapped opportunities in India’s diabetes market: John Dawber, Global Business Head, Novo Nordisk",https://www.financialexpress.com/business/healthcare-fe-exclusive-there-is-still-a-lot-of-untapped-opportunity-in-indias-diabetes-market-john-dawber-global-business-head-novo-nordisk-2983956/,2023-02-16T22:30:50+05:30,2023-02-16T17:00:50,0.4767
Pharma major Novo Nordisk completes 100 years; Hopes to advance further in diabetic care in coming years,https://www.financialexpress.com/business/healthcare-pharma-major-novo-nordisk-completes-100-years-hopes-to-advance-further-in-diabetic-care-in-coming-years-2983570/,2023-02-16T15:53:00+05:30,2023-02-16T10:23:00,0.7184
Artificial intelligence facilitates low-cost drug repurposing: GlobalData,https://www.financialexpress.com/business/healthcare-artificial-intelligence-facilitates-low-cost-drug-repurposing-globaldata-2978111/,2023-02-10T17:34:40+05:30,2023-02-10T12:04:40,0.4767
Lupin reports decline in profit by 72 percent to Rs. 153 crore in Q3FY23,https://www.financialexpress.com/business/healthcare-lupin-reports-decline-in-profit-by-72-percent-to-rs-153-crore-in-q3fy23-2977829/,2023-02-10T15:25:18+05:30,2023-02-10T09:55:18,0.4404
IOL Chemicals and Pharmaceuticals’ net profit declines 39.73 percent in December 2022 quarter,https://www.financialexpress.com/business/healthcare-iol-chemicals-and-pharmaceuticals-net-profit-declines-39-73-percent-in-december-2022-quarter-2975378/,2023-02-08T15:46:56+05:30,2023-02-08T10:16:56,0.4404
Olezarsen’s fast track FDA approval strengthens Ionis Pharmaceuticals outlook in cholesterol disorder space: GlobalData,https://www.financialexpress.com/business/healthcare-olezarsens-fast-track-fda-approval-strengthens-ionis-pharmaceuticals-outlook-in-cholesterol-disorder-space-globaldata-2975334/,2023-02-08T15:31:36+05:30,2023-02-08T10:01:36,0.5267
Akums Pharma gets DCGI approval to launch drug for type 2 diabetic patients,https://www.financialexpress.com/business/healthcare-akums-pharma-gets-dcgi-approval-to-launch-diabetes-drug-for-type-2-diabetic-patients-2972660/,2023-02-06T14:21:11+05:30,2023-02-06T08:51:11,0.4767
USFDA accepts Sandoz’ Biologics License Application for proposed osteoporosis drug biosimilar,https://www.financialexpress.com/business/healthcare-usfda-accepts-sandoz-biologics-license-application-for-proposed-osteoporosis-drug-biosimilar-2972565/,2023-02-06T13:09:57+05:30,2023-02-06T07:39:57,0.3182
Zynerba’s drug could target genetic condition that causes developmental problems but likely to face barrier in uptake: GlobalData,https://www.financialexpress.com/business/healthcare-zynerbas-drug-could-target-genetic-condition-that-causes-developmental-problems-but-likely-to-face-barrier-in-uptake-globaldata-2970802/,2023-02-03T16:36:13+05:30,2023-02-03T11:06:13,-0.3818
"Sun Pharma reports rise in net profit by 5 percent to Rs. 2,166 crore yoy in Q3FY22",https://www.financialexpress.com/business/healthcare-sun-pharma-reports-rise-in-net-profit-by-5-percent-to-rs-2166-crore-yoy-in-q3fy22-2965813/,2023-01-31T14:47:55+05:30,2023-01-31T09:17:55,0.4404
USFDA tentatively approves Lupin’s HIV/AIDS tablets,https://www.financialexpress.com/business/healthcare-usfda-tentatively-approves-lupins-hivaids-tablets-2965772/,2023-01-31T14:25:19+05:30,2023-01-31T08:55:19,0.4019
Sun Pharma acquires three brands from Aksigen to strengthen its anti-inflammatory portfolio,https://www.financialexpress.com/business/healthcare-sun-pharma-acquires-three-brands-from-aksigen-to-strengthen-its-anti-inflammatory-portfolio-2964085/,2023-01-30T13:00:09+05:30,2023-01-30T07:30:09,0.3182
"Alkem, BDR Pharma launch antibiotics for multiple drug-resistant infections in India",https://www.financialexpress.com/business/healthcare-alkem-launches-antibiotic-for-multiple-drug-resistant-infections-in-india-2964014/,2023-01-30T12:20:37+05:30,2023-01-30T06:50:37,0.0
Domestic deals dominate M&A in healthcare and Pharma; Trend to continue in 2023,https://www.financialexpress.com/business/healthcare-domestic-deals-dominate-ma-in-healthcare-and-pharma-trend-to-continue-in-2023-2958791/,2023-01-28T13:00:00+05:30,2023-01-28T07:30:00,-0.128
Dr. Reddy’s Laboratories launches eye drops for post-surgery care in United States,https://www.financialexpress.com/business/healthcare-dr-reddys-laboratories-launches-eye-drops-for-post-surgery-care-in-united-states-2961662/,2023-01-27T13:18:28+05:30,2023-01-27T07:48:28,0.7184
Dr. Reddy’s labs PAT up by 77% y-o-y to Rs. 1247 crore in Q3FY23,https://www.financialexpress.com/business/healthcare-dr-reddys-labs-pat-up-by-77-y-o-y-to-rs-1247-crore-in-q3fy23-2960200/,2023-01-25T17:08:35+05:30,2023-01-25T11:38:35,0.0
Cipla’s profit rises 10 percent y-o-y to Rs. 801 in Q3FY23,https://www.financialexpress.com/business/healthcare-ciplas-profit-rises-10-percent-yoy-to-rs-801-in-q3fy23-2960158/,2023-01-25T16:43:04+05:30,2023-01-25T11:13:04,0.4404
Pharma companies that develop vaccines with efficacy against Omicron variants will gain competitive advantage in China: GlobalData,https://www.financialexpress.com/business/healthcare-pharma-companies-that-develop-vaccines-with-efficacy-against-omicron-variants-will-gain-competitive-advantage-in-china-globaldata-2959929/,2023-01-25T14:38:54+05:30,2023-01-25T09:08:54,0.7269
Mankind Pharma reduces price of its heart failure drug by 70 percent in India,https://www.financialexpress.com/business/healthcare-mankind-pharma-reduces-price-of-its-heart-failure-drug-by-70-percent-in-india-2959704/,2023-01-25T12:39:09+05:30,2023-01-25T07:09:09,-0.5106
Gland Pharma’s net profit declines 15 percent; Shares hit 52-week low,https://www.financialexpress.com/business/healthcare-gland-pharmas-net-profit-declines-15-percent-shares-hit-52-week-low-2958363/,2023-01-24T12:32:10+05:30,2023-01-24T07:02:10,0.4588
Sandoz announces agreement to acquire leading antifungal agent from Astellas,https://www.financialexpress.com/business/healthcare-sandoz-announces-agreement-to-acquire-leading-antifungal-agent-from-astellas-2958314/,2023-01-24T11:40:16+05:30,2023-01-24T06:10:16,0.4939
"After Gambia and Uzbekistan cough syrup row, WHO urges action to protect children from contaminated medicines",https://www.financialexpress.com/business/healthcare-after-gambia-and-uzbekistan-cough-syrup-row-who-urges-action-to-protect-children-from-contaminated-medicines-2958292/,2023-01-24T11:19:31+05:30,2023-01-24T05:49:31,0.3818
USFDA rejects accelerated approval for Eli Lilly’s Alzheimer’s drug,https://www.financialexpress.com/business/healthcare-usfda-rejects-accelerated-approval-for-eli-lillys-alzheimers-drug-2955112/,2023-01-20T16:36:21+05:30,2023-01-20T11:06:21,-0.0258
Dr. Reddy’s reduces price of its heart failure drug,https://www.financialexpress.com/business/healthcare-dr-reddys-reduces-price-of-its-heart-failure-drug-2954715/,2023-01-20T12:20:54+05:30,2023-01-20T06:50:54,-0.5106
Dr. Reddy’s completes clinical studies of its biosimilar for autoimmune disease,https://www.financialexpress.com/business/healthcare-dr-reddys-completes-clinical-studies-of-its-biosimilar-for-autoimmune-disease-2954605/,2023-01-20T11:19:10+05:30,2023-01-20T05:49:10,0.0
Lupin launches generic version of Novartis’ heart failure drug in India,https://www.financialexpress.com/business/healthcare-lupin-launches-generic-version-of-novartis-heart-failure-drug-in-india-2952673/,2023-01-18T18:42:44+05:30,2023-01-18T13:12:44,-0.5106
Pfizer to sell its full drug portfolio on not-for-profit basis in low-income countries,https://www.financialexpress.com/business/healthcare-pfizer-to-sell-its-full-drug-portfolio-on-not-for-profit-basis-in-low-income-countries-2952112/,2023-01-18T13:33:11+05:30,2023-01-18T08:03:11,0.0
89bio’s drug has potential to become a major player in cholesterol disorder market: GlobalData,https://www.financialexpress.com/business/healthcare-89bios-drug-has-potential-to-become-a-major-player-in-cholesterol-disorder-market-globaldata-2950950/,2023-01-17T14:21:27+05:30,2023-01-17T08:51:27,-0.4019
Leqembi’s prospects in Alzheimer’s disease market remain uncertain despite its advantages over Aduhelm: GlobalData,https://www.financialexpress.com/business/healthcare-leqembis-prospects-in-alzheimers-disease-market-remain-uncertain-despite-its-advantages-over-aduhelm-globaldata-2950678/,2023-01-17T11:19:51+05:30,2023-01-17T05:49:51,-0.2755
USFDA tentatively approves Lupin’s two HIV/AIDS tablets,https://www.financialexpress.com/business/healthcare-usfda-tentatively-approves-lupins-two-hivaids-tablets-2949695/,2023-01-16T14:52:23+05:30,2023-01-16T09:22:23,0.4019
HempStreet collaborates with MGC Pharma to launch COVID-19 mouth spray,https://www.financialexpress.com/business/healthcare-hempstreet-collaborates-with-mgc-pharma-to-launch-covid-19-mouth-spray-2949505/,2023-01-16T13:07:58+05:30,2023-01-16T07:37:58,0.0
How will QR Codes on drug packaging help prevent the sale of spurious drugs?,https://www.financialexpress.com/business/healthcare-how-will-qr-codes-on-drug-packaging-help-prevent-the-sale-of-spurious-drugs-2948920/,2023-01-15T17:01:41+05:30,2023-01-15T11:31:41,0.4215
Novartis’ heart failure drug to go off patent this month; Will this make cardiac care in India affordable?,https://www.financialexpress.com/business/healthcare-novartis-heart-failure-drug-to-go-off-patent-this-month-will-this-make-cardiac-care-in-india-affordable-2948902/,2023-01-15T16:05:18+05:30,2023-01-15T10:35:18,-0.0258
Dr. Reddy’s acquires trademark rights of Pfizer’s breast cancer drug,https://www.financialexpress.com/business/healthcare-dr-reddys-acquires-trademark-rights-of-pfizers-breast-cancer-drug-2947569/,2023-01-13T18:00:31+05:30,2023-01-13T12:30:31,-0.6597
Western companies to play key role in improving cardiovascular disease management approach in China: GlobalData,https://www.financialexpress.com/business/healthcare-western-companies-to-play-key-role-in-improving-cardiovascular-disease-management-approach-in-china-globaldata-2945671/,2023-01-12T11:56:13+05:30,2023-01-12T06:26:13,0.6369
Genomics identified as most impactful emerging pharma industry trend for 2023: GlobalData survey,https://www.financialexpress.com/business/healthcare-genomics-identified-as-the-most-impactful-emerging-pharmaceutical-industry-trend-for-2023-globaldata-survey-2944968/,2023-01-11T17:28:58+05:30,2023-01-11T11:58:58,0.0
"BDR, Sun Pharma launch new drug for advanced breast cancer treatment in India",https://www.financialexpress.com/business/healthcare-bdr-pharma-launches-new-drug-for-advanced-breast-cancer-treatment-in-india-2944472/,2023-01-11T12:13:29+05:30,2023-01-11T06:43:29,-0.5267
USFDA approves Lupin’s generic heart disorder tablets,https://www.financialexpress.com/business/healthcare-usfda-approves-lupins-generic-heart-disorder-tablets-2942720/,2023-01-10T17:08:54+05:30,2023-01-10T11:38:54,0.0
Lupin launches fixed-dose triple drug combination to treat uncontrolled asthma,https://www.financialexpress.com/business/healthcare-lupin-launches-fixed-dose-triple-drug-combination-to-treat-uncontrolled-asthma-2937464/,2023-01-05T13:15:18+05:30,2023-01-05T07:45:18,0.1779
BDR Pharmaceutical launches first generic to treat Prostate cancer in India,https://www.financialexpress.com/business/healthcare-bdr-pharmaceutical-launches-first-generic-to-treat-prostate-cancer-in-india-2934942/,2023-01-03T11:29:17+05:30,2023-01-03T05:59:17,-0.4019
"India is on cusp of massive leap towards being global biopharma leader: Gaurav Kaushik, Meteoric Biopharmaceuticals",https://www.financialexpress.com/business/healthcare-india-is-on-cusp-of-massive-leap-towards-being-global-biopharma-leader-gaurav-kaushik-meteoric-biopharmaceuticals-2929685/,2022-12-31T10:00:00+05:30,2022-12-31T04:30:00,0.0
China grants conditional approval to Merck’s COVID-19 drug,https://www.financialexpress.com/business/healthcare-china-grants-conditional-approval-to-mercks-covid-19-treatment-2931891/,2022-12-30T15:15:08+05:30,2022-12-30T09:45:08,0.6124
All manufacturing activities of Marion Biotech’s Noida unit have been stopped: Mansukh Mandaviya,https://www.financialexpress.com/business/healthcare-all-manufacturing-activities-of-marion-biotechs-noida-unit-have-been-stopped-mansukh-mandaviya-2931679/,2022-12-30T13:07:20+05:30,2022-12-30T07:37:20,-0.2263
Claims against Dr. Reddy’s dismissed over Revlimid in United States; Share price rises,https://www.financialexpress.com/business/healthcare-claims-against-dr-reddys-dismissed-over-revlimid-in-united-states-share-price-rises-2930880/,2022-12-29T18:09:49+05:30,2022-12-29T12:39:49,0.6124
"After Gambia, 18 children in Uzbekistan died allegedly due to India-made syrup; Probe on",https://www.financialexpress.com/business/healthcare-after-gambia-18-children-in-uzbekistan-die-allegedly-due-to-india-made-syrup-probe-on-2930317/,2022-12-29T12:07:33+05:30,2022-12-29T06:37:33,-0.5574
How Genomics will ensure a risk-free and beneficial treatment for good health and well-being,https://www.financialexpress.com/business/healthcare-how-genomics-will-ensure-a-risk-free-and-beneficial-treatment-for-good-health-and-well-being-2929561/,2022-12-29T08:00:00+05:30,2022-12-29T02:30:00,0.8126
Use of active pharmaceuticals in industrial processes,https://www.financialexpress.com/business/healthcare-use-of-active-pharmaceuticals-in-industrial-processes-2928629/,2022-12-28T11:00:00+05:30,2022-12-28T05:30:00,0.4019
"Rewind 2022: Innovative research, slew of crucial FDA approvals and new strides in genetic therapies became pivotal moments",https://www.financialexpress.com/business/healthcare-rewind-2022-innovative-research-slew-of-crucial-fda-approvals-and-new-strides-in-genetic-therapies-became-pivotal-moments-2928131/,2022-12-27T16:07:26+05:30,2022-12-27T10:37:26,0.4404
Pharma companies are launching generics of Sitagliptin post-patent expiry; Can this make diabetic care affordable?,https://www.financialexpress.com/business/healthcare-pharma-companies-are-launching-generics-of-sitagliptin-post-patent-expiry-can-this-make-diabetic-care-affordable-2927237/,2022-12-26T19:43:19+05:30,2022-12-26T14:13:19,0.4939
Lack of generic options for anti-cancer drugs increasing patients’ economic burden in India,https://www.financialexpress.com/business/healthcare-lack-of-generic-options-for-anti-cancer-drugs-increasing-patients-economic-burden-in-india-2926522/,2022-12-26T19:17:38+05:30,2022-12-26T13:47:38,-0.6369
"As Covid surges in China and other countries, will there be a shortage of paracetamol?",https://www.financialexpress.com/business/healthcare-as-covid-surges-in-china-and-other-countries-will-there-be-a-shortage-of-paracetamol-2924253/,2022-12-23T12:08:29+05:30,2022-12-23T06:38:29,-0.25
Bharat Biotech’s intranasal COVID-19 vaccine gets approved; To be available as booster dose soon,https://www.financialexpress.com/business/healthcare-bharat-biotechs-intranasal-covid-19-vaccine-gets-approved-to-be-available-as-booster-dose-soon-2924232/,2022-12-23T11:46:26+05:30,2022-12-23T06:16:26,0.4215
"Amid global uptick in COVID-19 cases, pharma industry’s supply chain may take a hit",https://www.financialexpress.com/business/healthcare-amid-global-uptick-in-covid-19-cases-pharma-industrys-supply-chain-may-take-a-hit-2923591/,2022-12-22T17:51:39+05:30,2022-12-22T12:21:39,0.0
USFDA gives final nod to Lupin’s seizure tablets,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-lupins-seizure-tablets-2921741/,2022-12-21T14:01:23+05:30,2022-12-21T08:31:23,0.0
"Pharma, Diagnostics stocks rally amid renewed Covid fears; Dr Lal PathLabs, Cipla shares jump up to 6%",https://www.financialexpress.com/market/pharma-diagnostics-stocks-rally-amid-renewed-covid-fears-dr-lal-pathlabs-cipla-shares-jump-up-to-6-2921684/,2022-12-21T13:36:46+05:30,2022-12-21T08:06:46,-0.1531
Mankind Pharma forays into pet-care segment; Launches dog food,https://www.financialexpress.com/business/healthcare-mankind-pharma-forays-into-pet-care-segment-launches-dog-food-2921570/,2022-12-21T12:09:52+05:30,2022-12-21T06:39:52,0.0
Diabetic neuropathic pain field presents significant opportunity for drug developers: GlobalData,https://www.financialexpress.com/business/healthcare-diabetic-neuropathic-pain-field-presents-significant-opportunity-for-drug-developers-globaldata-2920749/,2022-12-20T16:37:07+05:30,2022-12-20T11:07:07,0.0772
AstraZeneca gets EU support for its heart drug; Lung cancer drug fails to achieve main goal in trial,https://www.financialexpress.com/business/healthcare-astrazeneca-gets-eu-support-for-its-heart-drug-lung-cancer-drug-fails-to-achieve-main-goal-2920727/,2022-12-20T16:21:59+05:30,2022-12-20T10:51:59,-0.6705
Dr. Reddy’s Labs’ biosimilar candidate for arthritis drug shows positive outcome in Phase I study,https://www.financialexpress.com/business/healthcare-dr-reddys-biosimilar-candidate-for-arthritis-drug-shows-positive-outcome-in-phase-i-study-2919243/,2022-12-19T13:38:23+05:30,2022-12-19T08:08:23,0.5574
Biosimilar: An alternative to reduce treatment costs as demand for chronic disease management rises,https://www.financialexpress.com/business/healthcare-biosimilar-an-alternative-to-reduce-treatment-costs-as-demand-for-chronic-disease-management-rises-2918646/,2022-12-18T20:41:24+05:30,2022-12-18T15:11:24,-0.128
Only if the truth could come in a pill,https://www.financialexpress.com/life/lifestyle-only-if-the-truth-could-come-in-a-pill-2917979/,2022-12-18T01:15:00+05:30,2022-12-17T19:45:00,0.3182
Dr. Reddy’s subsidiary Aurigene Oncology halts clinical trials of its psoriasis drug in US,https://www.financialexpress.com/business/healthcare-dr-reddys-subsidiary-aurigene-oncology-halts-clinical-trials-of-its-psoriasis-drug-in-us-2917036/,2022-12-16T15:41:50+05:30,2022-12-16T10:11:50,0.0
Pfizer launches assistance app for patients in India,https://www.financialexpress.com/business/healthcare-pfizer-launches-assistance-app-for-patients-in-india-2915993/,2022-12-16T14:20:26+05:30,2022-12-16T08:50:26,0.0
Small molecule approvals for rare diseases in China reach all-time highs this year: GlobalData,https://www.financialexpress.com/business/healthcare-small-molecule-approvals-for-rare-diseases-in-china-reach-all-time-highs-this-year-globaldata-2915569/,2022-12-16T12:10:13+05:30,2022-12-16T06:40:13,0.0258
"Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women’s health segment",https://www.financialexpress.com/business/healthcare-bharat-serums-and-vaccines-will-acquire-firstline-pharma-genomicks-to-enhance-its-presence-in-womens-health-segment-2914565/,2022-12-15T16:36:59+05:30,2022-12-15T11:06:59,0.0
AstraZeneca India appoints Dr. Sanjeev Panchal as Country President and Managing Director,https://www.financialexpress.com/business/healthcare-astrazeneca-india-appoints-dr-sanjeev-panchal-as-country-president-and-managing-director-2913610/,2022-12-14T21:24:57+05:30,2022-12-14T15:54:57,0.0
JB Pharma inks agreement with Glenmark to acquire statin franchise for Rs. 314 crores,https://www.financialexpress.com/business/healthcare-jb-pharma-inks-agreement-with-glenmark-to-acquire-statin-franchise-for-rs-314-crores-2913433/,2022-12-14T19:20:22+05:30,2022-12-14T13:50:22,0.4939
Takeda biopharmaceuticals launches new injectable drug for rare genetic disorder in India,https://www.financialexpress.com/business/healthcare-takeda-pharmaceuticals-launches-new-injectable-drug-for-rare-genetic-disorder-in-india-2911881/,2022-12-14T11:01:00+05:30,2022-12-14T05:31:00,-0.4019
"We have significant plans to introduce our global drugs and therapy pipeline in India: Gagandeep Singh, MD, AstraZeneca Pharma India",https://www.financialexpress.com/business/healthcare-we-have-significant-plans-to-introduce-our-global-drugs-and-therapy-pipeline-in-india-gagandeep-singh-md-astrazeneca-pharma-india-2910185/,2022-12-12T16:50:02+05:30,2022-12-12T11:20:02,0.2023
"Entod Pharmaceuticals expands its business portfolio; Enters into glaucoma, dermatology and ophthalmic surgical equipment segment",https://www.financialexpress.com/business/healthcare-entod-pharmaceuticals-expands-its-business-portfolio-enters-into-glaucoma-dermatology-and-ophthalmic-surgical-equipment-segment-2909713/,2022-12-12T13:09:37+05:30,2022-12-12T07:39:37,0.1027
Lupin appoints Spiro Gavaris as President of U.S. Generics business,https://www.financialexpress.com/business/healthcare-lupin-appoints-spiro-gavaris-as-president-of-u-s-generics-business-2907794/,2022-12-09T17:05:41+05:30,2022-12-09T11:35:41,0.0
Lupin launches generic version of Horizon Pharma’s anti-inflammatory drug in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-generic-version-of-horizon-pharmas-anti-inflammatory-drug-in-united-states-2907585/,2022-12-09T15:16:09+05:30,2022-12-09T09:46:09,0.4215
Novartis’ investigational drug shows positive outcomes in patients with rare blood disorder,https://www.financialexpress.com/business/healthcare-novartis-investigational-drug-shows-positive-outcomes-in-patients-with-rare-blood-disorder-2905916/,2022-12-08T13:12:03+05:30,2022-12-08T07:42:03,0.2263
"GSK, Pfizer, Sanofi get relief after court found claims of Zantac-linked cancer not ‘backed by science’",https://www.financialexpress.com/business/healthcare-gsk-pfizer-sanofi-get-relief-after-court-found-claims-of-zantac-linked-cancer-not-backed-by-science-2904359/,2022-12-07T15:06:10+05:30,2022-12-07T09:36:10,-0.3182
An Overview of Emerging Technologies within the Pharmaceutical Industry,https://www.financialexpress.com/business/healthcare-an-overview-of-emerging-technologies-within-the-pharmaceutical-industry-2901360/,2022-12-06T09:00:00+05:30,2022-12-06T03:30:00,0.0
Global biopharma cos report over 9% Quarter-on-Quarter decline in market capitalisation during Q3: GlobalData,https://www.financialexpress.com/business/healthcare-global-biopharma-cos-report-over-9-quarter-on-quarter-decline-in-market-capitalisation-during-q3-globaldata-2901307/,2022-12-05T17:19:00+05:30,2022-12-05T11:49:00,0.0
Lupin launches anti-seizure tablets in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-anti-seizure-tablets-in-united-states-2901051/,2022-12-05T14:51:56+05:30,2022-12-05T09:21:56,0.4215
"Dr Reddy’s, Sun Pharma recall products due to manufacturing issues in United States",https://www.financialexpress.com/business/healthcare-dr-reddys-sun-pharma-recall-products-due-to-manufacturing-issues-in-united-states-2900772/,2022-12-05T11:22:59+05:30,2022-12-05T05:52:59,0.4215
"Indian pharmaceutical sector needs to focus on R&D and innovations: Yogesh Mudras, MD, Informa Markets in India",https://www.financialexpress.com/business/healthcare-indian-pharmaceutical-sector-needs-to-focus-on-rd-and-innovations-yogesh-mudras-md-informa-markets-2900409/,2022-12-04T20:38:31+05:30,2022-12-04T15:08:31,0.0
Roivant partners with Pfizer and launches new company for experimental bowel disease treatment,https://www.financialexpress.com/business/healthcare-roivant-partners-with-pfizer-launches-new-company-for-experimental-bowel-disease-treatment-2898857/,2022-12-02T14:26:46+05:30,2022-12-02T08:56:46,0.0
Akums partners with Leiutis and Biophore India to strengthen R&D in multiple therapies,https://www.financialexpress.com/business/healthcare-akums-partners-with-leiutis-and-biophore-india-to-strengthen-rd-in-multiple-therapies-2897955/,2022-12-01T16:21:58+05:30,2022-12-01T10:51:58,0.3182
Max Healthcare inks pact with Georgia’s Evex Hospitals to setup Bone Marrow Transplant programme,https://www.financialexpress.com/business/healthcare-max-healthcare-inks-pact-with-georgias-evex-hospitals-to-setup-bone-marrow-transplant-programme-2897805/,2022-12-01T15:50:03+05:30,2022-12-01T10:20:03,0.0
USFDA approves Alembic Pharmaceuticals’ arthritis drug,https://www.financialexpress.com/business/healthcare-usfda-gives-final-nod-to-alembic-pharmaceuticals-arthritis-drug-2897714/,2022-12-01T13:03:26+05:30,2022-12-01T07:33:26,0.4019
Freudenberg Medical launches new product at CPhI and PMEC India,https://www.financialexpress.com/business/healthcare-freudenberg-medical-launches-new-product-at-cphi-and-pmec-india-2897584/,2022-12-01T11:35:46+05:30,2022-12-01T06:05:46,0.0
Roche Pharma India launches patient support app to simplify treatment,https://www.financialexpress.com/business/healthcare-roche-pharma-india-launches-patient-support-app-to-simplify-treatment-2920434/,2022-11-29T14:30:00+05:30,2022-11-29T09:00:00,0.4019
Lupin launches nasal drug for breathing problems in United States,https://www.financialexpress.com/business/healthcare-lupin-launches-nasal-drug-for-breathing-problems-in-united-states-2895564/,2022-11-29T13:54:42+05:30,2022-11-29T08:24:42,0.0258
AstraZeneca’s anti-diabetic drug receives CDSCO approval for patients with chronic kidney disease and heart failure,https://www.financialexpress.com/business/healthcare-astrazenecas-anti-diabetic-drug-receives-cdsco-approval-for-patients-with-chronic-kidney-disease-and-heart-failure-2895511/,2022-11-29T13:16:03+05:30,2022-11-29T07:46:03,-0.0516
Cipla launches injection for advanced prostate cancer in United States,https://www.financialexpress.com/business/healthcare-cipla-launches-advanced-prostate-cancer-injection-in-united-states-2895333/,2022-11-29T11:08:28+05:30,2022-11-29T05:38:28,-0.1531
"Lupin’s Brazilian subsidiary, MedQuimica acquires rights to 9 brands from Bausch Health",https://www.financialexpress.com/business/healthcare-lupins-brazilian-subsidiary-medquimica-acquires-rights-to-9-brands-from-bausch-health-2894824/,2022-11-28T18:14:56+05:30,2022-11-28T12:44:56,0.0
USFDA declines to approve Spectrum Pharmaceuticals’ lung cancer drug,https://www.financialexpress.com/business/healthcare-usfda-declines-to-approve-spectrum-pharmaceuticals-lung-cancer-drug-2892258/,2022-11-25T18:30:47+05:30,2022-11-25T13:00:47,-0.6597
"Luye Pharma’s schizophrenia drug will create more options for disorder management, but faces a crowded market: GlobalData",https://www.financialexpress.com/business/healthcare-luye-pharmas-schizophrenia-drug-will-create-more-options-for-disorder-management-but-faces-a-crowded-market-globaldata-2891674/,2022-11-25T12:17:48+05:30,2022-11-25T06:47:48,-0.1108
Takeda’s Dengue vaccine candidate gets USFDA’s priority review,https://www.financialexpress.com/business/healthcare-takedas-dengue-vaccine-candidate-gets-usfdas-priority-review-2887421/,2022-11-23T16:30:00+05:30,2022-11-23T11:00:00,0.0
Lumos Pharma’s oral LUM-201 holds potential to improve compliance in pediatric hormone disorder: GlobalData,https://www.financialexpress.com/business/healthcare-lumos-pharmas-oral-lum-201-holds-potential-to-improve-compliance-in-pediatric-hormone-disorder-globaldata-2887005/,2022-11-23T12:37:39+05:30,2022-11-23T07:07:39,0.0516
Generic drugmakers Teva and Sandoz planning to ramp up biosimilars production,https://www.financialexpress.com/business/healthcare-generic-drugmakers-teva-and-sandoz-planning-to-ramp-up-biosimilars-production-2886107/,2022-11-22T20:54:40+05:30,2022-11-22T15:24:40,0.0
Glenmark Pharmaceuticals reaches settlement agreement with Pfizer for breast cancer tablets,https://www.financialexpress.com/business/healthcare-glenmark-pharmaceuticals-reaches-settlement-agreement-with-pfizer-for-breast-cancer-tablets-2885890/,2022-11-22T17:08:14+05:30,2022-11-22T11:38:14,-0.25
Pills or insulin: What is right for diabetes?,https://www.financialexpress.com/business/healthcare-pills-or-insulin-what-is-right-for-diabetes-2869286/,2022-11-22T11:00:00+05:30,2022-11-22T05:30:00,0.0
Major pharma cos may have to reveal government deals in WHO’s draft pandemic rules,https://www.financialexpress.com/business/healthcare-major-pharma-cos-may-have-to-reveal-government-deals-in-whos-draft-pandemic-rules-2842249/,2022-11-18T15:49:35+05:30,2022-11-18T10:19:35,0.0
Biocon’s net profit declines 10% to Rs 168 crore in Q2FY23; Revenue up 26%,https://www.financialexpress.com/business/healthcare-biocons-net-profit-declines-10-to-rs-168-crore-in-q2fy23-revenue-up-26-2812769/,2022-11-14T22:44:08+05:30,2022-11-14T17:14:08,0.4404
The front of pack labelling draft regulation is not a healthy affair at all for consumers,https://www.financialexpress.com/business/healthcare-the-front-of-pack-labelling-draft-regulation-is-not-a-healthy-affair-at-all-for-consumers-2806339/,2022-11-12T15:00:00+05:30,2022-11-12T09:30:00,-0.3089
Novo Nordisk likely to maintain lead against competitor Eli Lilly in global type 2 diabetes market: GlobalData,https://www.financialexpress.com/business/healthcare-novo-nordisk-likely-to-maintain-lead-against-competitor-eli-lilly-in-global-t2d-market-globaldata-2805627/,2022-11-11T11:29:34+05:30,2022-11-11T05:59:34,0.0
AstraZeneca India collaborates with 4baseCare to enhance access to genomic testing for cancer patients,https://www.financialexpress.com/business/healthcare-astrazeneca-india-collaborates-with-4basecare-to-enhance-access-to-genomic-testing-for-cancer-patients-2797165/,2022-11-09T16:06:44+05:30,2022-11-09T10:36:44,-0.6597
Indonesia suspends licenses of 2 more drugs companies over child deaths,https://www.financialexpress.com/business/healthcare-indonesia-suspends-licenses-of-2-more-drugs-companies-over-child-deaths-2797076/,2022-11-09T15:40:12+05:30,2022-11-09T10:10:12,0.0
New pharma entrants can alter aHUS digital landscape in Japan: GlobalData,https://www.financialexpress.com/business/healthcare-new-pharma-entrants-can-alter-ahus-digital-landscape-in-japan-globaldata-2795449/,2022-11-09T11:39:21+05:30,2022-11-09T06:09:21,0.0
Piramal Pharma reports y-o-y loss in Q2FY23; Records after-tax losses of Rs 37.3 crore,https://www.financialexpress.com/business/healthcare-piramal-pharma-reports-y-o-y-loss-in-q2fy23-company-witnesses-after-tax-losses-of-rs-37-3-crore-2795386/,2022-11-09T11:09:51+05:30,2022-11-09T05:39:51,-0.6124
USFDA tentatively approves Lupin’s anti-bacterial infection capsules,https://www.financialexpress.com/business/healthcare-usfda-tentatively-approves-lupins-anti-bacterial-infection-capsules-2790009/,2022-11-08T15:33:04+05:30,2022-11-08T10:03:04,0.4019
Novartis’ bad cholesterol drug shows ‘sustained’ efficacy and safety among cardiac patients,https://www.financialexpress.com/business/healthcare-novartis-bad-cholesterol-drug-shows-sustained-efficacy-and-safety-among-cardiac-patients-2787571/,2022-11-08T11:28:53+05:30,2022-11-08T05:58:53,-0.1779
Sandoz to support increased global demand for essential antibiotics; Announces additional investment in manufacturing facility in Austria,https://www.financialexpress.com/business/healthcare-sandoz-to-support-increased-global-demand-for-essential-antibiotics-announces-additional-investment-in-manufacturing-facility-in-austria-2782181/,2022-11-07T16:45:40+05:30,2022-11-07T11:15:40,0.5106
Balaxi Pharmaceuticals consolidated net profit rises over 28 percent in Q2FY23,https://www.financialexpress.com/business/healthcare-balaxi-pharmaceuticals-consolidated-net-profit-rises-over-28-percent-in-q2fy23-2780686/,2022-11-07T12:26:03+05:30,2022-11-07T06:56:03,0.4404
USFDA tentatively approves Lupin’s birth control tablets,https://www.financialexpress.com/business/healthcare-usfda-tentatively-approves-lupins-birth-control-tablets-2780410/,2022-11-07T12:08:25+05:30,2022-11-07T06:38:25,0.4019
Summer sun getting under your skin? Help is at hand,https://www.financialexpress.com/life/summer-sun-getting-under-your-skin-help-is-at-hand-3823485/,2025-04-26T20:36:02+05:30,2025-04-26T15:06:02,0.7096
Perihelion Day 2024: Earth is closest to the Sun today! Find out all about this cosmic phenomenon,https://www.financialexpress.com/life/science-perihelion-day-2024-earth-is-closest-to-the-sun-today-find-out-all-about-this-cosmic-phenomenon-bkg-3354159/,2024-01-03T14:18:55+05:30,2024-01-03T08:48:55,0.0
Surya Grahan 2023 | Rare Hybrid Solar Eclipse on April 20: Here is all you need to know about this phenomenon,https://www.financialexpress.com/life/science-rare-hybrid-solar-eclipse-on-april-20-here-is-all-you-need-to-know-about-thisnbspphenomenon-3052183/,2023-04-18T15:28:33+05:30,2023-04-18T09:58:33,0.0
Demand for bigger sunroofs with new features to grow significantly in India,https://www.financialexpress.com/auto/car-news/demand-for-bigger-sunroofs-with-new-features-to-grow-significantly-in-india/2995344/,2023-03-02T16:01:26+05:30,2023-03-02T10:31:26,-0.128
"Mysteries of Sun: ISRO’s Chandrayaan 2 mission provides key insights into solar coronal heating, FIP bias",https://www.financialexpress.com/life/science-mysteries-of-sun-isros-chandrayaan-2-mission-provides-key-insights-into-solar-coronal-heating-fip-bias-2277205/,2021-06-23T21:26:05+05:30,2021-06-23T15:56:05,-0.1027
Solar Missions: NASA approves 2 new missions to explore system between Sun and Earth; details,https://www.financialexpress.com/life/science-solar-missions-nasa-approves-2-new-missions-to-explore-system-between-sun-and-earth-details-2160718/,2020-12-30T15:02:14+05:30,2020-12-30T09:32:14,0.4019
"Trump drug price order: Nomura says Sun Pharma may be hit hardest, uncertainty looms ahead",https://www.financialexpress.com/business/industry-trump-drug-price-order-nomura-says-sun-pharma-may-be-hit-hardest-uncertainty-looms-ahead-3842967/,2025-05-13T18:56:56+05:30,2025-05-13T13:26:56,-0.4588
"Nifty, Sensex end flat and Defence stocks rally as India launches Operation Sindoor; Tata Motors top Index gainer",https://www.financialexpress.com/market/nifty-sensex-end-flat-and-defence-stocks-rally-as-india-launches-operation-sindoor-tata-motors-top-index-gainer-3836017/,2025-05-07T15:46:34+05:30,2025-05-07T10:16:34,0.5994
"Markets open flat, Nifty, Sensex in green even as Tariff worries continue; Auto, pharma under pressure, Gensol slides 5%",https://www.financialexpress.com/market/markets-flat-nifty-below-233000-auto-pharma-under-pressure-gensol-slides-5-3810863/,2025-04-16T09:28:05+05:30,2025-04-16T03:58:05,-0.3182
Trump tariff impact: Pharma stocks surge over 4% on tariff exemption,https://www.financialexpress.com/market/trump-tariff-impact-pharma-stocks-surge-over-4-on-tariff-exemption-3797271/,2025-04-03T10:45:07+05:30,2025-04-03T05:15:07,0.0
"Markets end flat but Nifty closes below 22,500; IndusInd Bank sees biggest single-day fall, plunges 27%",https://www.financialexpress.com/market/markets-end-flat-but-nifty-closes-below-22500-indusind-bank-sees-biggest-single-day-fall-plunges-27-3774450/,2025-03-11T15:52:11+05:30,2025-03-11T10:22:11,0.5499
Sun Pharma surges 3%. 3 reasons why Motilal Oswal has ‘Buy’ rating,https://www.financialexpress.com/market/sun-pharma-surges-3-3-reasons-why-motilal-oswal-has-buy-rating-3774303/,2025-03-11T13:47:53+05:30,2025-03-11T08:17:53,0.0
Stocks To Watch: From Godrej Consumer to IndusInd Bank- Here’s a list of 7 stocks in news today,https://www.financialexpress.com/market/stocks-to-watch-godrej-consumer-products-indusind-bank-vodafone-idea-syngene-international-sun-pharmaceutical-icici-securities-adani-energy-solutions-3773850/,2025-03-11T07:27:08+05:30,2025-03-11T01:57:08,0.0
Sun Pharma to acquire Checkpoint Therapeutics to strengthen global onco-derma franchise,https://www.financialexpress.com/business/healthcare-sun-pharma-to-acquire-checkpoint-therapeutics-to-strengthen-global-onco-derma-franchise-3772815/,2025-03-10T10:43:06+05:30,2025-03-10T05:13:06,0.3182
Sun Pharma shares slip over 3% after US court’s ruling on LEQSELVI launch,https://www.financialexpress.com/market/sun-pharma-shares-in-focus-after-us-courts-ruling-on-leqselvitm-launch-3655713/,2024-11-04T11:18:00+05:30,2024-11-04T05:48:00,0.296
Sun Pharma to invest upto $15 million for 5% stake in US-based Pharmazz,https://www.financialexpress.com/business/healthcare-sun-pharma-to-invest-upto-15-million-for-5-stake-in-us-based-pharmazz-3583132/,2024-08-14T19:01:10+05:30,2024-08-14T13:31:10,0.0
"Sun Pharma Q1 Results: Net profit up 40% on higher sales, completes acquisition on outstanding Taro shares",https://www.financialexpress.com/business/industry/sun-pharma-q1-results-net-profit-at-40-2-year-on-year/3571293/,2024-08-01T18:50:01+05:30,2024-08-01T13:20:01,0.8442
Sun Pharma gets USFDA nod for its formulation to treat Severe Alopecia Areata,https://www.financialexpress.com/business/healthcare-sun-pharma-gets-usfda-nod-for-its-formulation-to-treat-severe-alopecia-areata-3565976/,2024-07-26T17:14:55+05:30,2024-07-26T11:44:55,0.0258
Sun Pharma completes Taro merger to make it a wholly-owned private company,https://www.financialexpress.com/business/healthcare-sun-pharma-completes-taro-merger-to-make-it-a-wholly-owned-private-company-3533494/,2024-06-24T17:20:41+05:30,2024-06-24T11:50:41,0.0
"Sun Pharma Q4 Results: Profit rises by 33.8% to Rs 2654.58 crore, dividend of Rs 5 announced",https://www.financialexpress.com/business/industry-sun-pharma-q4-results-profit-rises-by-33-8-to-rs-265458-crore-dividend-of-rs-5-announced-3497484/,2024-05-22T15:34:29+05:30,2024-05-22T10:04:29,0.4404
Sun Pharma gets regulatory nod in Australia for acne treatment cream,https://www.financialexpress.com/business/healthcare-sun-pharma-gets-regulatory-nod-in-australia-for-acne-treatment-cream-3429679/,2024-03-19T11:16:21+05:30,2024-03-19T05:46:21,0.0
"Sun Pharma to acquire remaining 21.52% shares of Taro for Rs 2,891.76 crore",https://www.financialexpress.com/business/industry-sun-pharma-to-acquire-remaining-21-52-shares-of-taro-for-rs-289176-crore-3368067/,2024-01-18T13:47:48+05:30,2024-01-18T08:17:48,0.296
"Who is Indian billionaire Dilip Sanghvi, the man behind Sun Pharma? Know about his Rs 15.65 lakh crore net worth",https://www.financialexpress.com/life/lifestyle-who-is-indian-billionaire-dilip-sanghvi-the-man-behind-sun-pharma-know-about-his-rs-15-65-lakh-crore-net-worth-3340397/,2023-12-21T00:37:57+05:30,2023-12-20T19:07:57,0.2263
"Sun Pharma’s shares advance on Q2 results; Should you buy, hold or sell the stock?",https://www.financialexpress.com/market/sun-pharmas-shares-advance-on-q2-results-should-you-buy-hold-or-sell-the-stock-3294739/,2023-11-02T11:28:15+05:30,2023-11-02T05:58:15,0.296
Sun Pharma and Zydus sign licensing agreement to co-market critical drug for Chronic Kidney Disease patients in India,https://www.financialexpress.com/business/healthcare-sun-pharma-and-zydus-sign-licensing-agreement-to-co-market-critical-drug-for-chronic-kidney-disease-patients-in-india-3291109/,2023-10-30T13:23:20+05:30,2023-10-30T07:53:20,0.2263
Sun Pharma and Philogen’s melanoma drug shows promising outcome in Phase 3 trial,https://www.financialexpress.com/business/healthcare-sun-pharma-and-philogens-melanoma-drug-shows-promising-outcome-in-phase-3-trial-3274444/,2023-10-16T17:20:05+05:30,2023-10-16T11:50:05,0.4019
Sun Pharma launches novel topical treatment for acne in Canada,https://www.financialexpress.com/business/healthcare-sun-pharma-launches-novel-topical-treatment-for-acne-in-canada-3256390/,2023-09-27T14:28:06+05:30,2023-09-27T08:58:06,0.3182
"Generic and biosimilar products are still out of reach for many patients in LMICs, reveals new report",https://www.financialexpress.com/business/healthcare-major-generic-biosimilar-makers-need-to-step-up-to-improve-access-to-their-products-in-lmics-reveals-new-report-3255366/,2023-09-26T15:06:52+05:30,2023-09-26T09:36:52,0.0258
Sun Pharma proposes to fully acquire Israel-based Taro Pharmaceutical Industries,https://www.financialexpress.com/business/industry-sun-pharma-proposes-to-fully-acquire-israel-based-taro-pharmaceutical-industries-3104247/,2023-05-27T17:50:06+05:30,2023-05-27T12:20:06,0.0
"Sun Pharma posts Q4FY23 profit at Rs 1,984.47 crore, revenue up 15.7% on-year; dividend declared",https://www.financialexpress.com/business/industry-sun-pharma-posts-q4fy23-profit-at-rs-1984-47-crore-revenue-up-157-on-year-dividend-declared-3103185/,2023-05-26T15:27:55+05:30,2023-05-26T09:57:55,0.4404
"Meet Padma Shri Dilip Shanghvi, a visionary who transformed Indian healthcare industry: Know about his journey, education, net worth and more",https://www.financialexpress.com/life/lifestyle-meet-padma-shri-dilip-shanghvi-a-visionary-who-transformed-indian-healthcare-industry-know-about-his-journey-education-net-worth-and-more-3062982/,2023-04-29T09:00:00+05:30,2023-04-29T03:30:00,0.6486
Sun Pharma: Speciality pipeline gets a boost,https://www.financialexpress.com/market/sun-pharma-speciality-pipeline-gets-a-boost-2956734/,2023-01-23T02:30:00+05:30,2023-01-22T21:00:00,0.4019
"Reliance Industries, HUL, Sun Pharma, PVR, Asian Paints, TCS, Hindustan Zinc, LTTS, JSW Energy stocks in focus",https://www.financialexpress.com/market/stocks-to-watch-reliance-industries-hul-sun-pharma-pvr-asian-paints-tcs-hindustan-zinc-jsw-energy-stocks-in-focus-2954296/,2023-01-20T07:13:52+05:30,2023-01-20T01:43:52,0.2732
Sun Pharma acquires Concert for $576 million,https://www.financialexpress.com/business/industry-sun-pharma-acquires-concert-for-576-million-2954280/,2023-01-20T05:45:00+05:30,2023-01-20T00:15:00,0.0
USFDA pulls up Sun Pharma for lapses in Halol plant,https://www.financialexpress.com/business/healthcare-usfda-pulls-up-sun-pharma-for-lapses-in-halol-plant-2948198/,2023-01-14T14:58:20+05:30,2023-01-14T09:28:20,0.0
Sun Pharma’s Chairman Israel Makov to retire this month,https://www.financialexpress.com/business/healthcare-sun-pharmas-chairman-israel-makov-to-retire-this-month-2615612/,2022-08-03T11:23:05+05:30,2022-08-03T05:53:05,0.0
Sun Pharmaceuticals rating: Buy | Specialty sales boost prospects,https://www.financialexpress.com/market/sun-pharmaceuticals-rating-buy-specialty-sales-boost-prospects-2613926/,2022-08-02T01:30:00+05:30,2022-08-01T20:00:00,0.5994
"Sun Pharma stock falls 3.5% intraday; analysts bullish, see up to 20% upside potential; what should you do?",https://www.financialexpress.com/market/sun-pharma-stock-falls-3-5-intraday-analysts-bullish-see-up-to-20-upside-potential-what-should-you-do-2613424/,2022-08-01T15:06:37+05:30,2022-08-01T09:36:37,0.0
Sun Pharmaceuticals rating – Buy: One-offs hit bottomline in Q4FY22,https://www.financialexpress.com/market/sun-pharmaceuticals-rating-buy-one-offs-hit-bottomline-in-q4fy22-2549332/,2022-06-06T02:15:00+05:30,2022-06-05T20:45:00,0.0
Sun Pharma share price falls 2% after Q4 results fail to beat estimates; brokerages see up to 22% upside,https://www.financialexpress.com/market/sun-pharma-share-price-falls-2-after-q4-results-fail-to-beat-estimates-brokerages-see-up-to-22-upside-2543225/,2022-05-31T10:11:13+05:30,2022-05-31T04:41:13,-0.3182
"Sun Pharma reports Q4 net loss at Rs 2,277 cr",https://www.financialexpress.com/business/industry-sun-pharma-reports-q4-net-loss-at-rs-2277-cr-2542610/,2022-05-30T17:20:53+05:30,2022-05-30T11:50:53,-0.3182
Sun Pharma gets 10 observations for Halol plant from USFDA,https://www.financialexpress.com/business/industry-sun-pharma-gets-10-observations-for-halol-plant-from-usfda-2519475/,2022-05-11T05:50:00+05:30,2022-05-11T00:20:00,0.0
Sun Pharma gets 10 observations from USFDA for Halol plant,https://www.financialexpress.com/business/healthcare-sun-pharma-gets-10-observations-from-usfda-for-halol-plant-2518784/,2022-05-10T13:18:21+05:30,2022-05-10T07:48:21,0.0
"Sun Pharma, Titan among 143 stocks to hit new 52-week highs on BSE; Future Retail, Eureka Forbes at new lows",https://www.financialexpress.com/market/sun-pharma-titan-company-trent-vedanta-52-week-high-future-retail-lifestyle-hinduja-etf-bse-sensex-nse-21-ma-2022-2466529/,2022-03-21T12:55:31+05:30,2022-03-21T07:25:31,0.5267
Nifty finds crucial support at 16800 for this week; buy these two stocks for upside potential,https://www.financialexpress.com/market/cafeinvest-nifty-finds-crucial-support-at-16800-for-this-week-buy-these-two-stocks-for-upside-potential-2439171/,2022-02-21T08:48:59+05:30,2022-02-21T03:18:59,0.6597
"Nifty needs to hold above 17400 for upside; buy Hindalco, Sun Pharma stocks, charts show strength",https://www.financialexpress.com/market/cafeinvest-nifty-needs-to-hold-above-17400-for-upside-buy-hindalco-sun-pharma-stocks-charts-show-strength-2433104/,2022-02-14T09:15:46+05:30,2022-02-14T03:45:46,0.7096
Nifty needs to hold above 18181 for upside; check top stocks to buy,https://www.financialexpress.com/market/cafeinvest-nifty-needs-to-hold-above-18181-for-upside-check-top-stocks-to-buy-2408336/,2022-01-17T11:35:14+05:30,2022-01-17T06:05:14,0.5423
Buy these two stocks for medium-term gains while Nifty remains in downtrend,https://www.financialexpress.com/market/cafeinvest-buy-these-two-stocks-for-medium-term-gains-while-nifty-remains-in-downtrend-2381180/,2021-12-16T09:04:52+05:30,2021-12-16T03:34:52,0.6249
"Titan, Power Grid, SBI among 347 stocks to hit 52-week highs on BSE; 19 shares hit 52-week lows",https://www.financialexpress.com/market/52-week-high-52-week-low-stocks-bse-nse-sensex-nifty-stock-markets-13-oct-2021-wednesday-titan-power-grid-sbi-tata-motors-tata-power-dmart-2349231/,2021-10-13T14:33:23+05:30,2021-10-13T09:03:23,0.1027
Sun Pharma forays into nutrition bar segment with launch of Revital NXT,https://www.financialexpress.com/business/industry-sun-pharma-forays-into-nutrition-bar-segment-with-launch-of-revital-nxt-2326482/,2021-09-08T16:32:50+05:30,2021-09-08T11:02:50,0.0
No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma,https://www.financialexpress.com/business/industry-no-plans-to-get-into-vaccine-production-as-it-requires-separate-manufacturing-infra-sun-pharma-2270501/,2021-06-13T14:06:16+05:30,2021-06-13T08:36:16,-0.296
"If Nifty continues to trade below 15,600, it may touch 15,510; HCL Tech, Sun Pharma look strong on charts",https://www.financialexpress.com/market/cafeinvest-if-nifty-continues-to-trade-below-15600-it-may-touch-15510-hcl-tech-sun-pharma-look-strong-on-charts-2263391/,2021-06-02T08:56:47+05:30,2021-06-02T03:26:47,0.7184
Sun Pharmaceuticals rating – Buy: One-offs impacted the bottomline in Q4,https://www.financialexpress.com/market/sun-pharmaceuticals-rating-buy-one-offs-impacted-the-bottomline-in-q4-2262575/,2021-06-01T02:15:11+05:30,2021-05-31T20:45:11,0.0
Sun Pharma Q4 net profit zooms over twofold to Rs 894.15 crore,https://www.financialexpress.com/business/industry-sun-pharma-q4-net-profit-zooms-over-twofold-to-rs-894-15-crore-2260288/,2021-05-27T19:25:18+05:30,2021-05-27T13:55:18,0.4404
"TCS, ICICI Bank, other must-have stocks: Time to rejig investment portfolio post Budget 2021? INTERVIEW",https://www.financialexpress.com/market/cafeinvest-tcs-icici-bank-other-must-have-stocks-time-to-rejig-investment-portfolio-post-budget-2021-interview-2192547/,2021-02-11T12:28:14+05:30,2021-02-11T06:58:14,0.0
"Stocks to buy ahead of Budget 2021: IRCTC, HUL, Maruti, HCL Tech, more; these sectors to be in focus",https://www.financialexpress.com/budget/stocks-to-buy-ahead-of-budget-2021-irctc-hul-maruti-hcl-tech-more-these-sectors-to-be-in-focus-2177357/,2021-01-25T16:41:15+05:30,2021-01-25T11:11:15,0.0
BSE Healthcare index doubles from March lows on COVID vaccine hopes; 3 healthcare stocks look set to gain,https://www.financialexpress.com/market/bse-healthcare-index-doubles-from-march-lows-on-covid-vaccine-hopes-3-healthcare-stocks-look-set-to-gain-2150394/,2020-12-15T15:20:09+05:30,2020-12-15T09:50:09,0.6597
Sun Pharma share price rallies 62% from March lows; should you buy the stock? Check target prices,https://www.financialexpress.com/market/sun-pharma-share-price-rallies-62-from-march-lows-should-you-buy-the-stock-check-target-prices/1989391/,2020-06-12T12:52:07+05:30,2020-06-12T07:22:07,0.1027
Sun Pharma launches novel therapy for skin disorders in India,https://www.financialexpress.com/business/healthcare-sun-pharma-launches-novel-therapy-for-skin-disorders-3590682/,2024-08-23T15:06:44+05:30,2024-08-23T09:36:44,0.3182
From Isha Ambani and Ananya Birla to Karan Adani and Jyoti Kabra: Meet 16 heirs of India’s billionaire families,https://www.financialexpress.com/life/lifestyle-from-isha-ambani-and-ananya-birla-to-karan-adani-and-jyoti-kabra-meet-16-heirs-of-indias-billionaire-families-3516661/,2024-06-24T13:21:28+05:30,2024-06-24T07:51:28,0.0
"Nifty could fall to 14592 in coming weeks; sell these two stocks to pocket gains, charts show downtrend",https://www.financialexpress.com/market/cafeinvest-nifty-could-fall-to-14592-in-coming-weeks-sell-these-two-stocks-to-pocket-gains-charts-show-downtrend-2569987/,2022-06-23T09:07:55+05:30,2022-06-23T03:37:55,0.6249
"HDFC, Sun Pharma, HUL among top technical stocks to buy; Nifty support at 17100-17250",https://www.financialexpress.com/market/cafeinvest-hdfc-sun-pharma-hul-among-top-technical-stocks-to-buy-nifty-support-at-17100-17250-2475693/,2022-03-30T08:52:05+05:30,2022-03-30T03:22:05,0.7351
"52 week high, 52-week low: Sun Pharma, Dhampur, Cipla among 106 stocks to hit new highs on BSE; 26 at new lows",https://www.financialexpress.com/market/sun-pharma-dhampur-cipla-fresh-52-week-high-bse-go-fashion-paytm-jubilant-foodworks-at-new-lows-2460258/,2022-03-14T14:32:52+05:30,2022-03-14T09:02:52,-0.4404
"Infosys, TCS, Sun Pharma, IndiGo, Dish TV, Spicejet, ONGC, Indian Oil stocks in focus",https://www.financialexpress.com/market/infosys-tcs-sun-pharma-indigo-dish-tv-spicejet-ongc-indian-oil-stocks-in-focus-2454823/,2022-03-09T08:03:59+05:30,2022-03-09T02:33:59,0.0
"Infosys, Mahindra & Mahindra, Sun Pharma, Eicher Motors, IPCA Lab, UCO Bank stocks in focus",https://www.financialexpress.com/market/infosys-mahindra-and-mahindra-sun-pharma-eicher-motors-ipca-lab-central-bank-of-india-uco-bank-stocks-in-focus-2260510/,2021-05-28T08:36:34+05:30,2021-05-28T03:06:34,0.0
"Eicher Motors, Sun Pharma, Cadila, TCS, BPCL, Burger King, Pfizer, PNB Housing stocks in focus",https://www.financialexpress.com/market/eicher-motors-sun-pharma-cadila-tcs-bpcl-burger-king-pfizer-pnb-housing-stocks-in-focus-2259798/,2021-05-27T08:37:48+05:30,2021-05-27T03:07:48,0.0
"Nifty may hit 15,000, if it holds 14,700; Bank Nifty looks positive on charts; buy TCS, Wipro, among others",https://www.financialexpress.com/market/cafeinvest-nifty-may-hit-15000-if-it-holds-14700-bank-nifty-looks-positive-on-charts-buy-tcs-wipro-among-others-2244713/,2021-05-03T08:18:38+05:30,2021-05-03T02:48:38,0.8402
"Sun Pharma, Jindal Steel among top stocks to buy, sell; intraday chart suggests Nifty may fall up to 14,130",https://www.financialexpress.com/market/cafeinvest-sun-pharma-jindal-steel-among-top-stocks-to-buy-sell-intraday-chart-suggests-nifty-may-fall-up-to-14130-2237160/,2021-04-21T09:48:25+05:30,2021-04-21T04:18:25,0.5423
"Stocks to buy: HDFC Bank, HCL Tech look strong on charts; Nifty may hit 15,050 if Bank Nifty performs well",https://www.financialexpress.com/market/cafeinvest-stocks-to-buy-hdfc-bank-hcl-tech-look-strong-on-charts-nifty-may-hit-15050-if-bank-nifty-performs-well-2223671/,2021-03-31T08:51:10+05:30,2021-03-31T03:21:10,0.8689
"Stocks in focus today: HDFC, RIL, L&T, JSPL, Sun Pharma, Yes Bank, Adani Enterprises, Jubilant FoodWorks",https://www.financialexpress.com/market/hdfc-reliance-industries-ril-yes-bank-adani-enterprises-pi-industries-jubilant-foodworks-amfi-sun-pharma-jspl-jindal-steel-and-power-larsen-and-toubro-stocks-in-focus-2164348/,2021-01-05T08:17:28+05:30,2021-01-05T02:47:28,0.7717
"From TCS, Infosys, Bharti Hexacom to Tata Steel – Here are 8 stocks to watch",https://www.financialexpress.com/market/stocks-to-watch-tata-consultancy-services-nbcc-bharti-hexacom-infosys-tata-steel-bhel-coromandel-international-sun-pharma-3806028/,2025-04-11T07:13:34+05:30,2025-04-11T01:43:34,0.0
Motilal Oswal’s top 3 Buy recommendations at this hour,https://www.financialexpress.com/market/motilal-oswals-top-3-buy-recommendations-at-this-hour-3774506/,2025-03-11T16:37:41+05:30,2025-03-11T11:07:41,0.2023
Sun Pharma and Pharmazz Inc. enter into licensing agreement for introducing ischemic stroke drug in India,https://www.financialexpress.com/business/healthcare-sun-pharma-and-pharmazz-inc-enter-into-licensing-agreement-for-introducing-ischemic-stroke-drug-in-india-3243466/,2023-09-14T13:30:24+05:30,2023-09-14T08:00:24,0.4939
"Diwali 2021 technical stock picks: Buy Infosys, Sun Pharma, others in Samvat 2078; charts show up to 35% rally",https://www.financialexpress.com/market/diwali-2021-technical-stock-picks-buy-infosys-sun-pharma-others-in-samvat-2078-charts-show-up-to-35-rally-2357847/,2021-10-27T15:15:08+05:30,2021-10-27T09:45:08,0.0
"Stocks to buy: Nifty resistance at 17800-17850; charts show Sun Pharma, Britannia, others may rally",https://www.financialexpress.com/market/cafeinvest-stocks-to-buy-nifty-resistance-at-17800-17850-charts-show-sun-pharma-britannia-others-may-rally-2339979/,2021-09-29T09:06:08+05:30,2021-09-29T03:36:08,0.4019
"If Nifty trades above 15,870, it may rally up to 16,150; ICICI Bank, SBI Life among 4 technical stocks to buy",https://www.financialexpress.com/market/cafeinvest-if-nifty-trades-above-15870-it-may-rally-up-to-16150-icici-bank-sbi-life-among-4-technical-stocks-to-buy-2285312/,2021-07-07T08:32:18+05:30,2021-07-07T03:02:18,0.4019
Cipla share price hits record high on DCGI nod to import Moderna vaccine to treat COVID-19; may rally 12% more,https://www.financialexpress.com/market/cipla-share-price-hits-record-high-on-dcgi-nod-to-import-moderna-vaccine-to-treat-covid-19-may-rally-12-more-2281026/,2021-06-30T18:47:13+05:30,2021-06-30T13:17:13,0.5994
"Nifty may hit 15,700, Sensex seen at 52,000 in 2021; Sanjiv Bhasin tells top stocks to buy | IIFL INTERVIEW",https://www.financialexpress.com/market/cafeinvest-nifty-may-hit-15700-sensex-seen-at-52000-in-2021-sanjiv-bhasin-tells-top-stocks-to-buy-iifl-interview-2163656/,2021-01-04T11:31:24+05:30,2021-01-04T06:01:24,0.5423
Sun Pharma share price jumps 4.2%; $400 million outgo turns out to be company’s gain,https://www.financialexpress.com/market/sun-pharma-share-price-jumps-4-2-400-million-outgo-turns-out-to-be-companys-gain-2033734/,2020-07-24T12:04:09+05:30,2020-07-24T06:34:09,0.6808
Pharma earnings to reflect full COVID-19 impact in Apr-Jun quarter; 4 pharma stocks to gain up to 16%,https://www.financialexpress.com/market/pharma-earnings-to-reflect-full-covid-19-impact-in-apr-jun-quarter-pharma-stocks-to-gain-up-to-16-pc/2016031/,2020-07-07T15:38:47+05:30,2020-07-07T10:08:47,0.5267
Sun TV Network posts Rs 4282.10 crore in revenue from operations in FY24 while net profit stood at Rs 1925.8 crore,https://www.financialexpress.com/business/brandwagon-sun-tv-network-posts-rs-4282-10-crore-in-revenue-from-operations-in-fy24-while-net-profit-stood-at-rs-19258-crore-3500596/,2024-05-24T17:51:35+05:30,2024-05-24T12:21:35,0.4404
Buy these two stocks for gains; Nifty may stage sharp bounce back from the current levels,https://www.financialexpress.com/market/buy-these-two-stocks-for-gains-nifty-may-stage-sharp-bounce-back-from-the-current-levels-2566234/,2022-06-20T09:06:59+05:30,2022-06-20T03:36:59,0.6249
"Nifty to face resistance at 15,850 and 15,925; charts suggest momentum in these two stocks",https://www.financialexpress.com/market/cafeinvest-nifty-to-face-resistance-at-15850-and-15925-charts-suggest-momentum-in-these-two-stocks-2302212/,2021-08-02T08:52:41+05:30,2021-08-02T03:22:41,0.4019
Sun TV Network rating – Neutral: Results were largely in line with estimates,https://www.financialexpress.com/market/sun-tv-network-rating-neutral-results-were-largely-in-line-with-estimates-2274216/,2021-06-19T02:30:32+05:30,2021-06-18T21:00:32,0.0
"Market Watchlist: Nifty eyes 25,000. 9 stocks to track for reversals",https://www.financialexpress.com/market/stock-insights-market-watchlist-nifty-eyes-25000-9-stocks-to-track-for-reversals-3832523/,2025-05-05T05:30:00+05:30,2025-05-05T00:00:00,0.4019
Its official: Suven Pharma and Cohance Lifesciences merger to take effect from May 1,https://www.financialexpress.com/business/industry-its-official-suven-pharma-and-cohance-lifesciences-merger-to-take-effect-from-may-1-3822585/,2025-04-25T19:23:27+05:30,2025-04-25T13:53:27,0.0
Nuvama’s top Buy recommendations at this hour,https://www.financialexpress.com/market/nuvamas-top-pick-at-this-hour-3853224/,2025-05-22T10:05:43+05:30,2025-05-22T04:35:43,0.2023
"Torrent Pharmaceuticals posts Q2 profit at Rs 386 crore, aided by growth in India, globally",https://www.financialexpress.com/business/industry-torrent-pharmaceuticals-posts-q2-profit-at-rs-386-crore-aided-by-growth-in-india-globally-3284993/,2023-10-24T10:17:06+05:30,2023-10-24T04:47:06,0.6705
Torrent in talks with Apollo to borrow up to $1 billion for Cipla bid: Report,https://www.financialexpress.com/business/healthcare-torrent-in-talks-with-apollo-to-borrow-up-to-1-billion-for-cipla-bid-3248460/,2023-09-19T15:07:14+05:30,2023-09-19T09:37:14,0.0
Torrent Pharma shares sink 4% as reports suggest co is likely to acquire controlling stake in Cipla,https://www.financialexpress.com/market/torrent-pharma-shares-sink-4-as-reports-suggest-co-is-likely-to-acquire-controlling-stake-in-cipla-3229803/,2023-09-01T13:38:19+05:30,2023-09-01T08:08:19,0.296
"Torrent Pharma posts Q4FY23 profit at Rs 287 crore, revenue up 16.9%",https://www.financialexpress.com/business/industry-torrent-pharma-posts-q4fy23-profit-at-rs-287-crore-revenue-up-16-9-3107894/,2023-05-30T17:50:42+05:30,2023-05-30T12:20:42,0.4404
Torrent Pharma enters into consumer market to address calcium deficiency in India,https://www.financialexpress.com/business/healthcare-torrent-pharma-enters-into-consumer-market-to-address-calcium-deficiency-in-india-2981075/,2023-02-14T13:28:19+05:30,2023-02-14T07:58:19,0.0
Torrent Pharma announces Q2 results; Net profit declines marginally to Rs 312 crore,https://www.financialexpress.com/business/healthcare-torrent-pharma-announces-q2-results-net-profit-declines-marginally-to-rs-312-crore-2728484/,2022-10-21T21:29:45+05:30,2022-10-21T15:59:45,0.4404
Torrent Pharmaceuticals Rating: Buy | Deal could be marginally value accretive,https://www.financialexpress.com/market/torrent-pharmaceuticals-rating-buy-deal-could-be-marginally-value-accretive-2698118/,2022-10-03T01:15:00+05:30,2022-10-02T19:45:00,0.2748
"Reliance, HCL Tech, Dish TV, Torrent Pharma, Birla Corporation, IDBI Bank, Adani Group stocks in focus",https://www.financialexpress.com/market/stocks-to-watch-reliance-industries-ril-hcl-tech-dish-tv-torrent-pharma-birla-corporation-idbi-bank-adani-group-stocks-in-focus-today-2693348/,2022-09-28T06:59:57+05:30,2022-09-28T01:29:57,0.0
Torrent Pharma to acquire Curatio Healthcare,https://www.financialexpress.com/business/healthcare-torrent-pharma-to-acquire-curatio-healthcare-2692824/,2022-09-27T16:35:31+05:30,2022-09-27T11:05:31,0.0
Aman Mehta appointed as Director on Board of Torrent Pharma,https://www.financialexpress.com/business/healthcare-aman-mehta-appointed-as-director-on-board-of-torrent-pharma-2611110/,2022-07-29T19:59:14+05:30,2022-07-29T14:29:14,0.0
Torrent Pharma releases Q1 results; Net profit up 7 percent at Rs 354 crore,https://www.financialexpress.com/business/healthcare-torrent-pharma-releases-q1-results-net-profit-up-7-percent-at-rs-354-crore-2611095/,2022-07-29T19:48:47+05:30,2022-07-29T14:18:47,0.4404
"Stocks to buy: Charts suggest Tata Power, Torrent Pharma shares may soar higher, 18% upside seen",https://www.financialexpress.com/market/stocks-to-buy-charts-suggest-tata-power-torrent-pharma-shares-may-soar-higher-18-upside-seen-2584651/,2022-07-06T12:06:32+05:30,2022-07-06T06:36:32,0.296
USFDA inspection of company’s US plant completed successfully: Torrent Pharmaceuticals,https://www.financialexpress.com/business/healthcare-usfda-inspection-of-companys-us-plant-completed-successfully-torrent-pharmaceuticals-2381622/,2021-12-16T16:42:10+05:30,2021-12-16T11:12:10,0.4939
Buy these two stocks for near term gains as Nifty’s intermediate uptrend remains intact,https://www.financialexpress.com/market/cafeinvest-buy-these-two-stocks-for-near-term-gains-as-niftys-intermediate-uptrend-remains-intact-2246806/,2021-05-06T08:43:18+05:30,2021-05-06T03:13:18,0.4939
